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KIR CHANNELS IN CO2 CENTRAL CHEMORECEPTION:  
ANALYSIS WITH A FUNCTIONAL GENOMICS APPROACH  
by 
ASHEEBO ROJAS 
Under the Direction of Chun Jiang 
 
ABSTRACT 
 The process of respiration is a pattern of spontaneity and automatic motor control 
that originate in the brainstem. The mechanism by which the brainstem detects CO2 is 
termed central CO2 chemoreception (CCR).  Since the early 1960’s there have been 
tremendous efforts placed on identification of central CO2 chemoreceptors (molecules 
that detect CO2).  Even with these efforts, what a central CO2 chemoreceptor looks like 
remain unknown.  To test the hypothesis that inward rectifier K+ (Kir) channels are CO2 
sensing molecules in CCR, a series of experiments were carried out.  1)  The first 
question asked was whether the Kir4.1-Kir5.1 channel is expressed in brainstem 
chemosensitive nuclei.  Immunocytochemistry was performed on transverse medullary 
and pontine sections using antibodies raised against Kir4.1 and Kir5.1.  Positive 
immunoassays for both Kir4.1 and Kir5.1 subunits were found in CO2 chemosensitive 
neurons.  In the LC the Kir4.1 and Kir5.1 were co-expressed with the neurokinin-1 
receptor that is the natural receptor for substance P.   2)  The second question asked was 
whether the Kir4.1-Kir5.1 channel is subject to modulation by neurotransmitters critical 
for respiratory control.  My studies demonstrated that indeed the Kir4.1-Kir5.1 channel is 
 
 
 
 
subject to modulation by substance P, serotonin and thyrotropin releasing hormone. 3) I 
performed studies to demonstrate the intracellular signaling system underlying the 
Kir4.1-Kir5.1 channel modulation by these neurotransmitters. The modulation by all 
three neurotransmitters was dependent upon the activation of protein kinase C (PKC). 
The Kir4.1-Kir5.1 but not the Kir4.1 channel was modulated by PKC. Both the Kir4.1 
and Kir5.1 subunits can be phosphorylated by PKC in vitro. However, systematic 
mutational analysis failed to reveal the phosphorylation site.  4)  The fourth question 
asked was whether Kir channels share a common pH gating mechanism that can be 
identified.  Experiments were performed to understand the gating of the Kir6.2+SUR1 
channel as specific sites for ligand binding and gating have been demonstrated.  I 
identified a functional gate that was shared by multiple ligands that is Phe168 in the 
Kir6.2.  Other Kir channels appear to share a similar gating mechanism.  Taken together, 
these studies demonstrate the modulation of Kir channels in central CO2 chemoreception. 
 
INDEX WORDS: Kir4.1-Kir5.1, Kir6.2+SUR1, Central CO2 Chemoreception, 
Neuromodulation, Phosphorylation, Channel Gating, Ligand 
Modulation, CO2/pH sensing 
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F. SPECIFIC AIMS AND HYPOTHESES 
 
Central chemoreception, defined as the physiological response of the central 
nervous system to chemical stimuli (CO2 and H+) has been a puzzling area of medical 
science for the past 40-50 years. Although new information is constantly being produced 
in the literature about this topic, what a central chemoreceptor looks like remains elusive. 
Recent studies indicate that there are specific neurons in the brainstem that are CO2 
chemosensitive (Ballantyne & Scheid, 2001; Feldman et al., 2003; Nattie & Li, 2002; 
Paterson et al., 2006; Richerson et al., 2001). However, because of the diversity of cell 
types in the brainstem, the difficulty for finding the central chemoreceptor molecule has 
proven to be rather difficult. One approach to overcome this difficulty is to find 
molecules instead of cells, which are responsible for CO2 sensing, as proposed in our 
laboratory. Based on the criteria established recently by Jiang et al., 2001, a number of 
ion channels qualify as potential CO2/pH sensing candidates, i.e., various inward rectifier 
K+ channels (KIR), twik-related acid-sensitive K+ channels (TASK), and non selective 
cation channels such as transient receptor potential channels (TRP) and cyclic nucleotide 
gated channels (CNG). Immunocytochemistry and in situ hybridization studies have 
proposed the existence of members of these channel families in brainstem neurons. The 
brainstem neuronal expression of these channels may implicate an involvement in central 
CO2 chemoreception. In addition to brainstem expression these potential candidates 
satisfy other properties that are required of central CO2 chemoreceptors such as a high 
sensitivity to CO2/pH and an ability to detect both alkaline and acidic pH levels. 
Although many of these channels meet the criteria, the inward rectifier K+ (Kir) channels 
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are leading candidates because there is evidence showing that certain intrinsic Kir 
channel properties are detected in known chemosensitive neurons during changes in CO2 
(Kawai et al., 2006; Pineda & Aghajanian, 1997; Schultz et al., 2003). One major finding 
from studies involving these Kir channels is that they have the ability to change cellular 
excitability (Cui et al., 2001; Isomoto et al., 1997; Nichols & Lopatin, 1997). This is 
important because central CO2 chemoreception involves a change in neuronal excitability, 
such as a depolarization of brainstem chemosensitive neurons resulting in an increase in 
the firing rate of these neurons when challenged with acidosis. Over the past decade a 
number of Kir channels suggested to play a role in central CO2 chemoreception have 
declined because they fail to satisfy most or all of the requirements of a central CO2 
chemoreceptor. The heteromeric Kir4.1-Kir5.1 channel and the KATP channel (composed 
of Kir6.2/SUR1) remain strong candidates for a major involvement in central CO2 
chemoreception. However, even with extensive in vitro electrophysiological and protein 
modification studies carried out on these channels their neuronal specific function has not 
been elucidated. Therefore, a neuron-specific functional genomics approach is important 
because this may eventually lead to an identification of the long-searched central CO2 
chemoreceptors. However, it is not clear whether the Kir4.1-Kir5.1 protein is expressed 
in chemosensitive brainstem nuclei; whether the Kir4.1-Kir5.1 channel is modulated by 
neurotransmitters critical for respiratory control; what intracellular signaling mechanisms 
account for the modulation; and whether Kir6.2 modulation by ATP is important for 
central chemoreception. To address the issue of the Kir4.1-Kir5.1 and Kir6.2 channels 
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being central CO2 chemoreceptors, I have designed experiments to target four specific 
aims: 
 
A. To demonstrate the expression of the heteromeric Kir4.1-Kir5.1 channel 
protein in chemosensitive brainstem nuclei. 
B. To show the modulation of the Kir4.1-Kir5.1 channel by 
neurotransmitters critical for respiratory control.  
C. To elucidate the molecular basis for the modulation of the Kir4.1-Kir5.1 
channel by neurotransmitters. 
D. To understand a general gating mechanism shared by the Kir channels 
and its effect on CO2 central chemoreception.  
 
The following hypotheses will be tested: 
 
1. The Kir4.1-Kir5.1 channel protein is expressed in the plasma membrane of 
chemosensitive neurons in the brainstem where it is co-localized with the 
natural receptor for the neurotransmitter Substance-P (NK1R).  
 
2. The Kir4.1-Kir5.1 channel is modulated by the neurotransmitters substance-
P, serotonin, and thyrotropin releasing hormone, where channel activity is 
reduced by receptor activation via a protein kinase C-dependent mechanism. 
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3. Kir4.1-Kir5.1 channel activity is reduced by PKC activation and channel 
phosphorylation and such a regulation requires the presence of the Kir5.1 
subunit. 
 
4. Kir6.2+SUR1 channel gating involves a bulky phenylalanine residue located 
at the narrowest sector of the ion conductive pore where it allows the 
channel to affect cellular excitability. 
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G. BACKGROUND 
 
The ability to respire (breathe) is a basic fundamental function for human 
survival. Respiration can simply be defined as the process of gas exchange within the 
body.  The final goal of respiration is to maintain adequate concentrations of O2, CO2, 
and hydrogen ions in the body. It is fortunate therefore, that changes in the levels of these 
three molecules or any of the three results in increase respiratory activity to regulate the 
changes. When we breathe, we consume O2 during inhalation and liberate CO2 during 
exhalation. This exchange of gases is the respiratory system's means of getting O2 to the 
blood where it is then delivered to all regions of the body by red blood cells. Unlike O2, 
during metabolic processes CO2 is produced by the tissues of the body. It enters the 
vascular system where it is transported to the lungs so it can be expired. For this gas 
exchange process to be effective and efficient there has to be mechanisms in the body for 
the constant detection of the levels of O2 and CO2 that are present. O2 sensing and 
detection is carried out mainly by peripheral chemoreceptors, whereas CO2 sensing is 
mainly carried out by central CO2 chemoreceptors located within the brainstem (Donnelly 
& Carroll, 2005; Lahiri & Forster, 2003; Lahiri et al., 2006; Nattie, 1999; O'Regan & 
Majcherczyk, 1982). O2 does not have a significant direct effect on the respiratory center 
of the brain. Instead O2 acts on the peripheral chemoreceptors which were found to be 
located in the carotid and aortic bodies in the base of the neck (Lahiri et al., 2006). The 
effect of O2 on the carotid and aortic bodies is transmitted to the respiratory center in the 
brainstem via nerves. The information then travels from the respiratory center to the 
respiratory muscles.  Changes in CO2 stimulate the respiratory center in the brain directly 
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resulting in increases in both inspiratory and expiratory drive that are transmitted to the 
respiratory muscles, thus affecting ventilation. Indirectly, changes in CO2 are also 
detected by peripheral chemoreceptors via a change in arterial pH similar to O2 sensing 
 
Fig. G-1.  A schematic demonstrating the flow of information in the respiratory system when 
ventilation is reduced and CO2 is increased. 
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(Fig. 1).  
Although the brainstem contains the respiratory center that is responsible for 
generating the involuntary respiratory rhythm, our conscious though processes also affect 
respiration.  Higher brain centers such as the cerebrum and hypothalamus may send 
signals to the respiratory center and alter the activity of the central pattern generator 
leading to a change in ventilation.  These higher brain centers, although can affect and 
modulate respiratory drive are not necessary for respiration as experiments in animals 
with severe damage to higher brain areas demonstrate normal breathing. It is also known 
that respiration is affected by emotional processes such as fear and excitement.  Under 
these conditions the neural pathway may bypass the central pattern generator in the 
brainstem and go directly to the somatic motor neurons that innervate respiratory 
muscles.  No matter what information is sent to the respiratory center the chemoreceptor 
reflex is still dominant.  We cannot override the chemoreceptor reflex although 
consciously we can alter our respiratory output.  No matter how long we hold our breath 
voluntarily the increased PCO2 in our system will activate the chemoreceptor reflex and 
we will be forced to breath.  Therefore, the strong CO2 stimulus cannot be ignored. 
 
G-1. Central CO2 chemoreception 
 
The process by which the respiratory center in the brainstem detects CO2 is 
termed central CO2 chemoreception (CCR). Central CO2 chemoreception is an important 
process in the maintenance of brain function. The brain tightly monitors changes in pH in 
both acidic and alkaline directions. The presence of the blood-brain barrier does not allow 
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H+ to get from the periphery of the body into the brain. However, CO2 can cross the 
blood-brain barrier. Gaseous CO2 is recognized as the molecule that diffuses across the 
blood-brain barrier, but pH is the actual stimulus that elicits a response by chemosensing 
neurons leading to a change ventilation (Erlichman & leiter, 1997; Feldman et al., 2003; 
Jiang et al., 2001; Kawai et al., 2006; Lahiri & Forster, 2003; Lahiri et al., 2006; 
Lamanna, 2003; Nattie et al., 2002; Sugama et al., 1997). This leads to the question:  
What is the relationship between CO2 and H+?  Gaseous CO2 in the presence of the 
enzyme carbonic anhydrase is rapidly hydrated by water to form carbonic acid. Carbonic 
acid dissociates into a proton and bicarbonate ion.  The rate limiting factor in this reaction 
is the enzyme carbonic anhydrase.  This enzyme allows for the extremely rapid 
conversion of gaseous CO2 to carbonic acid. 
 
Fig. G-2.  Diagram showing the relationship between CO2 and H+. 
 
 
Therefore, increases in CO2 (hypercapnia) physiologically result in very rapid increases 
in hydrogen ions. The increase in hydrogen ions results in a decrease in pH (acidosis). 
Although pH is the accepted stimulus that elicits a ventilatory response, it is still possible 
that some central chemoreceptors can detect CO2 directly. This possibility cannot be 
completely excluded although there is no evidence supporting this idea.  
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G-2. Inability to identify the central CO2 chemoreceptor 
 
Unfamiliarity with the research conducted in the field of central CO2 
chemoreception may lead someone to the conclusion that the field is long on problems 
and short on solutions. Although this conclusion would be false, it is justified due to the 
inability of many researchers over a long period of time to detect and characterize the 
central chemoreceptor which is the molecule responsible for detecting changes in CO2 
within the brainstem. Although researchers have been unable to find the long searched for 
chemoreceptor molecule, many breakthroughs and accomplishments have occurred over 
the last 50-60 years within this field. For example, one important finding involving 
central chemoreception over the past decade has been the role of the brainstem in CO2 
chemoreception (Coates et al., 1993; Feldman et al., 2003; Lamanna et al., 2003; Nattie, 
2000;). The discovery that the brainstem is the area of the brain responsible for pH 
chemosensitivity is no longer controversial. However, although the location of the 
modulation of breathing in the brain is known (respiratory center in the brainstem), 
exactly how CO2 and pH can be detected by this area to generate a pattern of breathing 
remains elusive and is an area of interest. With the knowledge of the brainstem’s role in 
chemoreception researchers tried to detect specific cells in this region of the brain that are 
potential candidates for sensing changes in CO2 and pH and coupling this sensing to a 
ventilatory response.  
G-3. Various CO2 chemosensitive nuclei within the brainstem 
 
The search for chemosensitive neurons within the brainstem has led to the 
identification of many CO2 chemosensitive nuclei within the brainstem. These 
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chemosensitive nuclei share several common features. For example, the level of C-fos 
(the gene that encodes the nuclear protein FOS) increases in these areas when challenged 
with CO2 (Anton et al., 1991; Haxhiu et al., 1996; Ribas-Salgueiro et al., 2006; Sato et 
al., 1992).  Also, individual neurons in these nuclei exhibit CO2 chemosensitivity in vitro 
as measured by their firing activity (Dean et al., 1989; Dean et al., 1990; Guyenet et al., 
2005a; Guyenet et al., 2005b; Li & Nattie, 2006; Richerson et al., 2005; Severson et al., 
2003; Sugama et al., 1997).  And, focal acidification of these chemosensitive nuclei 
stimulates breathing in vivo (Budzinska et al., 1985; Hodges et al., 2004a; Hodges et al., 
2004b; Li & Nattie, 1997; Li et al, 2006; Nattie et al., 1991; Nattie & Li, 1994; Nattie & 
Li, 2002a; Nattie & Li, 2002b; Taylor et al., 2005; Wenninger et al., 2004). In addition to 
this, neurons in some chemosensitive nuclei have been shown to detect changes in 
intracellular CO2 and pH resulting in changes in membrane excitability (Kawai et al., 
2006; Lahiri & Forster, 2003; Nattie, et al., 2002; Sugama et al., 1997).  
For much of the history of CCR it was believed that the central chemoreceptors 
were located on the ventral surface of the medulla in an area known as the ventral lateral 
medulla (VLM). The VLM is now believed to be the area where the central pattern 
generators for respiration are located (Solomon, 2003a; Solomon, 2003b; Wu et al, 2005; 
Guyenet et al., 2005). In addition to the VLM we now know that there are chemosensitive 
sites located throughout the brainstem. Such nuclei as the nucleus tractus solatarius 
(NTS), the retrotrapezoid nucleus (RTN), nucleus paragigantocellularis, midline raphé 
nuclei in the medulla and midbrain, ventral respiratory column, area postrema, nucleus 
ambiguous, etc, have all been demonstrated to be CO2 chemosensitive nuclei (Dean et al., 
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1989; Dean et al., 1990; Guyenet et al., 2005a, Guyenet et al., 2005b; Hodges et al., 
2004a; Hodges et al., 2004b; Li & Nattie, 1997; Li et al., 2006; Miura et al., 1998; Nattie 
et al., 1991; Nattie et al., 1994; Nattie & Li, 2002). There are even CO2 chemosensitive 
nuclei within the dorsal pons such as the locus coeruleus (LC) nucleus and the Kolliker 
Fuse nucleus (Li & Nattie, 2006; Mizusawa et al., 1995; Pineda & Aghajanian, 1997). All 
of these chemosensitive nuclei have been classified into three groups that are the ventral 
respiratory group (VRG), the dorsal respiratory group (DRG), and the pontine respiratory 
group (PRG) (Fig. 3). The identification of these multiple chemosensitive nuclei located 
throughout the brainstem has raised the question; why are there so many CO2 
chemosensitive sites within the brainstem? One potential explanation is perhaps these 
chemosensitive sites are communicating with each other allowing for fine tuning of the 
respiratory system. Or, maybe these various sites allow for integration between the 
respiratory system and other neuronal systems. These multiple CO2 chemosensitive sites 
may be involved in the control of breathing, cardiovascular regulation, and other 
sympathetic functions such as hypercapnia-induced arousal, anxiety and aggression. The 
exact reason there are so many chemosensitive sites within the brainstem is not known.  
However, all of these CO2 chemosensitive nuclei appear to be important for the whole 
body response to changes in CO2 as ablation of these sites individually results in impaired 
respiration in animals. 
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Fig. G-3.  Brainstem anatomy demonstrating the location of the various respiratory groups.  A.  
Ventral view of the brainstem.  B.  Dorsal view of the brainstem.  C, D, E.  Representative 
transverse sections taken at different locations of the respiratory groups.  PRG=pontine 
respiratory group, DRG=dorsal respiratory group (medulla), VRG=ventral respiratory group 
(medulla). (Nattie, 1999) 
 
 
G-4. The involvement of neurotransmitter systems in central CO2 chemoreception 
 
 Recently, the importance of neurotransmitter systems in central CO2 
chemoreception has been under intense investigation. One reason for this is that there 
must be amplification of the stimulus during central CO2 chemoreception. There is a 
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significant discrepancy in central CO2 chemoreception. This discrepancy stems from 
results obtained from experiments conducted in vitro versus those that were conducted in 
vivo.  Based on the results from in vivo experiments none of the potential chemoreceptor 
candidates studied thus far demonstrates a CO2/pH sensitivity that is required of a central 
CO2 chemoreceptor molecule in vivo. The central CO2 chemoreceptor molecule should 
possess the capability to detect very minute changes in CO2. A change in pCO2 as low 
1mm Hg is sufficient enough to produce a 20-30% change in ventilation (Nattie, 1999; 
Putnam et al., 2004). No molecule identified to date demonstrates such sensitivity to 
CO2/pH. Therefore, perhaps there is amplification of the signal in central CO2 
chemoreception.  The involvement of neurotransmitter systems in this process may allow 
for amplification of the signal. Indeed, several neurotransmitters have been shown to be 
important for respiratory control. Different approaches have been used to demonstrate the 
importance of neurotransmitters in the control of respiration. The neurotransmitters 
substance P (SP), serotonin (5-HT), thyrotropin releasing hormone (TRH), GABA, and 
glutamate have all been shown to be important for respiratory control (Bonham, 1995; 
Chen et al., 1990; Nattie & Li, 2002; Nink et al., 1991a; Nink et al., 1991b; Severson et 
al., 2003; Taylor et al., 2005; Vonhof et al., 1991). Site-specific injections of these 
neurotransmitters in chemosensitive nuclei potently augment or suppress ventilation 
frequency (Chen et al., 1990; Li et al., 2006; Messier et al., 2002; Nink et al., 1991a; 
Nink et al., 1991b). Researchers have also site-specifically killed neurons containing 
receptors for some of these neurotransmitters and assayed to determine whether the 
animal’s ventilatory response to CO2 was the same or compromised (Hodges et al., 2004; 
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Nattie et al., 1991; Nattie & Li, 1994; Nattie & Li, 2002). Site specific lesions of neurons 
containing the neurokinin-1 receptor (NK1R), the natural receptor for SP, using a 
saporin-SP conjugate (SAP-SP) compromised the ventilatory response in rats challenged 
with CO2 (Hodges et al., 2004; Nattie & Li, 2002; Wenninger et al., 2004). In these 
experiments SP guides the toxin saporin to neurokinin receptor positive neurons.  Once 
substance P binds to the receptor the SAP-SP is internalized and the toxin kills the 
neurons. The technique has been shown to be very effective for site-specific lesioning of 
nuclei within the brainstem. Experiments have also been carried out to show the 
importance of neurons that produce the neurotransmitter serotonin in central CO2 
chemoreception (Hodges et al., 2004; Richerson et al., 2005; Severson et al., 2003; 
Taylor et al., 2005). The finding that neurotransmitters such as serotonin, substance-P and 
thyrotropin releasing hormone are involved in and are critical for the control of 
respiration suggests that they may play a role in the amplification of the CO2/pH signal. 
This idea is further strengthened by the demonstration that the receptors for the 
neurotransmitters, SP, 5-HT, and TRH are G-protein coupled receptors (GPCR). Ligand 
binding to these receptors activates a guanine nucleotide binding protein (G-protein) 
which in turn leads to the activation of multiple second messenger cascades. One such 
activation cascade involves activation of phospholipase-C β that cleaves 
phosphatidylinositol bisphosphate (PIP2) into inositol triphosphate (IP3) and 
diacylglycerol (DAG). The PIP2 derivative, DAG, activates protein kinase C (PKC) and 
IP3 increases intracellular calcium which is also often necessary for PKC activation. The 
G-protein involved in this activation cascade is Gαq. Interestingly, there are receptor 
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subtypes for SP, 5-HT, and TRH that are coupled to Gαq. This Gαq signaling cascade may 
lead to the amplification of the signal as many intracellular messengers are activated 
following ligand binding to Gαq coupled receptors. 
G-5. Potential chemoreceptor candidates 
 
According to Jiang et al., 2001 there are at least four requirements for a molecule 
to be considered a possible central CO2 chemoreceptor.  Based on experimental 
observations the central CO2 chemoreceptor molecule should:  1) be highly sensitive to 
CO2/pH changes within the physiological range; 2) it should be able to detect CO2/pH 
changes in both acidic and alkaline (hypercapnic or hypocapnic) directions; 3) it should 
be able to couple the variation in CO2/pH to a change in neuronal membrane excitability 
(depolarization or hyperpolarization); and 4) it should be expressed in CO2 
chemosensitive sites within the brainstem. Of these four requirements the last one is 
arguably the most important for limiting the number of potential chemoreceptor 
candidates. However, based on the criteria above a number of molecules can be 
considered possible CO2 chemoreceptors. Amongst the different membrane proteins ion 
channels receive the most consideration as central CO2 chemoreceptors because, ion 
channels posess qualities necessary for central CO2 chemoreception that are lacking in 
other membrane proteins, such as an ability to rapidly change cellular excitability.  The 
list of ion channels considered potential chemoreceptor molecules include inward 
rectifier K+ (Kir) channels, twik-related acid-sensitive K+ (TASK) channels, gap junction 
channels, voltage activated K+ channels, and several non-selective cation channels such 
as cyclic nucleotide gated (CNG) channels  and transient receptor potential (TRP) 
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channels. Some of these channel families contain several potential candidates, making 
this list very long.  None of the ion channels studied thus far have been shown to be the 
central CO2 chemoreceptor. These channels however are all still candidates for different 
reasons. For example, some ion channels such as TASK channels are sensitive to 
CO2/pH, but these channels are expressed abundantly throughout the brain suggesting a 
more universal role in neuronal functional than a specific role in central CO2 
chemoreception. The finding that a large number of ion channels can detect CO2/pH has 
raised the question: Why are there so many potential CO2/pH sensing molecules? 
Perhaps, there is more that one central CO2 chemoreceptor molecule and potentially they 
work together to detect changes in CO2. Indeed, we know that in addition to the 
requirement for high CO2 sensitivity discussed in the previous section, the central 
chemoreceptor molecule should be able to detect a wide range of CO2 changes. In 
humans the partial pressure of CO2 (PCO2) can range from ~40 mmHg to ~80 mmHg. To 
date no known molecule possess the ability to cover such a wide range of CO2 changes. 
The use of multiple molecules to detect a wide range of stimuli can be found in other 
homeostatic systems. For example, temperature sensing and transduction has been shown 
to be carried out by multiple molecules many of which are transient receptor potential 
channels (Caterina et al., 1999; Jiang et al., 2005; Story et al., 2003; Watanabe et al., 
2002; Xu et al, 2002). Perhaps, central CO2 chemoreception has adopted a similar 
mechanism.  This idea is becoming more and more popular with researchers in the field 
of central CO2 chemoreception. 
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G-6. Kir channels as potential chemoreceptor molecules 
 
Inward rectifier K+ channels are key players in the maintenance of membrane 
excitability and the control of intracellular as well as extracellular K+ homeostasis 
(Baukrowitz et al., 1999; Jan & Jan, 1997; Nichols & Lopatin, 1997; Oliver et al., 2000; 
Reimann & Ashcroft, 1999). In addition to satisfying criteria necessary for a central CO2 
chemoreceptor, the Kir channels demonstrate an additional characteristic that makes them 
strong candidates as sensing molecules, which is their involvement in setting the resting 
membrane potential (Baukrowitz et al., 1999; Nichols & Lopatin, 1997; Oliver et al., 
2000). This characteristic allows these channels to directly alter cellular excitability. 
Unlike other K+ channels, Kir channels conduct inward currents more readily than 
outward currents through a process known as “rectification”. The property of inward 
rectification makes these Kir channels unique potassium channels (Fig. 4A). The K+ 
channel family is one of the largest ion channel family. Within this super-family there are 
several sub-families. Currently, there are more than 70 cloned mammalian K+ channels. 
Amongst the numerous K+ channel sub-families the Kir channel family is the largest, 
containing the most members.  In the Kir channel family there are seven sub-families, 
i.e., Kir1 (ROMK), Kir2 (IRK), Kir3 (GIRK), Kir4, Kir5, Kir6 and Kir7 (Fig. 4B). 
Totally, there are more than 15 functional Kir channels.  
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Fig. G-4.  Diagram showing rectification in Kir channels and the Kir channel family tree.  A.  
Current-voltage relationship observed in Kir channels.  These are representative currents recorded 
from Kir channels in a high extracellular potassium environment.  The red trace represents 
currents from a strong rectifier and the blue represents currents from a weak rectifier.  Note that at 
positive membrane voltages the current changes direction (rectification).  B.  Phyllogenetic tree of 
Kir channels.  The channels highlighted in blue are the channels discussed in this thesis. (Nichols 
& Lopatin, 1997) 
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Kir channels have a unique architecture. Each channel is composed of four 
subunits arranged in a tetrameric fashion (Fig. 5A, B). Each subunit is composed of two 
transmembrane spanning domains (TMD1, TMD2) that are joined by a pore loop and 
selectivity filter (H5) with intracellular N and C termini (Fig. 5C). The H5 (pore) contains 
a “TIGYG” motif that determines the selectivity for K+. The N-termini in Kir channels 
are shorter (consisting of ~80 residues) than the C-termini (consisting of ~200 residues). 
Both termini have been shown to contain ligand binding and gating sites. 
 
Fig. G-5.  Kir channel structure.  A, B.  Structural representation of a typical Kir channel viewing 
from outside-in and from inside-out, respectively in a tetrameric arrangement.  C.  Diagram 
showing the architecture of one Kir channel subunit cross-sectioned through the plasma 
membrane. (Doyle et al., 1998) 
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Kir channels are functional in a number of specialized tissues such as the heart, 
brain, pancreas, skeletal muscle, testis, and kidney (Cuevas et al., 1991; Doi et al., 1996; 
Donley et al., 2005; Doring et al., 1998; Haller et al., 2001; Jiang et al., 2001; Karschin et 
al., 1998; Karschin & Karschin, 1997; Karschin et al., 1997; Lagrutta et al., 1996; Quayle 
et al., 1997; Salvatore et al., 1999; Vivaudou & Forestier, 1995; Wu et al., 2004). 
Although some Kir channels such as the Kir6.2 can be found in a variety of tissues, 
others such as the Kir1.1 and Kir7.1 are more localized to specific areas. The various Kir 
channels are regulated by a number of intracellular ligands such as ATP, PIP2, proton, G-
proteins, etc (Baukrowitz et al., 1999; Baukrowitz & Fakler, 2000; Cui et al., 2001; Doi 
et al., 1996; Jan & Jan, 1997; Matsuo et al., 2005; Nichols & Lopatin, 1997; Oliver et al., 
2000; Quayle et al., 1997; Reimann & Ashcroft, 1999; Takano & Kuratomi, 2003). The 
ligand modulation of each Kir channel is specific for that channel. For example, only the 
Kir6 channels are sensitive to intracellular ATP. This property allows these Kir6x 
channels to couple the cellular metabolism to cellular excitability. The Kir6 family 
members are also the only Kir channels that associate with the sulphonylurea receptor 
(SUR) to form fully functional channels that are sensitive to ATP and ADP (Baukrowitz 
& Fakler 2000; Karschin et al., 1998; Karschin et al., 1997; Matsuo et al., 2005; 
Mikhailov et al., 2000; Moreau et al., 2005). Together the Kir6 and the SUR families 
form the KATP channel whose arrangement is based on a tetrameric structure with a 1:1 
ratio of Kir to SUR. In the KATP channels the Kir6 subunits forms the center of the 
channel (pore) and the SUR subunits are regulatory subunits that surround the Kir6 
subunits. 
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In addition to the homomeric channels, there are also several heteromeric Kir 
channels that exist as well. The heteromeric combinations increase the number of 
members in the Kir channel sub-family. One such interesting heteromeric channel is the 
Kir4.1-Kir5.1 channel. This channel is a unique Kir channel for several reasons. The 
Kir4.1-Kir5.1 channel is formed by the heteromultimerization of two inter-subfamily 
members (Kir4.1 and Kir5.1). In this channel there are two Kir4.1 subunits and two 
Kir5.1 subunits arranged in a “trans” configuration. The heteromultimerization of 
different proteins typically generates a new protein with unique properties and a 
specialized function. Indeed, this has been found to be the case for the Kir4.1-Kir5.1 
channel. Although the Kir4.1 channel functions homomerically and exist in nature, its 
properties are very different than those of the heteromeric Kir4.1-Kir5.1. On the other 
hand, the Kir5.1 channel is the only Kir channel cloned with no identified homomeric 
function. The Kir5.1 is believed to only exist as a heteromer with members in the Kir4 
sub-family. This is puzzling to researchers because as previously mentioned the Kir4.1-
Kir5.1 heteromer has several different characteristics than the Kir4.1 suggesting that two 
Kir5.1 subunits are enough to function, however, four is not. This has led to intense 
investigation into the function of the Kir5.1 protein. Many researchers have tried to 
express this protein in vitro using heterologous systems. Unfortunately, detectable Kir 
currents are never identified although protein expression experiments show the presence 
of the Kir5.1 protein in the cells. Therefore, it is currently believed that this channel can 
only function as a heteromer with Kir4.1 or Kir4.2. 
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The heteromeric interaction of Kir4.1 and Kir5.1 produces a channel with distinct 
properties. The Kir4.1-Kir5.1 channel has increased pH sensitivity with a pKa at 7.35 
(Yang et al., 2000). The channel also has distinct biophysical properties such as 
conductance, Popen, sensitivity to barium, and activation kinetics (Yang et al., 2000). The 
Kir4.1-Kir5.1 is considered a strong candidate sensing molecule for central CO2 
chemoreception because of its ability to satisfy the requirements of a central CO2 
chemoreceptor in addition to its fine tuned pH sensitivity (Cui et al., 2001; Xu et al., 
2000; Yang et al., 2000). This channel is able to detect both hypocapnia and hypercapnia 
and couple this sensing to a change in membrane excitability (Cui et al., 2001). The role 
of the Kir4.1-Kir5.1 in central CO2 chemoreception may be to detect changes in CO2/pH 
and change the firing rate of respiratory neurons via membrane excitability. An increase 
in the firing rate of respiratory neurons from baseline is generated by a depolarization that 
causes the neurons to fire more action potentials, whereas a decrease in the firing rate of 
respiratory neurons is typically generated by hyperpolarization that can cause neurons to 
become silent firing fewer action potentials. Figure 6 show that the Kir4.1-Kir5.1 channel 
has a sigmoid response to pHi with a pKa at 7.35.  This allows the channel to detect both 
acidic and alkaline pH levels with acidic pH levels inhibiting the channel and alkaline pH 
levels stimulating the channel, as such, the channel may be involved in both the 
augmentation and supression in the firing rate of respiratory neurons. Inhibition of the 
Kir4.1-Kir5.1 channel by slight acidosis may lead to augmentation of the firing frequency 
whereas stimulation of the channel by slight alkalization may lead to reduction of the 
firing frequency of respiratory neurons. Although previous in vitro studies with the 
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Kir4.1-Kir5.1 demonstrated its potential as a CO2 chemoreceptor molecule, it’s identity 
as a central CO2 chemoreceptor molecule remains to be proven. This is mostly due to the 
lack of information regarding the expression level of this channel in the chemosensitive 
sites within the brainstem. Evidence for the expression of the heteromeric Kir4.1-Kir5.1 
channel in brainstem neurons will strengthen its candidacy as a chemoreceptor molecule. 
However, a clear demonstration of the role played by this channel in central CO2 
chemoreception is necessary for the identification of this channel as one of the long 
searched for chemoreceptor molecules. 
The Kir6.2 channel expressed with the SUR1 receptor has been shown to be 
expressed in several tissues including the brain. This KATP channel has been shown to 
be present in brainstem neurons at mRNA and protein levels (Haller et al., 2001; 
Karschin et al., 1998; Karschin et al., 1997). These important findings suggest that this 
channel may function in these neurons as the level of expression is not low. Several 
reports have suggested that during the process of central CO2 chemoreception 
intracellular ATP levels decrease and appear to regulate an ATP sensitive K+ channel 
(Gourine et al., 2003; Gourine, 2005; Haller et al., 2001). The level of intracellular ATP 
is critical for the regulation of the Kir6.2/SUR1 channel. An increase in intracellular ATP 
inhibits this channel whereas a decrease in ATP stimulates the channel activity. This 
channel contains ATP binding sites in the Kir6.2 and ATP/ADP binding sites in the 
SUR1 subunits. In the Kir6.2 the ATP binding sites are located in the N and C-termini 
where they form a three dimensional pocket for the binding of ATP (Cukras et al., 2002; 
Drain et al., 1998; Wu et al., 2002). Experiments performed on the Kir6.2 channel (in the 
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absence of the SUR1) demonstrated that the Kir6.2 channel is inhibited by high 
concentrations of ATP whereas the SUR1 is regulated by ATP and ADP.   
Unlike the other Kir channels the Kir6.2 channel is activated by intracellular 
acidosis. When the channel current is plotted as a function of intracellular pH the channel 
shows a bell shaped response curve to acidosis (Fig. 6). Slight acidification activates the 
channel whereas strong acidification leads to channel inhibition. Alkalization also 
inhibits this channel. Independent of changes in intracellular ATP, acidification of a 
respiratory neuron may activate the Kir6.2 channel leading to a hyperpolarization of the 
cell. Although depolarization is seen in many chemosensitive neurons in response to 
acidosis, hyperpolarization of an inhibitory presynaptic motor neuron may release this 
neuron’s inhibition and allow firing of the postsynaptic cell. However, when considering 
the function of the KATP channel the regulation by ATP has to be considered as ATP is a 
major modulator of the channel. In the situation where there is a change in intracellular 
ATP during acidosis, the pH sensitivity of the channel may be changed. Indeed, it has 
been shown that ATP and H+ have allosteric effects on the Kir6.2/SUR1 channel. This 
characteristic gives this channel an advantage over other potential central CO2 
chemoreceptor molecules as the concentrations of ATP and H+ that change during central 
CO2 chemoreception may convert on the same molecule. However, the identification of 
this Kir6.2/SUR1 channel as a chemoreceptor molecule remains to be proven. Therefore, 
a clear demonstration of the role played by this channel is also necessary for the 
identification of this channel as one of the long searched chemoreceptor molecules. 
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Fig. G-6.  pH sensitivity of the various Kir channels.  A.  The channel current (I) is plotted as a 
function of intracellular pH.  Most Kir channels are inhibited by intracellular acidosis.   B.  The 
Kir6.2 channel shows a bi-phasic response to intracellular acidification.  The asterisks show the 
shift in the pH sensitivity of the Kir4.1 versus the Kir4.1-Kir5.1 channel.  The blue bar represents 
an intracellular pH of 7.4 that is close to neutral. (Jiang et al., 2001; Xu et al., 2001)
A 
B 
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G-7. The molecular basis for CO2/pH sensing 
 
The ability to detect pH is carried out by the titration of amino acids in the 
primary sequence of the proteins. There are only a few amino acids that are titratable (i.e. 
histidine, lysine, apartate, etc). Among the titratable amino acids only histidine is 
titratable at or near physiological levels. Although lysine has been demonstrated as a 
titratable residue in some pH sensing proteins, the titration of histidine appears to be 
much more common. The detection of elevated levels of protons resulting in the titration 
of amino acids is not sufficient for central CO2 chemoreception. As discussed earlier, the 
central CO2 chemoreceptor molecule has to have the ability to change cellular 
excitability. Therefore, following titration of the amino acid histidine, there has to be a 
coupling between the sensing and the effect. In ion channels this is done through a 
mechanism called “channel gating”.  
Gating refers to the opening and closure of ion channels. The mechanism for 
channel gating is poorly understood. The gating mechanism of a channel would allow for 
or reduce the flow of ions through the channel resulting in a change in cellular 
excitability. Ligand binding in ion channels leads to a change in the gating conformation 
of the channel through a “binding-gating” coupling mechanism. Therefore, the 
demonstration of the gating mechanism of a potential chemoreceptor candidate channel 
may lead to an understanding of the role played by this channel in central CO2 
chemoreception and how this molecule may lead to a change in cellular excitability. 
Clearly, in order to demonstrate that a molecule is a central CO2 chemoreceptor, 
experiments should be performed indicating that the whole body response to changes in 
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CO2/pH is compromised in the absence of this molecule and is restored in its presence.   
This is usually done by the genetic manipulation of the gene of interest.  However, before 
experiments can be performed involving genetic manipulations of a gene, there should be 
a clear demonstration of the basic properties of the gene product.  In this way the removal 
of the gene and its by-product can be analyzed thoroughly.  Therefore, the identification 
of Kir channels in chemosensitive brainstem neurons in addition to a demonstration of 
the modulation by neurotransmitters and CO2 combined with an identification of the 
channel gating mechanism may correlate a particular protein such as a Kir channel with 
central CO2 chemoreception and help to solidify the identification of the long sought after 
CO2 chemoreceptor molecule.  
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H. SIGNIFICANCE 
 
H-1. The problem and its clinical relevance 
 
Since the early 1960’s there have been tremendous efforts placed on identification 
of central CO2 chemoreceptors. The widespread interests can be attributed to several 
medical complications associated with CO2 detection.  The ability to sense and regulate 
CO2/pH has been found to be linked to diseases such as sleep apnea as well as sudden 
infant death syndrome (SIDS). Another specific disease that is caused by the central 
chemoreceptors inability to sense changes in CO2 is Central Congenital Hypoventilation 
Syndrome (CCHS). CCHS is a human condition recognized within the first year of life in 
which central chemoreceptors are absent or malfunctional. These children breathe 
normally during the day. The problem arises at night when they are asleep. In order to 
survive during the night some sort of ventilation support is needed. Although there is a 
change in the response to hypoxia, the most dramatic and consistent abnormalities are the 
result of the loss of CO2 chemosensitivity. There is a high incidence of death amongst 
children diagnosed with CCHS. In the normal population the increased respiratory drive 
response to the build up of CO2 during a stoppage of ventilation of blockage of the lung 
airways is still poorly understood.  The molecular mechanism for the detection of 
CO2/pH under normal and pathophysiological conditions remains elusive.  Therefore it is 
imperative to understand the molecular basis of central CO2 chemoreception. 
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H-2. Why study the Kir4.1-Kir5.1 and Kir6.2+SUR1 channels? 
 
While several Kir channels are recognized as potential chemoreceptors, the 
Kir4.1-Kir5.1 and Kir6.2+SUR1 channels are arguably the strongest candidates for 
central chemoreception. The Kir4.1-Kir5.1 is probably the strongest candidate amongst 
the Kir channels. This is mostly attributed to the fact that the Kir4.1-Kir5.1 channel 
satisfies the criteria required for a central CO2 chemoreceptor molecule. The Kir4.1-
Kir5.1, unlike any other Kir channels, has a pKa at 7.35 that allows it to detect both 
alkaline and acidic pH levels within the physiological range (Cui et al., 2001; Yang et al., 
2000). This property is a result of the heteromultimerization of these two Kir channel 
subfamily members (Kir4.1, Kir5.1). However, the candidacy of the Kir4.1-Kir5.1 
channel is weakened by the lack of information regarding its expression in 
chemosensitive brainstem nuclei. A demonstration of neuronal brainstem expression of 
the heteromeric Kir4.1-Kir5.1 channel may solidify a role of this channel in central CO2 
chemoreception. 
Most of the focus placed on Kir6.2+SUR1 has been to understand its role in 
insulin secretion. However, immunocytochemistry and in situ hybridization studies have 
revealed high levels of expression of Kir6.2 and SUR1 in the brainstem (Haller et al., 
2001; Karschin et al., 1998; Karschin et al., 1997). In addition to its expression in the 
brainstem, it is suggested that during the process of central CO2 chemoreception 
intracellular ATP levels change and this change may regulate an ATP sensitive potassium 
channel (Gourine et al., 2003; Gourine, 2005).  
 
 
30 
 
Since both the Kir4.1-Kir5.1 and the Kir6.2+SUR1 channels are strong CO2/pH 
chemoreceptor candidates, a clear demonstration of their function may answer questions 
lurking in the field of central CO2 chemoreception and respiratory control.  Although 
genetic manipulation will eventually solidify these channels as CO2 chemoreceptors, 
prior experiments are necessary to strengthen their candidacy.  In this thesis, a series of 
experiments was proposed to elucidate the role played by Kir channels (Kir4.1-Kir5.1, 
Kir6.2/SUR1) in central CO2 chemoreception using a combined electrophysiological and 
molecular biological approach.  
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I. MATERIALS AND METHODS 
 
I-1. Xenopus Oocyte Preparation and Injection  
 All experimental procedures were carried out in accordance with the Guidelines 
for the Care and Use of Laboratory Animals by the NIH and the Animal Welfare 
Assurance of Georgia State University (#A97008). Oocytes from female Xenopus laevis 
frogs (Xenopus One, Inc, Dexter, MI) were used in the present studies. Frogs were 
anesthetized by bathing them in 0.3% 3-aminobenzoic acid ethyl ester. After a few lobes 
of ovaries were removed through a small abdominal incision (~5 mm), the frog was 
allowed to recover from the anesthesia. The Xenopus oocytes were treated with 1 mg/ml 
of collagenase (Type IA, Sigma Chemicals, St. Louis, MO) in the OR2 solution 
containing (in mM): NaCl 82, KCl 2, MgCl2 1 and HEPES 5 (pH 7.4) for 60 min at room 
temperature. After five washes (10 min each) of the oocytes with the OR2 solution, 
cDNAs (25–50 ng or 5-10 femtomoles in 50 nl DD water) were injected into the oocytes. 
The oocytes were then incubated at 18 °C in the ND-96 solution containing (in mM): 
NaCl 96, KCl 2, MgCl2 1, CaCl2 1.8, HEPES 5, and sodium pyruvate 2.5 with 100 mg/l 
G418 sulfate (Medlatech, INC, Herndon, VA) and 50 mg/l tetracycline (Sigma 
Chemicals) added (pH 7.4). 
I-2. Molecular Biology  
Standard molecular biology techniques were used including site-directed 
mutagenesis, polymerase chain reaction (PCR), gene expression, and DNA sequencing. 
Rat Kir4.1 cDNA (GenBank #X83585) and rat Kir5.1 cDNA (GenBank #AF249676) are 
gifts from Dr. John Adelman at Oregon Health and Science University, Portland, OR. For 
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co-expression of Kir4.1 and Kir5.1, a tandem dimer of these two cDNAs was constructed 
using the overlapping extension technique, in which full length Kir4.1 and Kir5.1 
sequences were obtained using Pfu DNA polymerase (Stratagene, La Jolla, CA) chain 
reaction (PCR). The PCR products were joined to each other at the 3’ end of Kir4.1 and 
5’ end of Kir5.1. Mouse Kir6.2 (GenBank #D50581) was generously provided by Dr. 
S. Seino at Kobe University Graduate School of Medicine, Kobe, Japan. The Kir6.2 with 
a truncation of 36 AAs at the C-terminus end (Kir6.2∆C36) expresses functional currents 
without the SUR subunit and retains ATP and pH sensitivities (Tucker et al., 1997; Xu et 
al., 2001). Rat Kir1.1 (GenBank #X72341) (from Dr. Steven Hebert, Yale University) 
and Mouse Kir2.1 (GenBank #X73052) (from Dr. Lily Jan, University of California at 
San Francisco) were also used in the present studies. Hamster SUR1 (GenBank#L40623) 
was a gift from Dr. L. Bryan at Baylor College of Medicine, Houston, TX. All of the 
above mentioned cDNAs were sub-cloned into the eukaryotic expression vector 
pcDNA3.1 (Invitrogen, Carlsbad, CA) and used for Xenopus oocyte expression without 
cRNA synthesis. 
Rat neurokinin-1 receptor (NK1R) cDNA (Genbank #J05097) was generously 
provided by Dr. Shigetada Nakanishi at Kyoto University Faculty of medicine, Kyoto, 
Japan. Rat serotonin 2A receptor (5-HT2A) cDNA (Genbank #M30705) was generously 
provided by Dr. David Julius at the University of California at San Francisco, San 
Francisco, CA. Mouse thyrotropin-releasing hormone receptors R1 (mTRH-R1) 
(Genbank #M59811) and R2 (mTRH-R2) (Genbank #NM_133202) were generously 
provided by Dr. Marvin Gershengorn at the National Institutes of Health, Bethesda, MD. 
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Rat mu-opioid receptor cDNA (MOR) (Genbank #L22455) was generously provided by 
Dr. Stanley Watson at the University of Michigan, Ann Arbor, MI. All receptor cDNAs 
were sub-cloned into the eukaryotic expression vector pcDNA3.1 (Invitrogen, Carlsbad, 
CA) and used for Xenopus oocyte expression without cRNA synthesis. 
Dynamin II (aa) wild-type and Dynamin II (aa) K44A are gifts from Dr. Mark 
McNiven at the Mayo Clinic. These two cDNAs were subcloned into the eukaryotic 
expression vector pEGFP-N1 creating an N-terminal GFP-Dynamin fusion and used 
directly for expression in Xenopus oocytes.  
 Site-specific mutations were made using a pfu DNA polymerase-based site-
directed mutagenesis kit (Quickchange, Stratagene, La Jolla, CA). Orientation of the 
correct mutations and constructions were confirmed with DNA sequencing. 
I-3. Expression and purification of MBP and C-terminal-MBP fusion proteins 
 
 The membrane and C-terminal cytoplasmic junction for the Kir4.1 (GenBank 
#X83585) and Kir5.1 (GenBank #X83581) was determined by ScanProsite.  The C-
terminal fragments were amplified by PCR and inserted into the pMALc2x vector (New 
England Biolabs) using EcoRI and XbaI.  The PCR fragments contained these restriction 
enzyme sites as well as a stop codon to terminate transcription after the C-terminus.  To 
express the maltose binding protein (MBP) alone a stop codon was introduced to prevent 
expression of part of the LacZ gene present in the pMALc2x vector. Correct 
constructions were confirmed with DNA sequencing.   
 
 
34 
 
 Expression and purification of the fusion proteins were carried out in Eschericia 
coli BL21 competent cells.  The cells were grown overnight at 37 ºC.  The next morning 
the cultures were diluted in LB broth medium and grown to an A600 ~1 at 37 ºC.  Protein 
induction was achieved by the addition of 1 mM isopropylthiogalactoside (IPTG) to the 
cultures which were then incubated at 25 ºC for 2 hours.  The cells were harvested by 
centrifugation (4,000 x g, 15 min, 4 ºC).  The bacterial pellet was washed with STE (150 
mM NaCl; 10 mM Tris, pH 8.0; 1 mM EDTA) plus protease inhibitors (EDTA-free) 
(Roche Molecular Biochemicals) once and then resuspended in the same buffer.  The cell 
membranes were lysed by the addition of lysozyme (100 µg/ml) added immediately 
following resuspension.  The samples were incubated on ice for 15 min.  Dithiothreitol 
(DTT) (5 mM) was added to the samples and the cell membranes were further lysed by 
sonication (4 x 20 s) followed by centrifugation (4,000 x g, 15 min, 4 ºC).  The resulting 
supernatant was collected and Triton X-100 was added to a final concentration of 1%.  
The supernatant was then loaded onto amylose resin (New England Biolabs) pre-
equilibrated with protein elution buffer (PEB) (50 mM Tris, pH 8.0; 1 mM EDTA) and 
incubated on ice for 45 minutes.  The amylose resin was centrifuged and the supernatant 
was discarded.  The resin was washed 7 times with 2 volumes of PEB.  Elution of the 
maltose binding protein (MBP) and MBP fusion proteins was achieved by incubating the 
amylose resin with 1 volume of PEB containing 10 mM maltose.  All fractions containing 
the fusion proteins were pooled and concentrated using centricon YM-10 centrifugal 
units (Millipore, Bedford, MA).  Protein purity was determined by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (10%) and subsequent 
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coomassie blue staining.  The protein concentration was determined using a UV 
spectrophotometer at A280.     
I-4. In vitro kinase assay 
 
 One µg of purified proteins (Kir4.1-C-terminus-MBP, Kir5.1-C-terminus-MBP, 
MBP, Histone III-S) was added to a reaction mixture consisting of the catalytically active 
PKC subunit (20 ng) (BioMol, Plymouth Meeting, PA) 10 µCi of 32P-γ-ATP (Perkin 
Elmer, Waltham, MA), Magnesium/ATP cocktail (75 mM MgCl2 and 500 µM ATP in 20 
mM MOPS, pH 7.2, 25 mM β-glycerol phosphate, 5 mM EGTA, 1 mM sodium 
orthovanadate and 1 mM dithiothreitol) and 5x reaction buffer (containing: 125 mM Tris-
HCl, pH 7.5 and 0.1 mM EGTA) in a total volume of 25 µl.  The samples were incubated 
at 30 ºC for 1 hour and 5x loading buffer was added to stop the reaction.  The samples 
were then analyzed by running a symmetric 10% SDS-PAGE gel.  The gel was cut down 
the middle and one half was stained with Coomassie brilliant blue solution and destained 
and the other half was dried and subjected to autoradiography.  The autoradiograph was 
taken using the Fujifilm BAS 2500 phosphor imager and analyzed with the Multigauge 
software. 
I-5. Transfection of HEK293 Cells 
 
 Human Embryonic Kidney cells (HEK293, CRL-1573, Batch #2187595, ATCC, 
Rockville, MD) were chosen to express the Kir4.1-Kir5.1, Kir1.1, and Kir2.1 channels. 
HEK293 Cells were cultured as a monolayer in MEM-E medium with 10% fetal bovine 
serum and penicillin/streptomycin added. The cells were incubated at 37 °C in the 
presence of 5% atmospheric CO2 and split twice weekly.  
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The cells were transfected using Lipofectamine2000 (Invitrogen, Carlsbad, CA) 
with 5 µg wild-type Kir cDNA per petri dish (35 mm). To facilitate the identification of 
positively transfected cells, 0.5 µg of green fluorescent protein (GFP) cDNA (pEGFP-
N2, Clontech, Palo Alto, CA) was added to the cDNA mixture. Cells were disassociated 
from the monolayer using 0.01% trypsin 24 hours post-transfection. A few drops of the 
cell suspension were added to a new petri dish. The cells were then incubated at 37 °C for 
48 hrs before experiments.  
I-6. Primary culture of brainstem neurons  
 
 The medulla oblongata and pons of fetal (P16-20) sprague dawley rat embryos 
were surgically removed and rapidly placed in ice cold Earle’s Balanced Salt Solution 
(EBSS). The tissue was dissociated by treatment using a papain preparation kit 
(Worthington, Lakewood, NJ). The neurons were then plated on a polyethyleneimine, 
polyornithine, and laminin coated MEA dish which has 64 planar microelectrodes (ALA 
Scientific, Westbury, NY) containing dulbecco's modified minimum essential medium 
(Invitrogen-Gibco, Carlsbad, CA), with 5% horse serum (Invitrogen-Gibco), and 5% fetal 
calf serum (Invitrogen-Gibco) added. Two-thirds of the culture medium was replaced 
twice weekly. The neurons showed a similar morphology as in regular cell culture plates. 
The dissociated neurons were cultured at 37 oC in 5% CO2/95% air at saturating humidity 
(Su & Jiang, 2006; Su et al., 2007).  
I-7. Electrophysiology 
  
Two-electrode voltage clamp (TEVC) was used to record whole-cell currents were 
studied on oocytes 2–4 days post cDNA injection using an amplifier (Geneclamp 500, Axon 
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Instruments Inc., Foster City, CA) at room temperature (~24 °C). The extracellular solution 
contained (in mM): KCl 90, MgCl2 3, and HEPES 5 (pH 7.4). The cells were impaled with 
recording pipettes filled with 3 M KCl. The potential leakage of KCl from the recording 
electrodes was not corrected because of the large volume of oocytes. One of the 
electrodes (1.0-3.0 MΩ) served as the voltage recording which was connected to the HS-
2 x1L headstage (input resistance=1011 Ω), and the other (0.3-0.6 MΩ) was used for 
current recording connected to the HS-2 x10MG headstage (maximum current=130 µA). 
Oocytes were accepted for further experiments if they did not show evident leakage in 
membrane currents. Current records were low-pass filtered (Bessel, 4-pole filter, 3 dB at 
5 kHz), digitized at 5 kHz (12-bit resolution) and stored on a computer disk for later 
analysis (pClamp6.0.3, Axon Instruments). 
Patch clamp experiments for Kir4.1-Kir5.1 were performed at room temperature (~ 
25 °C) using the Axo-patch 200B amplifier (Axon Instruments). In brief, the vitelline 
membranes were mechanically removed after exposing the oocytes to a hypertonic solution 
(400 mOsm). The stripped oocytes were placed in a petri dish containing the regular bath 
solution (see below). Fire-polished patch pipettes (2-4 MΩ) were made of 1.2 mm 
borosilicate glass capillaries (Sutter Instruments, Novato, CA). The pipette tip was ~2 μm. 
The bath solution (FVPP) contained (in mM): 40 KCl, 75 potassium gluconate, 5 potassium 
fluoride, 0.1 sodium vanadate, 10 potassium pyrophosphate, 1 ethylene glycol-bis-β-
aminoethylether-N,N,N’,N’-tetraacetic acid (EGTA), 0.2 adenosine diphosphate (ADP), 
10 piperazine-N,N’-bis-2-ethanesulfonic acid (PIPES), 10 glucose, and 0.1 spermine 
(pH=7.4). The pipette was filled with the same FVPP solution used in the bath or a solution 
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containing: 40 KCl, 110 potassium gluconate, 0.2 ADP, 1 EGTA, 10 N-2-hydroxyethyl-
piperazine-N’-2-ethanesulfonic acid (HEPES), 10 glucose, 2 MgCl2 (pH 7.4). Single 
channel currents were recorded from cell-attached patches. Current records were low-pass 
filtered (2,000 Hz, Bessel, 4-pole filter, -3 dB), digitized (10 kHz, 12-bit resolution), and 
stored on computer disk for later analysis using the pClamp 9 software. Junction potentials 
between bath and pipette solutions were appropriately nulled before seal formation. The 
open-state probability (NPo) was calculated by first measuring the time, tj, spent at current 
levels corresponding to j=0, 1, 2,...N channels open. The Popen was then obtained as Popen = 
(∑Nj=1 tj j)/TN, where N is the number of channels active in the patch and T is the duration 
of recordings. Popen values were calculated from one or a few stretches of data having a 
duration of 20 s each.  
Single-electrode whole-cell voltage-clamp was performed using the HEK293 cell 
line (American Type Culture Collection, Manassas, VA) at room temperature as described 
previously (Li et al., 2004; Wu et al., 2002a; Zhu et al., 1998). In brief, fire-polished 
patch pipettes were made from 1.2 mm borosilicate capillary glass (Sutter Instruments, 
Novato, CA). Tight seals (>1 gigaohm before breaking into the whole-cell mode) were 
obtained with the transfected cells. The patch electrodes had an open tip resistance of 0.5-
1.0 MΩ. The series resistance during recording varied from 5 to 10 MΩ and was not 
compensated. Recordings were terminated whenever significant increase (>20%) in series 
resistance occurred. Current records were low-pass filtered (2 kHz, Bessel, 4-pole filter, -3 
dB), digitized (20 kHz, 16-bit resolution), and stored on computer disk for later analysis 
using the pCLAMP 9 software (Axon Instruments Inc, Foster City, CA). Recordings were 
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performed using solutions containing equal concentrations of K+ applied to the bath and 
recording pipettes. This solution contained (in mM): KCl 40, potassium gluconate 110, 
ADP 0.2, EGTA 1, Hepes 10, glucose 10 and MgCl2 2 (pH 7.4). 100 nM thymeleatoxin 
dissolved in DMSO and the same concentration of DMSO alone was applied to the bath 
solution. 
Patch clamp experiments for Kir6.2 were performed at room temperature (about 
25 °C) as described previously (Xu et al., 2001; Wu et al., 2002a; Wu et al., 2002b). In 
brief, fire-polished patch pipettes were made from 1.2 mm borosilicate glass capillaries 
using a Sutter P-97 puller (Sutter Instrument, Novato, CA). Giant inside-out patches were 
employed to study macroscopic currents in a cell-free condition using recording pipettes 
of 0.5–1.0MΩ and an Axo-patch 200B amplifier (Axon Instruments, Foster City, CA). 
The current records were low-pass filtered (Bessel, 4-pole filter, -3 dB at 2 kHz), 
digitized with pClamp 9 software (Axon Instruments), and stored on computer disk for 
later data analysis. Patch clamp recording solutions contained equal concentrations of K+ 
applied to the bath and recording pipettes. The solution contained (in mM): 10 KCl, 105 
potassium gluconate, 5 KF, 5 potassium pyrophosphate, 0.1 sodium vanadate, 5 EGTA, 5 
glucose, and 10 HEPES (pH = 7.4) (Xu et al., 2001; Wu et al., 2002a; Wu et al., 2002b). 
Pyrophosphate and vanadate are known to alleviate channel rundown in the Kir6.2. In 
several control experiments, we did not find any evident difference in current profile and 
channel responses to pH and ATP from those recorded in the absence of pyrophosphate 
and vanadate. The open-state probability (Po) was calculated by measuring the time, tj, 
spent at current levels corresponding to j = 0,1,2,······N channels open, based on all 
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evident openings during the entire period of record (Wu et al., 2002b). The Po was then 
obtained as Po = (∑Nj=1 tj j)/TN, where N is the number of channels active in the patch and 
T is the duration of recordings. Open and closed times were measured from records in 
which only a single channel was active. In the some patches, the second active channel 
appeared during recording. The data from such patches were used for the open-time and 
closed-time analysis only if the Po for the second openings was not larger than 0.002. The 
open-time and closed-time distributions were fitted using the Marquardt-LSQ method in 
the Pstat6 software (Axon Instruments Inc.) (Wu et al., 2002b). Open/closed events < 
200µs were ignored.  
A parallel perfusion system was used to deliver perfusates with different 
concentrations of ATP (K+ Salt) at a rate of ~1 ml/min with no dead space (Xu et al., 
2001; Wu et al., 2002a). All solutions with ATP were prepared immediately before 
experiments and were used for less than 4 hours. The ATP-current relationship was 
expressed with the Hill equation: y = 1 / (1 + ([ATP] / IC50)h), where [ATP] = ATP 
concentration, and IC50 = the [ATP] at midpoint channel inhibition. 
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Our data was fitted to the kinetic scheme 1 in which O is the open state, C1 
represents the short-lived closure, and C2 refers to the long-lived closed state in the 
absence of ATP. A third long-lived close state (C3) appears in the presence of ATP for 
the Kir6.2∆C36. In the scheme the bold arrows indicate the transitions that are more 
favored and the dashed arrow refers to transitions that are lessened. The rate constants for 
Kir6.2∆C36 were calculated from our single channel data based on the following 
equations (equations 1-6) (Colquhoun & Hawkes, 1990; Trapp et al., 1998): 
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where τc1 is the time constant for short closures, τc2 for long closures, τc3 for the 
additional long closures in the presence of ATP, and τo is the time constant for openings. 
POB is the open state probability in the absence of ATP. In the F168G mutant, an 
additional closed state appeared in the absence of ATP. Thus, additional equations 
(equations 7-10) were used to calculate the rate constant kinetics (Colquhoun & Hawkes, 
1990; Trapp et al., 1998). Under this condition τc3 is the additional long closed time 
constant, Nc3 and Nc1 are the number of C3 and C1 events. Notice that the equations 
used to calculate the F168G mutant are very similar to those used to calculate the kinetics 
of Kir6.2∆C36. The difference is that the k3 and k-3 in the F168G mutant represents the 
rate constant kinetics of the closed time in the baseline level (in the absence of ATP), 
which requires additional calculations. 
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I-8. Recording of Neuronal Activity Using Multi-Electrode Arrays  
 
 Extracellular recordings were carried out in the DMEM medium using a 
preamplifier (MCS MEA1060, Reutingen, Germany) 10-60 days post culture at 37 ºC. 
The spikes were digitized at 40 kHz with a 64-channel A-D converter and the MEA 
workstation software (Plexon inc. Dallas, TX). Single units were identified using the 
Offline Sorter software (Plexon Inc.) based on the Principal Component Analysis method 
(Horn & Friedman, 2003), with which the likelihood to achieve pure single unit recording 
is greatly improved over the traditional window discriminators. Single-unit recordings 
were also determined by the absence of action potentials in the initial period (5-100ms) of 
the inter-spike histogram.  
I-9. CO2 Exposure 
 
For acidification experiments with CO2, the oocytes were placed in a semi-closed 
recording chamber (BSC-HT, Medical System, Greenvale, NY, USA), on a supporting 
nylon mesh, where perfusion solution 90 K+ (90mM NaCl, 3mM MgCl2, and HEPES (pH 
7.4) bathed both the top and bottom surfaces of the oocytes. The perfusate and 
superfusion gas (15% CO2) entered the chamber from the inlet at one end and flowed out 
through the other end. At the top of the chamber, enough space was provided for the 
gases to escape and also for the recording microelectrodes to be injected into the oocytes. 
During baseline-control recording, the chamber was ventilated with atmospheric air. 
Exposure of the oocytes to CO2 was carried out by exposing the oocytes to a gas mixture 
containing CO2 at 15% balanced with 21% O2 and N2. The oocytes were exposed to this 
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mixture for ~4-8 minutes or until the current reached a steady state. The high solubility of 
CO2 resulted in very rapid changes in intracellular and extracellular pH levels. The pH 
level was stabilized within 4 min (Xu et al., 2001; Yang et al., 2000; Zhu et al., 2000).  
Intracellular acidification alone of oocytes was carried out by using 90mM 
KHCO3 to replace all KCl (90 mM) in the extracellular solution, so that the K+ 
concentration remained the same in these experiments. This solution was titrated to pH 
7.4 immediately before use to selectively acidify the cytosol of the oocytes to pH 6.6. 
I-10. Chemical Administration and Exposure 
  
4-α-Phorbol 12-myristate 13-acetate (PMA) and 4α-phorbol-12,13-didecanoate 
(4α-PDD) were purchased from Calbiochem (La Jolla, CA). 1-Oleoyl-2-acetyl-sn-
glycerol (OAG), thymeleatoxin, chelerythrine chloride and calphostin-C were purchased 
from Sigma (St Louis, MO). Genistein and wortmannin were purchased from Tocris 
(Ellisville, MO). Substance-P (SP) (acetate salt), Spantide I, L-703,606, 4-Iodo-2, 5-
dimethoxyamphetamine (DOI), serotonin (5-HT), thyrotropin releasing hormone (TRH), 
and [D-Ala2, N-Me-Phe4, Gly5-ol]-Enkephalin (DAMGO) were also purchased from 
sigma. Spiperone and Ketanserin Tartate were purchased from Tocris (Ellisville, MO). 
PMA, OAG, thymeleatoxin, genistein, wortmannin, chelerythrine, calphostin-C, 
spiperone and 4α-PDD were dissolved in dimethylsulfoxide (DMSO) as stocks and 
mixed with a recording solution reaching a final concentration as indicated in the results. 
The final DMSO concentration was ≤0.1%. Other chemicals were dissolved in double-
distilled water or experimental solutions. Exposures to these chemicals were done after 
baseline currents were stabilized.  
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I-11. Data Analysis  
 
 Data are presented as means ± S.E. (standard error). Student t test or single-factor 
ANOVA was used. Differences of chemical effects before versus during chemical 
exposures were considered to be statistically significant if P ≤ 0.05. 
I-12. HEK293 Cell Culture Immunocytochemistry 
 
For single-label immunohistochemistry of Kir4.1 and Kir5.1 the cultured 
HEK293 cells transfected 3 days prior with Kir4.1-Kir5.1 dimer cDNA were fixed with 
4% paraformaldehyde in Phosphate Buffered Saline (PBS) (0.01 M, pH 7.4) for 30 min. 
The cells were washed three times with PBS and then blocked for 30 min in PBS 
containing: 1% bovine serum albumin (BSA), 10% normal serum (NS), and 0.3% Triton 
X-100. The cultures were then incubated overnight at 4 °C in primary antibodies of rabbit 
anti-Kir4.1 (1:400) (Alomone Labs, Jerusalem, Israel) or goat anti-Kir5.1 (1:400) (Santa 
Cruz Biotechnology, Santa Cruz, CA), diluted in Antibody Dilution Solution (ADS), 
containing: 0.1% gelatin, 0.1% NaN3, and 0.3% Triton X-100 in PBS. Both antibodies 
were used to detect antigen of human, rat, and mouse origin. After washing three times 
with ADS, the cultured cells were then incubated with biotinylated goat anti-rabbit IgG 
(Kir4.1) or biotinylated donkey anti-goat (Kir5.1) (Jackson Immuno Research, West 
Grove, PA) diluted to 1:1000 in ADS for 2 hr at 25 °C. The cells were rinsed with ADS 
and then incubated at 25 °C with a 546 fluorophore conjugated streptavidin (Molecular 
Probes, Eugene, OR) diluted to 1:1000. The fluorescence reaction was visualized using a 
Zeiss axioscope 200 fluorescence microscope (Zeiss, Oberkochen, Germany). Pictures 
were taken using the software AxioVision AC 4.1 (Zeiss, Oberkochen, Germany). 
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Subsequently, fluorescence imaging was performed with a confocal microscope (LSM 
510) (Zeiss, Jena, Germany). The confocal images were taken using a 40x oil immersion 
objective lens. 
I-13. Brainstem Neuron Culture Immunocytochemistry  
 
 Brainstem neurons were fixed with 4% paraformaldehyde in phosphate buffered 
saline (PBS, 0.1 M, pH 7.4) for 30 min. The cells were washed three times with PBS and 
then blocked for 30 min in PBS containing 1% bovine serum albumin (BSA), 10% 
normal donkey serum (NDS) or 10% normal goat serum (NGS), and 0.3% Triton X-100. 
The cells were then incubated overnight with the primary antibodies: rabbit polyclonal anti-
Kir4.1 (1:1000) (Alomone Lab, Israel), goat polyclonal anti-Kir5.1 (1:500), (Santa Cruz 
Biotech, Santa Cruz, CA), and mouse monoclonal anti-MAP2 (1:400, Sigma, St. Louis, 
MO) diluted in antibody dilution solution (ADS), containing 0.1% gelatin, 0.1% NaN3, 
and 0.3% Triton X-100 in PBS. After washing five times with ADS (5 min each), the 
cultured cells were incubated at 25 °C with the secondary antibodies for 2 hrs: 
AlexaFluor488-conjugated donkey anti-rabbit IgG for demonstration of Kir4.1 (1:1000) 
(Molecular Probes, Eugene, OR), AlexaFluor594-conjugated donkey anti-goat IgG for 
Kir5.1 (1:1000) (Molecular Probes, Eugene, OR), and AMCA (7-amino-4-
methylcoumarin-3-acetic acid) conjugated donkey anti-mouse IgG (1:100, Jackson 
ImmunoRes, West Grove, PA) for MAP2. In control experiments, the primary antibodies 
were omitted for Kir5.1 and MAP2 or pre-absorbed with a 3-fold excess of the epitope for 
Kir4.1 (Alomone Lab). All of these control experiments showed negative stainings. The 
fluorescence reaction was first visualized using a Zeiss axioscope 200 fluorescence 
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microscope (Zeiss, Oberkochen, Germany). Subsequently, fluorescence imaging was 
performed with a confocal microscope (LSM 510) (Zeiss, Jena, Germany). The confocal 
images were taken using a 20x and 40x objective lenses. 
I-14. Brainstem Tissue Slice Immunocytochemistry 
 
All experimental procedures were carried out in accordance with the Guidelines 
for the Care and Use of Laboratory Animals by the NIH and Georgia State University. 
Male Sprague-Dawley rats (200-250 g) were deeply anesthetized by inhalation with 
halothane and perfused transcardially with 0.9% saline followed by 4% (wt/vol) 
paraformaldehyde in 0.1 M PBS (pH 7.4).The brains were rapidly dissected, post-fixed in 
the same solution at 4 °C for 3 hrs, and transferred to 30% (wt/vol) sucrose in PB at 4 °C 
overnight. The brains were then mounted onto a tissue cutting block and frozen in 
optimum cutting temperature (OCT) compound (VWR, West Chester, PA). Transverse 
sections (10 µm, 20 µm and 40 µm) were cut on a cryostat (Leica, Wetzlar, Germany) 
and placed in PBS (free-floating for 40 µm sections) or mounted on a slide (fixed for 10 
µm, 20 µm sections). The sections were washed five times with PBS for 5 min each and 
pre-treated with PBS containing: 1% bovine serum albumin (BSA), 10% normal serum 
(NS), and 0.3% Triton X-100 at 25 °C for 30 min to reduce nonspecific immunostaining. 
The sections were then incubated in the primary antibodies [Kir4.1 (1:400) (Alomone 
Labs, Jerusalem, Israel); Kir5.1(1:200) (Santa Cruz Biotechnology, Santa Cruz, CA); 
Tyrosine Hydroxylase (TH) (1:5000) (Sigma-Aldrich, St. Louis, MO); NK1R (1:3000) 
(Sigma-Aldrich, St. Louis, MO); and 5-HT2AR (1:500) (Immunostar Inc, Hudson, WI)] 
diluted with ADS at 4 °C for 48 hrs. The sections were then washed five times with ADS 
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at 25 °C for 5 min each and incubated with the corresponding secondary antibody 
(Jackson Immuno Research, West Grove, PA) diluted to 1:1000 in ADS for 2 hrs at 25 
°C. In the case where ABC was used the sections were subsequently rinsed with ADS 
and then incubated at 25 °C with a 546 fluorophore conjugated streptavidin (Molecular 
Probes, Eugene, OR) diluted to 1:1000. The fluorescence reaction was visualized using a 
Zeiss axioscope 200 fluorescence microscope (Zeiss, Oberkochen, Germany). Pictures 
were taken using the software AxioVision AC 4.1 (Zeiss, Oberkochen, Germany). 
Confocal images were obtained with a LSM510 confocal imaging system (Zeiss, 
Oberkochen, Germany) and manipulated with Adobe Photoshop 5.5 software (Adobe 
Systems, Mountain View, CA). 
 Diaminobenzidine (DAB) with enhanced nickel staining was used to increase 
the sensitivity of the antibody staining. Ni-DAB immunocytochemistry was performed on 
free-floating and fixed sections similarly as described above. Briefly, sections were 
washed 3 times with 0.05 M Tris Buffered Saline (TBS) and then exposed to 0.5% H2O2 
for 30 min. The sections were then washed 3 times again with 0.05 M TBS and pre 
incubated for 30 min at 25 °C in the corresponding blocking solution (see above section). 
Following blocking the sections were incubated for 48 hours at 4 °C with specific 
primary antibodies against (Kir4.1, Kir5.1, and TH) diluted in ADS made with TBS. The 
sections were washed five times with ADS for 5 min each and subsequently exposed to 
ADS containing the horse radish peroxidase (HRP) conjugated secondary antibody at 25 
°C overnight. The sections were washed again 5 times for 5 min each and then soaked in 
ADS containing an HRP-conjugated streptavidin for 4 hours at 25 °C. The sections were 
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washed with TBS and exposed to DAB and nickel ammonium sulfate in the presence of 
glucose oxidase. The floating sections were subsequently mounted onto clean slides and 
allowed to dry. After drying the sections were dehydrated by exposure to increasing 
concentrations of ethanol. The sections were made transparent with Xylene and then 
cover slipped in the presence permount. The Ni-DAB reaction was visualized using a 
Zeiss axioscope 200 microscope as well as a bright-field microscope and digit-imaged. 
Protein expression was judged according to the relative optical intensity of the stain. 
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J. EXPERIMENTAL DESIGN AND RESULTS 
 
 
 
 
I. IDENTIFICATION OF THE HETEROMERIC KIR4.1-KIR5.1 CHANNEL 
IN BRAINSTEM NEURONS* 
 
 
 
 
 
 
 
 
 
 
 
 
Manuscript in preparation: 
 
Asheebo Rojas, Junda Su, Xiaoli Zhang, Ming Lee, Morium Chowdhury & Chun Jiang.  
Identification of the Heteromeric Kir4.1-Kir5.1 channel in brainstem neurons. 
 
*In this part, Dr. Junda Su and Ms. Xiaoli Zhang helped me to perform 
immunocytochemistry on brainstem sections.  Dr. Junda su performed 20 % of the DAB 
immunocytochemistry on sections taken from the LC and the ventralateral medulla.  Ms. 
Xiaoli Zhang performed 10 % of the fluorescence immunocytochemistry on sections 
taken from the LC.  Mr. Ming Lee helped me by obtaining and preparing the 10 µM 
adjacent sections from the LC.  All of the adjacent sections were obtained by Mr. Ming 
Lee.  Ms. Morium Chowdhury assisted me with 40 % of the animal perfusions and she 
prepared solutions in addition to mounting the brainstem sections onto the slides.  All of 
their help is greatly appreciated.  
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Ia. INTRODUCTION 
  
 The candidacy of the Kir4.1-Kir5.1 channel as a central CO2 chemoreceptor 
molecule is strengthened by demonstrating expression of the channel in brainstem 
chemosensitive neurons where it is co-expressed with receptors for neurotransmitters that 
are critical for respiratory control.  Recently, a study using in situ hybridization 
demonstrated the presence of mRNAs of both Kir4.1 and Kir5.1 in chemosensitive 
neurons of the brainstem (Wu et al., 2004).  However, in situ hybridization results 
showing the presence of mRNAs are suggestive.  Although mRNAs are present in 
neurons, the channel may not exist at the protein level.  Therefore, we have conducted the 
present study to demonstrate the presence of the Kir4.1-Kir5.1 channel in brainstem 
neurons.  The locus coeruleus (LC) nucleus is chosen as the primary site of interest as 
this nucleus is highly sensitive to changes in pH/CO2, it is easy to identify, and also 
mRNAs for both Kir4.1 and Kir5.1 are found in LC neurons.  We also conducted 
experiments to demonstrate that the Kir4.1-Kir5.1 channel is co-expressed with the NK1 
recepter, the natural receptor for SP.  Here we present evidence showing expression of 
the Kir4.1, Kir5.1, and NK1R subunits in the locus coeruleus, and the Kir4.1 and Kir5.1 
in the hypoglossal and trigeminal motor nuclei. 
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Ib. RESULTS 
 
Ib-1. Specificity of the Kir4.1 and Kir5.1 antibodies 
 
 The Kir4.1 and Kir5.1 antibodies are both commercially available.  We first 
performed control experiments to demonstrate the specificity and efficiency of these 
antibodies in our system.  The specificity of the Kir4.1 and Kir5.1 antibodies was 
demonstrated using HEK293 cells.  HEK293 cells were transfected with the Kir4.1-
Kir5.1 dimer cDNA along with GFP cDNA as described in the methods 
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Fig I-1. Specificity and efficiency of the Kir4.1 and Kir5.1 antibodies.  A. The Kir4.1 and Kir5.1 
antibodies are highly effective.  HEK293 cells were transfected with the Kir4.1-Kir5.1 cDNA 
along with the GFP cDNA.  Immunocytochemistry was performed on these cells.  Strong 
labellings were seen when cells expressing the Kir4.1-Kir5.1 were stained with the anti-Kir4.1 
(A) and anti-Kir5.1 (C).  No labellings were seen when cells expressing the Kir1.1 (B) and Kir2.1 
(D) were stained with the anti-Kir4.1 and anti-Kir5.1, respectively.  GFP was used as an indicator 
of transfection efficiency.  The arrows represent typical and healthy HEK293 cells.  Bar=50 µm. 
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 sections.  GFP was used as an indicator of transfection efficiency.  Positive 
immunoassays were identified for both Kir4.1 and Kir5.1 when the HEK293 cells were 
incubated with the Kir4.1 and Kir5.1 antibodies as described in the methods section, 
suggesting that the antibodies can efficiently label the Kir4.1 and Kir5.1 proteins (Fig. 1 
A, C).  Similar experiments were repeated using two other Kir channels that share high 
homology to Kir4.1 and Kir5.1 to demonstrate the specificity of the antibodies.  The 
Kir1.1 was used to demonstrate the specificity of the Kir4.1 antibody as the Kir1.1 shares 
the highest homology to Kir4.1.  The Kir1.1 also shares the highest identity with the 
Kir4.1 in the epitope region that was used to generate the Kir4.1 antibody used here.  
When cells transfected with Kir1.1 were exposed to the Kir4.1 antibody no positive 
immunostains were detected although the GFP fluorescence suggests that the Kir1.1 
channel was expressed (Fig. 1B).  The same experiment was carried out using Kir2.1 to 
demonstrate specificity of the Kir5.1 antibody.  The Kir2.1 channel shows the highest 
homology to the Kir5.1 and the highest idenitity in the epitope region of Kir5.1 used to 
generate the antibody.  Cells transfected the Kir2.1 cDNA failed to reveal positive 
immunostains after incubation with the Kir5.1 antibody although GFP fluorescence 
indicated that the Kir2.1 channel was expressed (Fig. 1D).  Experiments were also 
conducted with the homomeric Kir4.1 and Kir5.1 and positive immunostains were also 
detected (data not shown).  Taken together, these results suggests that the Kir4.1 and 
Kir5.1 antibodies are specific and can be used to detect the presence of the Kir4.1 and 
Kir5.1 subunits in the heteromeric Kir4.1-Kir5.1 channel. 
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Ib-2. Expression of Kir4.1 and Kir5.1 in hypoglossal and trigeminal motor neurons 
 
 Recently, tremendous efforts have been placed on detecting the tissue specific 
expression of various Kir channels.  Although these efforts have led to the identification 
of many Kir channels in various tissues, there still remains debate as to the cellular 
expression of certain Kir channels.  For example, the Kir4.1 and Kir5.1 has been shown 
to be highly expressed in brain tissue (Hibino et al., 2004; Ma et al., 1998; 
Poopalasundaram et al., 2000), however, it is not known whether these channels are 
expressed in neurons, in glia, or in both.  There is overwhelming evidence showing that 
the Kir4.1 and Kir5.1 channels are expressed in glial cells within various regions of the 
brain (Hibino et al., 2004; Higashi et al., 2001; Horio 2001), suggesting that these 
channels may not function in neurons.  However, recently a study using in situ 
hybridization demonstrated the presence of mRNA for both Kir4.1 and Kir5.1 in many 
brainstem neurons, suggesting that these channels may be expressed in neurons in 
addition to glial cells (Wu et al., 2004).  To strengthen this conclusion we used 
immunocytochemistry to detect the Kir4.1 and Kir5.1 proteins in brainstem motor 
neurons, which are large and easily identifiable.  Also, motor neuron clusters are not 
easily contaminated by neurons from adjacent nuclei.  DAB immunocytochemistry was 
performed on brainstem sections as indicated in the methods section.  Positive 
immunostains were detected for both Kir4.1 and Kir5.1 in hypoglossal motor neurons at 
the level of the medulla (Fig. 2).   
 Immunoassay experiments were also performed to detect Kir4.1-Kir5.1 
expression in motor neurons at the level of the pons.  Using DAB immunocytochemistry, 
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positive immunostains were detected for both Kir4.1 and Kir5.1 in trigeminal motor 
neurons (Fig. 3). These results suggest that the Kir4.1 and Kir5.1 channels are not only 
localized to glia, but are also expressed in neurons.  
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Fig I-2. Detection of Kir4.1 and Kir5.1 in hypoglossal motor neurons.  DAB 
immunocytochemistry was performed on medullary sections (40 µm) obtained from rats.  Strong 
staining was seen in the hypoglossal motor neurons for Kir4.1 (B1) and Kir5.1 (D1) at 10x 
magnification.  Higher magnification (20x) revealed expression of both Kir4.1 (B2) and Kir5.1 
(D2).  For the controls the medullary sections were treated in a similar manner as the 
experimental sections except the control sections were not exposed to the primary antibody.  In 
both cases no DAB staining was detected in the absence of the primary antibody at low and high 
magnifications (A1, A2, C1, C2).  The horizontal arrow in A1-D1 represents the central canal.  
Vertical arrows in B2 and D2 represent typical hypoglossal motor neurons expressing Kir4.1 and 
Kir5.1.  Bar=100 µm. 
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Fig I-3. Expression of Kir4.1 and Kir5.1 in trigeminal motor neurons.  Labelling of Kir4.1 and 
Kir5.1 proteins in trigeminal motor neurons of rats.  DAB immunocytochemistry was performed 
on brainstem (pons) sections (40 µm) at the area of the trigeminal motor neurons. At 10x these 
neurons were differentially stained with some showing strong labelling for Kir4.1 (B1) and 
Kir5.1 (D1).  Higher magnification (20x) revealed expression of both Kir4.1 (B2) and Kir5.1 
(D2).  For the controls the pontine sections were treated in a similar manner as the experimental 
sections except the control sections were not exposed to the primary antibody.  In both cases no 
DAB staining was detected in the absence of the primary antibody at low and high magnifications 
(A1, A2, C1, C2). The horizontal arrow in A1-D1 represents the 4th ventricle.  Vertical arrows in 
B2 and D2 represent typical trigeminal motor neurons expressing Kir channels.  Bar=100 µm. 
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Ib-3. Co-expression of Kir4.1 and Kir5.1 in Locus Coeruleus neurons of rats 
 
 There are several primary chemosensitive sites within the brainstem.  We focused 
our attention on the locus coeruleus (LC), because it is known to be highly 
chemosensitive (Elam et al., 1981; Haxhiu et al., 1996; Oyamada et al., 1998; Oyamada 
et al., 1999; Pineda & Aghajanian, 1997).  The ventilatory response to CO2 was 
significantly reduced in rats that had specific lesioning of LC neurons (Li & Nattie, 
2006).  According to the study carried out by Wu et al., Kir4.1 and Kir5.1 mRNA is 
highly abundant in the LC.  In addition to this, the LC is an easily identifiable nucleus in 
the brainstem with nearby markers such as the fourth ventricle and the trigeminal motor 
nucleus.  The neurons of the LC are densely packed and they are almost uniform in size.  
Since the LC is the major norepinephrine producing site in the brain, the presence of 
enzymes necessary for the production of NE is a useful tool used to identify the locus 
coeruleus. 
We performed DAB immunocytochemistry on 40 µm brainstem sections taken at 
the level of the pons as described in the materials and methods section.  Positive 
immunostains were identified for both Kir4.1 and Kir5.1 in the area of the LC (Fig. 4).  
As a positive control we assayed for expression of both channels in the trigeminal motor 
neurons in the same animals, as these motor neurons contain both Kir4.1 and Kir5.1 as 
previously mentioned.  Negative staining in the areas ventrolateral and dorsolateral to the 
trigeminal motor neurons again demonstrated the specificity of the antibodies (Fig. 4). 
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Fig I-4. The Kir4.1 and Kir5.1 expression in LC area.  DAB immunocytochemistry was 
performed on pontine sections (20 µm) at the region of the LC.  At 10x strong staining was seen 
in the LC nucleus for Kir4.1 (B1) and Kir5.1 (D1).  The staining was more apparent at a higher 
magnification (20x) for Kir4.1 (B2) and Kir5.1 (D2).  For the controls the pontine sections were 
treated in a similar manner as the experimental sections except the control sections were not 
exposed to the primary antibody.  In both cases no DAB staining was detected in the absence of 
the primary antibody at low and high magnifications (A1, A2, C1, C2).   The horizontal arrows in 
A1-D1 represent the 4th ventricle.  The arrow heads in B1 and D1represent trigeminal motor 
neurons expressing Kir4.1 and Kir5.1. The horizontal arrows in B2 and D2 represent typical 
neurons expressing Kir channels.    Bar=100 µm. 
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We took advantage of the fact that LC neurons, that have a diameter ranging from 15-25 
µM, produce norepinephrine to demonstrate the expression of the Kir4.1 and Kir5.1 
subunits in the same individual LC neurons.  The enzyme tyrosine hydroxylase (TH) is 
the rate limiting enzyme for the production of the catecholamines dopamine and 
norepinephrine.  Therefore, immunoassaying for TH would allow for the identification of 
LC neurons.  Brainstem sections were obtained at the level of the LC in the pons.  Groups 
of adjacent 10 µm sections were obtained using a cryostat.  Each group consisted of three 
consecutive sections that were used to stain for the presence of Kir4.1, Kir5.1 and TH.  
Using the DAB procedure described in the methods section we identified positive 
immunostains for Kir4.1, Kir5.1, and TH in the LC (Fig. 5).  Such a high magnification 
allowed for the positive detection of individual neurons identified by the presence of TH 
co-expressing the Kir4.1 and Kir5.1 (Fig. 5).   
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Fig I-5. Expression of Kir4.1 and Kir5.1 in individual LC neurons.  DAB immunocytochemistry 
was performed on three adjacent pontine sections (10 µm) at the region of the LC.  At 20x strong 
staining was seen in the LC nucleus for Kir4.1 (A1), Kir5.1 (B1), and TH (C1).  The staining was 
more apparent at a higher magnification (40x) (A2-C2).  For the controls the pontine sections 
were treated in a similar manner as the experimental sections except the control sections were not 
exposed to the primary antibody.  In each case no DAB staining was detected in the absence of 
the primary antibody at a high magnification (A3-C3). The red horizontal arrows represent the 
same LC neurons with positive labelling for Kir4.1, Kir5.1, and TH. The blue horizontal arrows 
represent the same LC neurons with positive labelling for Kir4.1 and Kir5.1.  Bar=50 µm. 
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To confirm the co-existence of the Kir4.1 and Kir5.1 in LC neurons we decided to use 
triple fluorescence immunocytochemistry.  Brainstem sections (20 µm) were obtained at 
the level of the LC in the pons and fixed on glass slides.  These sections were incubated 
with anti-Kir4.1, anti-Kir5.1 and anti-TH.  To simplify the antibody staining and reduce 
the amount of background signal we decided to use fluorescent conjugated secondary IgG 
antibodies for detection instead of the ABC method.  Kir4.1 was labeled with a 488-IgG 
fluorophore (green) (Fig. 6A); Kir5.1 with a 594-IgG fluorophore (red) (Fig. 6B); and TH 
with an AMCA-IgG (blue) (Fig. 6C).  Using these three fluorophores we assayed for 
positive immunostains for all three antigens in the same neurons.  Indeed, all three 
proteins were identified in the LC (Fig 6).  High magnification confocal images allowed 
us to view the expression at the single cell level.  When viewed at a higher magnification 
(40x) we were able to identify co-existence of both Kir4.1 and Kir5.1 in the same TH 
positive neurons (Fig. 6).  Taken together, these results suggest that the Kir4.1 and Kir5.1 
proteins co-exist in locus coeruleus neurons and the heteromeric channel may also exist 
here. 
Ib-4. Detection of the NK1R in the LC of Rats 
 
 The neuromodulators substance-P (SP) and serotonin (5-HT) have been shown to 
regulate the control of respiration (Moss et al., 1986; Nattie et al., 2004).  The receptors 
for these neurotransmitters are G protein coupled receptors (GPCRs).  Chemosensitive 
neurons co-expressing these receptors and the Kir4.1-Kir5.1 channel may be modulated 
by these neurotransmitters.  Therefore, we immunoassayed for the presence of the 
neurokinin-1 receptor (NK1R) and the serotonin 2A receptor subtypes (5-HT2AR) in the 
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LC of rats.  Using double fluorescence immunocytochemistry against TH (used to 
identify the LC) and the NK1R, we detected positive expression of the NK1R in a 
positive TH cluster of cells (Fig. 7A), suggesting that there may be a coupling of function 
between the Kir4.1-Kir5.1 channel and the NK1R as has been demonstrated  
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Fig I-6. Triple labelling of Kir4.1, Kir5.1 and TH in LC neurons. Fluorescence 
immunocytochemistry was performed on brainstem sections (20 µm) at the region of the LC.  
Strong staining was seen in LC neurons for Kir4.1 (A2), Kir5.1 (B2), and TH (C2) at 20x 
magnification using a confocal microscope.  Higher magnification (40x) revealed expression of 
Kir4.1 (A3) and Kir5.1 (B3) and TH (C3) in the LC. Panels D1-D3 show the overlay of A, B, and 
C.  The overlay shows the co-localization of Kir4.1, Kir5.1 and TH in the same individual LC 
neurons.  For the controls the pontine sections were treated in a similar manner as the 
experimental sections except the control sections were not exposed to the primary antibody.  In 
each case no fluorescence staining was detected in the absence of the primary antibody at a high 
magnification (A1, B1, C1).The box represents the area that was magnified to 40x.  Bar=40 µm. 
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Fig I-7. Expression of the NK1R in the LC. Fluorescence immunocytochemistry was performed 
ponto-medullary sections (20 µm) at the region of the LC.  Strong staining was seen in LC 
neurons for TH (A1) and the NK1R (A2) at 20x magnification using a confocal microscope.  The 
overlay shows that the NK1R is expressed in the same TH positive neurons (A3).  A4 shows the 
phase contrast. The same experiment was repeated for the 5-HT2A receptor.  Although there were 
positive labellings for TH (LC neurons) (B1), no labellings were seen for the 5-HT2A (B2).  The 
overlay shows that the 5-HT2A is not expressed in the same TH positive neurons (B3).  B4 shows 
the phase contrast.   For the controls the pontine sections were treated in a similar manner as the 
experimental sections except the control sections were not exposed to the primary antibody.  In 
each case no fluorescence staining was detected in the absence of the primary antibody at a high 
magnification (C1-C3). Bar=40 µm. 
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for G-protein coupled inward rectifier K+ (GIRK) channels.  The same experiment was 
carried out for the 5-HT2A receptor.  Unfortunately we failed to detect positive 
immunostains for the 5-HT2A in the LC of rats (Fig. 7B). 
Ib-5. Expression of Kir4.1, Kir5.1 and NK1R in the LC of mice 
 
  All of the previous experiments were carried out using Sprague Dawley rats.  We 
recently obtained a strain of transgenic mice that expresses GFP in the 98 % of LC 
neurons (van den Pol et al., 2002).  Therefore, we decided to take advantage of these 
transgenic (GFP expressing) LC mice to immunoassay for the co-existence of the Kir4.1 
and Kir5.1 proteins in the locus coeruleus.  In this way we could assay for expression of 
Kir4.1 and Kir5.1 without having to perform triple labelling.  This also made 
identification of the LC easier.  Single staining fluorescence immunocytochemistry 
showed the presence of the Kir4.1 and Kir5.1 in LC neurons of the GFP-transgenic mice 
(Fig. 8D-I). We immunoassayed for the neurokinin-1 receptor (NK1R) in these mice and 
similar to the results obtained with rats we also found expression of this receptor in the 
LC of mice (Fig. 8J-L). 
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Fig I-8. Expression of the Kir4.1, Kir5.1 and NK1R in the LC of mice. Fluorescence 
immunocytochemistry was performed on brainstem sections (20 µm) at the region of the LC.  
These mice express GFP in LC neurons as shown by panels B, E, H, and K.  Strong staining was 
seen in LC neurons of these mice for Kir4.1 (D) Kir5.1 (G) and the NK1R (J) at 20x 
magnification using a confocal microscope.  The overlay shows that the Kir4.1, Kir5.1 and NK1R 
are expressed in GFP positive LC neurons (F, I, L). For the controls the pontine sections were 
treated in a similar manner as the experimental sections except the control sections were not 
exposed to the primary antibody.  In each case no fluorescence staining was detected in the 
absence of the primary antibody at a high magnification (A1). Note that the trigeminal motor 
neurons were positively labeled for Kir4.1 and Kir5.1 as previously mentioned. Bar=40 µm. 
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I-c. DISCUSSION 
 
In the present study we have presented evidence for the expression of the Kir4.1 
and Kir5.1 proteins in neurons.  Our results show that hypoglossal motor neurons and 
trigeminal motor neurons contain both Kir4.1 and Kir5.1 subunits. There appeared to be a 
difference in the expression pattern of these two subunits.  The Kir4.1 subunit appeared 
to express predominantly on the surface of these motor neurons, whereas the Kir5.1 
channel was express throughout the cell.  However, both subunits were detected on the 
surface of several motor neurons suggesting that the heteromeric Kir4.1-Kir5.1 channel 
may be expressed there.  The expression of the heteromeric channel on the surface of 
these motor neurons may be important physiologically.  Both hypoglossal motor neurons 
and trigeminal motor neurons are chemosensitive (Komai et al., 1993; Necakov et al., 
2002).  Perhaps, the Kir4.1-Kir5.1 channel plays a role in the CO2 chemoreception of 
these motor neurons.   
We also showed evidence for the detection of both the Kir4.1 and Kir5.1 subunits 
in the same TH positive neurons using two different methods (DAB staining in adjacent 
sections and triple fluorescence immunoassaying in the same sections).  Although the 
DAB method is more sensitive than fluorescence we were able to detect significant levels 
of expression using triple labelling with fluorescence suggesting that the heteromeric 
Kir4.1-Kir5.1 channel may function in these LC neurons. 
This demonstration of the presence of the heteromeric Kir4.1-Kir5.1 channel in 
chemosensitive brainstem nuclei strengthens the candidacy of this channel as a central 
CO2 chemoreceptor molecule.  However, further functional studies with the Kir4.1-
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Kir5.1 in brainstem chemosensitive nuclei must be performed to solidify the roles of this 
channel in central CO2 chemoreception.  Now that we know the channel is expressed in 
brainstem neurons the next step is to demonstrate the role played by the channel in these 
brainstem neurons during central CO2 chemoreception.  Ultimately, the aim is to prove 
that the heteromeric Kir4.1-Kir5.1 channel is one of the central CO2 chemoreceptor 
molecules that have eluded researchers for more than 50 years. 
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I-d. SUMMARY AND CONCLUSION 
 
 Using immunocytochemistry we present evidence for the co-expression of the 
Kir4.1 and Kir5.1 proteins in the hypoglossal nucleus, the trigeminal motor nucleus, and 
the locus coeruleus (LC).  Both Kir4.1 and Kir5.1 subunits were present in these nuclei, 
suggesting that the heteromeric channel may be expressed in these cells.  We also show 
that the Kir4.1 and Kir5.1 subunits are located in the same tyrosine hydroxylase 
containing cells suggesting expression of the Kir4.1-Kir5.1 channel in the LC. The 
Kir4.1-Kir5.1 channel along with the NK1 receptor was also detected in LC neurons.  
Unfortunately, we were unable to obtain positive immunoassays for the 5-HT2A receptor 
in the LC.  Taken together these results suggest that the Kir4.1-Kir5.1 channel is indeed 
expressed in chemosensitive neurons and the channel may be regulated by 
neurotransmitters involved in the control of respiration. 
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II. MODULATION OF THE HETEROMERIC KIR4.1-KIR5.1 CHANNEL BY 
MULTIPLE NEUROTRANSMITTERS VIA Gαq-COUPLED 
RECEPTORS* 
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*In this part, Dr. Junda Su prepared 80 % of the neuronal cultures for MEA recording and 
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recordings.  Mr. Ming Lee and Ms. Xiaoli Zhang performed 20 % of the 
immunocytochemistry on the cultured neurons.  Ms. Dyanna Fountain constructed 30 % 
of the mutations on the Kir4.1-Kir5.1 channel and prepared cDNAs for injection.  I 
greatly appreciate all of their help. 
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IIa. INTRODUCTION 
 
 It is known that the brainstem control of respiration relies on several 
neurotransmitters including serotonin (5-HT), substance-P (SP) and thyrotropin releasing 
hormone (TRH) (Cream et al., 1997; Dekin et al., 1985; Moss et al., 1986; Mutolo et al., 
1999; Nattie et al., 2004; Nink et al., 1991; Pete et al., 2002; Richerson, 2004; Richerson 
et al., 2005; Schulz et al., 1996; Severson et al., 2003; Taylor et al., 2005; Wang et al., 
2001). Site-specific injections of these neurotransmitters can potently stimulate 
ventilation. Systemic CO2 response is reduced by selective disruption of serotonergic 
neurons and neurons expressing the neurokinin-1 receptor (NK1R) (Hodges et al., 2004; 
Nattie & Li, 2002; Wenninger et al., 2004a; Wenninger et al., 2004b). Receptors for these 
neurotransmitters have been identified in the ventral and dorsal respiratory groups (VRG, 
DRG). Midline raphe neurons that are known to be CO2 chemosensitive and project to 
the DRG and VRG also contain these neurotransmitters, suggesting that they may 
modulate the neuronal response to hypercapnia (Richerson, 2004; Richerson et al., 2005; 
Severson et al., 2003).  Therefore, we tested whether the Kir4.1-Kir5.1 channel is a 
downstream target of these neurotransmitters as this channel is expressed CO2 
chemosensitive neurons.  
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IIb. RESULTS 
 
IIb-1. Inhibition of the Kir4.1-Kir5.1 channel by SP, 5-HT, and TRH  
 The NK1 receptor cDNA was co-injected into Xenopus oocytes together with the 
Kir4.1-Kir5.1 tandem dimer cDNA. Inward rectifying currents were recorded from the 
oocytes 2-3 days post injection using two-electrode voltage clamp with the bath solution 
containing 90 mM K+. Typical Kir4.1-Kir5.1 currents were revealed: small outward 
currents and large inward currents with slow activation at highly negative membrane 
potentials (Fig. 1A, B, C). Following stabilization of the baseline, the Kir4.1-Kir5.1 
currents were inhibited by an exposure to 1 μM SP applied to the bath (Fig. 1A). Similar 
experiments were done by expressing the Kir4.1-Kir5.1 with the 5-HT2A or mTRH-R1 
receptor. The currents were inhibited by 40 μM 5-HT and 100 μM TRH, respectively 
(Fig. 1B, C).  
The current-voltage (I-V) relationship was examined for the neurotransmitter 
effects. Currents were recorded at baseline as well as at the peak plateau effect after 
exposure to 1 μM SP, 40 μM 5-HT, and 100 μM TRH, respectively. Both currents were 
then normalized to -160 mV and plotted against the membrane potential. The I-V plot 
indicated that current inhibition occurred at all negative membrane potentials and did not 
show evident voltage-dependence (Fig. 1D, E, F). Recordings using a ramp protocol 
showed that the Kir4.1-Kir5.1 channel was inhibited by SP, 5-HT, and TRH in both 
negative and positive membrane potentials without a change in rectification (Fig. 1G, H, 
I).  
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Fig II-1. Kir4.1-Kir5.1 channel is inhibited by SP, 5-HT, and TRH. A, B, C. Using TEVC whole-
cell Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days post-injection of the Kir4.1-
Kir5.1 dimer cDNA along with the NK1R, 5-HT2A, and mTRH-R1 receptor cDNAs. With 90 
mM K+ in the extracellular solution inward rectifying currents were recorded at baseline. 
Membrane potential (Vm) was held at 0 mV. A series of command pulse potentials from –160 mV 
to 140 mV with a 20-mV increment was applied to the cell. Note that in highly negative 
membrane potentials, there was slow activation of the currents. Exposure by bath application to 1 
µM SP, 40 µM 5-HT, and 100 µM TRH inhibited the currents by 36, 34, and 30%, respectively. 
D, E, F. When baseline and peak PMA affected currents were scaled to the same magnitude at -
160 mV, the I/V relationship of the currents recorded under these two conditions were 
superimposed, suggesting that the effects were voltage-independent. G, H, I. Using TEVC whole-
cell Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days post-injection of the Kir4.1-
Kir5.1 dimer cDNA along with the NK1R, 5-HT2A, and mTRH-R1 receptor cDNAs. With 90 
mM K+ in the extracellular solution inward rectifying currents were recorded at baseline. 
Membrane potential (Vm) was held at 0 mV with -100 mV and 100 mV applied to the cell using a 
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ramp protocol. Exposure to 1 µM SP, 40 µM 5-HT, and 100 µM TRH inhibited the currents in a 
similar manner as in A, B, C. 
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The response to SP, DOI (a potent 5-HT2A agonist), and TRH showed clear dose 
dependence. The maximum inhibition by SP (44.6±4.6% (n=9) occurred with 50 μM SP 
(Fig. 2A). Channel inhibition (8.7±1.2%, n=4) was seen with SP concentrations as low as 
1 nM. Similarly, 160 μM DOI produced the maximum inhibition of the Kir4.1-Kir5.1 
currents by 56.1±6.8% (n=4), while significant channel inhibition was seen with 10 μM 
DOI (21.9±7.5%, n=7) (Fig. 2B). Dose-dependent inhibition was also observed with TRH 
(Fig. 2C). The concentrations represented by the gray bars in Figure 2 were used in 
subsequent experiments as these concentrations are within the physiological range and 
have been used before (Bajic et al., 2002; Cream et al., 1997; Koike-Tani et al., 2005; Lei 
et al., 2001; Mao et al., 2004; Mutolo et al., 1999). 
 Specificity of the neurotransmitter effects was examined using specific 
antagonists. Pre-incubation of oocytes expressing the Kir4.1-Kir5.1+NK1R with 10 μM 
spantide I, a competitive peptide antagonist for SP, markedly attenuated the effect of 1 
μM SP (Fig. 2D). Higher concentrations of spantide I (30 μM) more potently attenuated 
the effect of 1 μM SP by over 60% (15.9±4.6% inhibition, n=4) (Fig. 2D). Similar 
attenuation was seen with 10 μM L-703,606, a non-competitive receptor blocker 
(23.7±3.0%, n=4) (Fig. 2D). Pre-incubation of oocytes expressing the Kir4.1-Kir5.1+5-
HT2A with 40 μM ketanserin or 40 μM spiperone, two 5-HT2A receptor antagonists, 
almost completely abolished the effect of 40 μM DOI that inhibited the currents by 
5.3±4.5% (n=6) and 8.9±3.1% (n=5), respectively (Fig. 2E). Since there is no 
commercially available antagonist for the mTRH-R1 receptor, we used the mTRH-R2 
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receptor to demonstrate the specificity as it is less sensitive to TRH than the mTRH-R1 
receptor. Indeed,  
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Fig II-2. Specificity and concentration-dependence of the neurotransmitter effect. A, B, C. The 
effect of SP, DOI, and TRH on the Kir4.1-Kir5.1 channel was clearly concentration-dependent 
(n≥4). The Kir4.1-Kir5.1 channel was inhibited by low concentrations of each agonist. Exposure 
to higher concentrations of the agonists resulted in greater channel inhibition. The gray bars 
represent the concentrations used for further experiments. The concentrations in A and B are µM.  
The concentrations in C are mM.  D, E, F. Specificity for the receptor-mediated channel 
inhibition was studied. The channel inhibition was attenuated in the presence of specific 
antagonists of the neurotransmitters or receptors. The Kir4.1-Kir5.1 channel expressed without 
receptors failed to be inhibited by the neurotransmitters. Also, SP, DOI, and TRH failed to inhibit 
the homomeric Kir4.1 channel expressed with the respective receptors. n≥4 for each experiment. 
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100 μM TRH inhibited the Kir4.1-Kir5.1+mTRH-R1 to a greater degree than the Kir4.1-
Kir5.1+mTRH-R2 (Fig. 2F).  
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 Injection of the Kir4.1 cDNA along with the NK1R, 5-HT2A, or mTRH-R1 
expressed typical Kir4.1 currents. Strikingly, the homomeric Kir4.1 channel was not 
capable of being inhibited by SP, DOI, or TRH (Fig. 2D, E, F). Furthermore, the Kir4.1-
Kir5.1 channel expressed without exogenous receptors failed to be inhibited by SP, DOI 
and TRH (Fig. 2D, E, F). Taken together these results strongly suggest that inhibition of 
Kir4.1-Kir5.1 currents by SP, DOI, and TRH is specific depending on their receptors and 
requiring the expression of both Kir4.1 and Kir5.1 subunits. 
  Although the exposure was carried out by application of the neurotransmitters to 
the bath solution, the time-dependent inhibition occurred rapidly. The inhibition started 
within the first minute and reached a maximal effect in ~15 min (Fig. 3A, B). At the 
maximal effect, 37.8% of the inward rectifying currents were inhibited by 1 μM SP. The 
effect of DOI on the Kir4.1-Kir5.1 currents was also time dependent. The inhibition 
occurred rapidly, starting within the first minute after exposure to the chemicals and 
reaching a maximal effect in ~10 min (Fig. 3C, D). In the presence of 100 μM TRH the 
Kir4.1-Kir5.1 currents were inhibited by 29% with a rapid onset and reaching a maximal 
effect in ~10 min (Fig. 3E, F). Thereafter, all neurotransmitter experiments were done 
with a 10-20 min exposure. 
The Kir4.1-Kir5.1 co-expressed with the mu-opioid receptor (MOR) failed to be 
regulated by 1 μM DAMGO, an enkephalin analog and potent activator of the MOR (Fig. 
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3G, H). Since the MOR is also a GPCR, this result suggests that the Kir4.1-Kir5.1 
channel may not interact with G-proteins directly.  
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Fig II-3. Time-dependent effects. A. Using TEVC whole-cell Kir4.1-Kir5.1 currents were 
recorded from an oocyte 3 days post-injection of the Kir4.1-Kir5.1 dimer cDNA along with the 
NK1R receptor cDNA. With 90 mM K+ in the extracellular solution inward rectifying currents 
were recorded at baseline. Membrane potential (Vm) was held at 0 mV. A series of command 
pulse potentials from –160 mV to 140 mV with a 20-mV increment was applied to the cell. 
Exposure to 1µM SP inhibited the channel currents by ~36%. B. The time profile showed that the 
current amplitude decreased rapidly when SP was present in the bath solution, and reached 
maximum inhibition in ~15 min. C. Whole cell currents were recorded from an oocytes 3 days 
post injection of the Kir4.1-Kir5.1 tandem-dimer along with the 5-HT2A as described in A. D. 
The time profile shows that DOI decreased the current amplitude rapidly when applied to the bath 
solution. The maximum inhibition was reached in ~10 min. E. Whole cell currents were recorded 
from an oocytes 3 days post injection of the Kir4.1-Kir5.1 tandem-dimer along with the mTRH-
R1 as described in A. F. The time profile shows that TRH decreased the current amplitude rapidly 
when applied to the bath solution. The maximum inhibition was reached in ~10 min. G. Using 
TEVC whole-cell Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days post-injection of 
the Kir4.1-Kir5.1 dimer cDNA along with the mu-opioid receptor (MOR) cDNA as described in 
A. Exposure to 1 µM DAMGO failed to affect the channel currents H. The time profile shows 
that the current amplitude did not change when DAMGO was present in the bath solution. 
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IIb-2. PKC involvement in the modulation of the Kir4.1-Kir5.1 channel by the 
neurotransmitters  
 The NK1, 5-HT2A, and TRH-R1 are G-protein coupled receptors (GPCRs). 
These receptors share a common cascade following ligand binding involving activations 
of Gαq, phospholipase C and protein kinase C (PKC). The latter has been shown to 
phosphorylate several Kir channels and regulate their activity (Fakler et al., 1994; Henry 
et al., 1996; Light et al., 2000; Zhu et al., 1999). For instance, we have previously shown 
that protein kinase C (PKC) phosphorylation underscores the inhibition of GIRK 
channels by SP (Mao et al., 2004). Therefore, we conducted experiments to determine 
whether PKC was involved in the Kir4.1-Kir5.1 channel inhibition by SP, DOI, and TRH 
as both the Kir4.1 and Kir5.1 subunits contain putative PKC phosphorylation sites. Pre-
incubation of oocytes expressing Kir4.1-Kir5.1+NK1R, Kir4.1-Kir5.1+5-HT2A, or 
Kir4.1-Kir5.1+mTRH-R1 with the specific PKC inhibitor chelerythrine showed a clear 
attenuation of the SP, DOI, and TRH effects (Fig. 4A, B, C). Calphostin-C, another 
specific and potent PKC inhibitor, showed strong attenuations of the channel inhibition to 
6.7±2.8% (n=6), 3.4±10.8% (n=6), and 11±4.0% (n=8) by SP, DOI, and TRH, 
respectively (Fig. 4A, B, C).  
 Exposure of oocytes expressing Kir4.1-Kir5.1+NK1R to 15 nM PMA, a specific 
and potent PKC activator, inhibited Kir4.1-Kir5.1 currents by 39.8±5.5% (n=5). The 
same degree of inhibition was also seen in the absence of the NK1R suggesting that the 
effect is not mediated by receptor phosphorylation (data not shown). The inhibition by 1 
μM SP was significantly lessened when the oocytes were prior exposed to PMA (Fig. 
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4D). Similar effects were observed for DOI and TRH (Fig. 4E, F). The attenuation of 
PKC activation was also observed when the order of the neurotransmitter and PMA 
exposure was reversed, suggesting that the effects of the neurotransmitters and PMA are 
mediated via a common mechanism (Fig. 4G, H, I).  
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Fig II-4. Involvement of PKC in the Kir4.1-Kir5.1 inhibition by SP, DOI and TRH. A, B, C. 
Currents were recorded from an oocyte in the same condition as in Figure 1A. Prior to exposure 
to SP, DOI or TRH the cells were incubated with PKC inhibitors. Pre-incubation of oocytes with 
specific PKC inhibitors (50 μM chelerythrine or 3 μM calphostin-C) strongly attenuated the effect 
of SP, DOI, and TRH (n≥4). D, E, F. Currents were recorded from an oocyte in the same 
condition as in Figure 1A. Following exposure to 15 nM PMA for ~30 minutes the cells were 
subsequently treated with 1 µM SP or 40 µM DOI. Prior exposure to PMA resulted in a much 
lower channel response to the neurotransmitters. Instead of 36% current inhibition for SP and 
43% current inhibition for DOI, the Kir4.1-Kir5.1 currents were barely inhibited (>10%).G, H, I. 
Currents were recorded from an oocyte in the same condition as in Figure 1A. Following 
exposure to SP, DOI or TRH the cells were subsequently treated with 15 nM PMA. Prior 
exposure to the neurotransmitters resulted in a reduced response to PMA. Instead of 40% current 
inhibition as indicated by the dashed lines, the Kir4.1-Kir5.1 currents were inhibited by 0~20%.  
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IIb-3. Effects of SP on single-channel properties 
 
 To identify the exact channel mechanism leading to a decrease in the whole cell 
currents, the effect of SP on the single-channel biophysical properties was studied in cell-
attached patches with 145 mM K+ applied to the extracellular solution at a membrane 
potential of -80 mV. Inward rectifying currents with a single-channel conductance of ~40 
pS (Pessia et al., 1996; Tanemoto et al., 2000; Tanemoto et al., 2004) showing long-
lasting openings and closures were recorded from oocytes expressing the Kir4.1-
Kir5.1+NK1R (Fig. 5). These currents were inhibited with an exposure to 1 μM SP (Fig. 
5A, B). Macroscopic currents also showed a clear inhibition by application of SP to the 
bath solution (Fig. 5C). The current inhibition was mainly produced by a suppression of 
the channel open-state probability (NPo). Plotting the baseline NPo versus SP NPo shows 
a clear reduction in the NPo (0.43±0.11 at baseline vs. 0.06±0.01 with SP, n=7), while the 
single-channel conductance did not show any significant changes (Fig. 5D).  
IIb-4. Relationship with CO2/pH Sensitivity  
 
 We have previously shown that the Kir4.1-Kir5.1 channel is strongly inhibited by 
intracellular acidosis (Cui et al., 2001; Xu et al., 2000a; Yang et al., 2000). To understand 
whether the neural modulation affects the channel sensitivity to pH, the Kir4.1-Kir5.1 
channel was co-expressed in Xenopus oocytes with the NK1R or 5-HT2A. Following 
stabilization the cells were perfused with 1 μM SP or 40 μM DOI until the plateau effect 
was reached. Subsequently, the cells were exposed to 90 mM KHCO3 that has been 
shown to reduce intracellular pH (pHi) to ~6.6. Intracellular acidosis inhibited the Kir4.1-
Kir5.1 channel expressed without receptors by 58.2±2.4% (n=8), by 60.8±1.5% (n=9) in 
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the presence of the NK1R and by 55.0±3.7% (n=5) with the 5-HT2A receptor, 
respectively. No significant difference was found, suggesting that the presence of the 
receptors do not interfere with the channel sensitivity to CO2. Following SP and DOI  
 
Fig II-5. Effects of SP on the single channel activity of Kir4.1-Kir5.1. A. Single Kir4.1-Kir5.1 
currents were recorded from an oocyte in a cell-attached patch configuration with 145 mM K+ in 
the patch pipette. At Vm of -80 mV, two active channels are seen at pH 7.4. B. Following 
stabilization, exposure to 1 µM SP reduced the channel activity mainly by a decrease in the NPo. 
Labels on the left: c, closure; 1, the first opening; 2, the second opening; etc. Labels on the top 
represent NPo at baseline and NPo at SP exposure level. C. Reduction of the macroscopic inward 
currents can be seen in the cell-attached patch configuration. D. Bargraph showing that 1 µM SP 
drastically reduced the NPo, but only slightly affected the single-channel conductance (n≥6). 
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exposure all of the oocytes tested were further inhibited by intracellular acidosis in the 
presence of the neurotransmitters (Fig. 6A, D), and recovered with washout. The time 
course showed that following SP and DOI inhibition, the channel was rapidly inhibited 
by intracellular acidosis to the same degree as in the absence of the neurotransmitters 
(Fig. 6B, E), suggesting that the neurotransmitters and CO2 inhibit the channel through 
independent mechanisms. Also both CO2 and neurotransmitters have a partial additive 
effect leading to a stronger channel inhibition when both are present (P<0.05, n≥4; Fig. 
6C, F). The same experiments were repeated with 15% CO2 and similar results were 
obtained (Fig. 6C, F). 
 
 
92 
 
 
Fig II-6. Independent regulation of the Kir4.1-Kir5.1 channel by neurotransmitters and pHi. A, B. 
Using TEVC whole-cell Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days post-
injection of the Kir4.1-Kir5.1 dimer cDNA along with the NK1R. With 90 mM K+ in the 
extracellular solution inward rectifying currents were recorded at baseline. Membrane potential 
(Vm) was held at 0 mV. A series of command pulse potentials from –160 mV to 140 mV with a 
20-mV increment was applied to the cell. Following exposure to 1 µM SP, the cells were 
perfused with 90 mM KHCO3 (pHi≈6.6). Such an exposure resulted in a further inhibition of the 
Kir4.1-Kir5.1 currents to the degree identical to that of KHCO3 exposure alone, suggesting that 
the two channel inhibitors are independent of each other. Washout allowed the currents to recover 
to the level prior to KHCO3 exposure. C. The percent effect shows that exposure to SP/KHCO3 
gives a larger inhibition of the Kir4.1-Kir5.1 currents than either modulator alone. D, E. Using 
TEVC whole-cell Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days post-injection of 
the Kir4.1-Kir5.1 dimer cDNA along with the 5-HT2A in a similar manner as in A. Following 
exposure to 40 µM DOI, the cells were perfused with 90 mM KHCO3 (pHi≈6.6). Such an 
exposure resulted in a further inhibition of the Kir4.1-Kir5.1 currents. Washout allowed the 
currents to recover to the level prior to KHCO3 exposure. F. The percent effect shows that 
exposure to DOI/KHCO3 gives a larger inhibition of the Kir4.1-Kir5.1 currents than either 
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modulator alone. Both sets of experiments were repeated with 15% CO2 represented by the gray 
bars. n≥4 for each experiment. The SP and DOI effects are relatively slow and long-lasting, while 
the effect of 90 mM KHCO3 is rapid and fully reversible. The asterisk represents the comparable 
difference between KHCO3 and neurotransmitter+KHCO3 as well as the comparible difference 
between 15% CO2 and the neurotransmitter+15% CO2. Differences were considered to be 
statistically significant if P ≤ 0.05.  The arrows in B and E represent the time points shown in panels 
A and D. 
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IIb-5. Modulation of brainstem neurons by neurotransmitters 
 
 To demonstrate the modulation of brainstem neurons by the neurotransmitters SP 
and 5-HT we took advantage of multi-electrode array (MEA) technology. Neurons were 
isolated from the brainstem of fetal rats and cultured on MEA dishes as detailed in the 
methods section (Su & Jiang, 2006; Su et al., 2007). Extracellular recordings were carried 
out in the DMEM medium at 37 ºC. Single-unit recordings were identified using the 
Offline Sorter software based on the principal component analysis methods (Horn & 
Friedman, 2003). Single-unit recordings were also determined by the absence of action 
potentials in the initial period (5-100ms) of the inter-spike histogram. Most spikes 
showed a negative-positive waveform with a duration > 1 ms, suggesting that they were 
recorded from the soma (Gustafsson & Jankowska, 1976; Jiang & Lipski, 1990). 
Neuronal responses to CO2, SP and DOI were studied. Changes in neuronal firing rate 
were determined with a change in CO2 from 5% (basal level) to 9.2% (hypercapnia). The 
CO2-augmented units whose firing rate increased during acidosis (Fig. 7A, E) were 
chosen for further study, although neurons that were inhibited by CO2 or showed no 
response were also observed (Su and Jiang, 2006; Su et al., 2007). Following washout of 
the CO2, the cells were exposed to SP and DOI that augmented reversibly the firing 
frequency of a group of neurons (Fig. 7B, C, F, G). To determine whether PKC played a 
role, 100 nM calphostin-C was applied to the MEA dish for 1 hour prior to application of 
SP and DOI. Action potentials were recorded before and after application of calphostin-
C. In the presence of calphostin-C, SP and DOI only modestly augmented the firing rate 
(Fig. 7D, H). Statistical analysis showed that the difference in the effects of SP and DOI 
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before versus after calphostin C treatment was significantly different (P<0.01 for both SP 
and DOI) (Fig. 7D, H).  
Immunocytochemistry showed that both Kir4.1 and Kir5.1 subunits were co-
localized in cultured brainstem neurons that also displayed positive immunoreactivity of 
the microtubule-associate protein 2 (MAP2) (Fig. 8). Control experiments were 
performed with HEK293 cells, demonstrating the specificity of the anti-Kir4.1 and anti-
Kir5.1 antibodies (shown in prior part).  
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Fig II-7. Modulation of brainstem neurons by neurotransmitters. A. A single unit was recorded 
from a 14-day brainstem neuronal culture using the multiple electrode arrays technique in 5% 
CO2. The spikes had a negative-positive waveform with a duration >1 ms, and the 2D cluster plot 
and the interspike interval (ISI) histogram indicated single-unit recording. Increasing CO2 to 
9.2% augmented the firing frequency shown in a period of 5 min. B. The same unit recorded in A 
was stimulated during exposure to 1 μM SP. C. The effect of SP on the average firing frequency 
from a 5 min recording. SP1=the first recording taken following SP application.  SP2=the second 
recording taken following SP application.  Nine units were stimulated during SP exposure. 
Washout led to complete recovery. D. Following pre-incubation with 100 nM calphostin-C (cal-
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C) for 1 hour the stimulatory effect of SP was greatly reduced. E. A single unit was recorded from 
a 14-day brainstem neuronal culture using the multiple electrode arrays technique in 5% CO2. 
The spikes had a negative-positive waveform with a duration >1 ms, and the 2D cluster plot and 
the interspike interval (ISI) histogram indicated single-unit recording. Increasing CO2 to 9.2% 
augmented the firing frequency shown in a period of 5 min. F. The same unit recorded in E was 
strongly stimulated during exposure to 40 μM DOI. G. The effect of DOI on the average firing 
frequency from a 5 min recording. Ten units were stimulated during DOI exposure. Washout led 
to complete recovery. DOI1=the first recording taken following DOI application.  DOI2=the 
second recording taken following DOI application.  H. Following pre-incubation with 100 nM 
calphostin-C for 1 hour the stimulatory effect of DOI was greatly reduced. CTL=control, 
SP=substance P, DOI=4-Iodo-2, 5-dimethoxyamphetamine, WS=washout. 
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Fig II-8. Expression of Kir4.1-Kir5.1 in brainstem neurons. A. Immunocytochemistry was 
performed on cultured brainstem neurons. A. Shows positive immunoassaying for Kir4.1. B. 
Shows positive immunoassaying for Kir5.1. C. Blue fluorescence indicates the presence of the 
neuronal marker microtubule associated protein 2 (MAP2). D. Overlay of A, B, C. The horizontal 
arrows represent typical neurons expressing the Kir4.1 and Kir5.1 subunits. Vertical arrows 
represent typical glia cells expressing Kir4.1 and Kir5.1. Horizontal arrowheads indicate neurons 
void of Kir4.1 and Kir5.1. The vertical arrowheads indicate glia void of Kir4.1 and Kir5.1. E. 
Shows the phase contrast (note that majority of cells are neurons). Bar=20 µm. 
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IIb-6. Amplification of CO2 chemosensitivity by synaptic transmission  
 
The high sensitivity of central chemoreceptors may be attributed to a potential 
amplification mechanism in the neuronal network. If this is the case, blockade of 
presynaptic input should reduce neuronal CO2 chemosensitivity. We thereby performed 
studies to test this hypothesis. Since several groups of serotonin producing neurons in the 
brainstem are CO2 chemosensitive (Wang et al. 1998; Severson et al. 2003), we used 20 
μM ketanserin to block 5-HT2A receptors known to play an important role in respiratory 
control (Richerson 2004; Tryba et al. 2006). Ketanserin markedly diminished neuronal 
responses to hypercapnia from 4.88 ± 0.84 Hz to 3.07 ± 0.69 Hz (P<0.001, n=28, paired t 
test) (Fig. 9, Fig. 10A). Amongst 29 CO2-stimulated units in 3 MEA dishes, only 2 cells 
lost their CO2 sensitivity completely. The CO2 chemosensitivity of such a small number 
of cells was interpreted to be derived solely from presynaptic input. The other 27 units 
remained to be stimulated by hypercapnia to various degrees. Of these 27 units, 20 
showed significant reduction in their CO2 sensitivity, suggesting that the CO2 
chemosensitivity of most neurons is determined by both pre- and postsynaptic 
mechanisms. The CO2 chemosensitivity of the remaining 7 units was either retained 
(n=2) or slightly enhanced (n=5) with ketanserin, suggesting that their CO2 
chemosensitivity is independent of serotonergic input or slightly inhibited by serotonergic 
input.  
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Fig II-9. Neuronal FR before, during and after ketanserin during CO2 exposure.  Neuronal FR 
was studied before, during and after ketanserin (20µM) exposure in two MEA dishes. Neuronal 
FR was normalized to the peak frequency, and plotted against PCO2 levels. Ketanserin drastically 
attenuated neuronal response to hypercapnia (0.62 ± 0.06 to 0.79 ± 0.04, P<0.05, n=28, 
ANOVA). C is the slope of the bold black line and it represents the sensitivity index that was 
determined: ΔFR / ΔPCO2, where ΔFR is the percentage change in the firing rate and ΔPCO2 is the 
change in PCO2 (mm Hg). The value C = 0.0067 corresponds to a 0.67% change in FR per mm Hg 
PCO2. 
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Another group of candidate CO2 chemoreceptors are glutamatergic neurons, 
especially those in the retrotrapezoid nucleus that are activated by glutamate (Mulkey et 
al. 2004). We found that neuronal CO2 sensitivity was significantly inhibited from 2.41 ± 
0.57 Hz to 1.40 ± 0.44 Hz (P<0.001, n=28, paired t test) in the presence of 10μM CNQX, 
a non-NMDA receptor antagonist (23 reduced, 2 enhanced, and 4 lost response out of 29 
units in 4 MEAs) (Fig. 10B). Similar effect was found with blockade of NK1 receptors 
(from 1.57 ± 0.40 Hz to 0.85 ± 0.25 Hz; P<0.01, n=21, paired t test) in the presence of 
100μM spantide (of 22 units in 3 MEAs, CO2 sensitivity was reduced in 17 units, 
enhanced in 3, and lost in 2) (Fig. 10C). In contrast, blockade of purinergic P2x receptors 
that have been suggested to be involved in CO2 chemosensitivity (Thomas et al. 1999; 
Gourine et al. 2005) with 10μM PPADS did not show any significant effect (from 2.24 ± 
0.79 Hz to 2.66 ± 0.92 Hz; P>0.05, n=36) (Fig. 10D), suggesting that the enhancement of 
CO2 chemosensitivity is rather specific to certain synaptic connections. 
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Fig II-10. A. Average FR with and without ketanserin during CO2 exposure.  When the average 
FR was compared with and without ketanserin, significant reductions in the FR were seen during 
CO2 (70 mm Hg) exposure (P<0.001, n=28 from 3 MEAs, paired t test). B,C. Similar attenuations 
of the hypercapnic response were observed with CNQX (P<0.001, n=28 from 4 MEAs, paired t 
test) and spantide (P<0.01, n=21 from 3 MEAs, paired t test). D. PPADS, a P2x receptor blocker, 
did not have significant effect (P>0.05, n=36 from 3 MEAs, paired t test). Note that the units 
studied did not show significant differences in their baseline FR with and without the blockers 
(A-D). 
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IIc. DISCUSSION 
 
In the present study, we have demonstrated a novel property of the Kir4.1-Kir5.1 
channel but not the Kir4.1, i.e., the capability to be modulated by several 
neurotransmitters. This finding provides more evidence for the functional significance of 
the heteromultimerization.  
The Kir4.1 and Kir5.1 subunits are expressed in brainstem neurons. The mRNAs 
of both Kir subunits have been detected in various nuclei within the brainstem (Wu et al., 
2004). Several studies have demonstrated specific expression of Kir4.1 and Kir5.1 at the 
protein and mRNA level in oligodendrocytes and astrocytes in the CNS (Hibino et al., 
1999; Hibino et al., 2004; Higashi et al., 2001). Here, we have shown expression of both 
the Kir4.1 and Kir5.1 proteins in cultured brainstem neurons. Although direct evidence 
demonstrating the involvement of this channel in central CO2 chemoreception is lacking 
the co-expression of the Kir4.1 and Kir5.1 subunits in the same neurons strongly suggests 
that the heteromeric Kir4.1-Kir5.1 channel may form in brainstem neurons.  
Several neurotransmitters are particularly important for the brainstem control of 
respiration including substance-P, serotonin, and thyrotropin releasing hormone. These 
neuromodulators have been shown to regulate central respiratory activity in vitro and in 
vivo (Cream et al., 1997; Dekin et al., 1995; Hodges et al., 2004; Moss et al., 1986; 
Mutolo et al., 1997; Nattie & Li, 2002; Nattie et al., 2004; Nink et al., 1991; Pete et al., 
2002; Richerson, 2004; Richerson et al., 2005; Schulz et al., 1996; Severson et al., 2003; 
Taylor et al., 2005; Wang et al., 2001; Wenninger et al., 2004a; Wenninger et al., 2004b). 
In the present study, we have shown evidence for the inhibition of the heteromeric 
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Kir4.1-Kir5.1 channel by these neurotransmitters. Exposures to SP, 5-HT, and TRH 
resulted in inhibition of the Kir4.1-Kir5.1 channel currents when the channel was 
expressed with the corresponding receptors in Xenopus oocytes. The neurotransmitter 
effects were reversible, specific and dependent on ligand concentrations. The current 
inhibition is voltage-independent and is mediated by selective inhibition of Po with no 
effect on single-channel conductance. 
 We previously showed that PKC underscored the inhibition of GIRK channels by 
substance-P (Mao et al., 2004). Therefore, we assayed for the involvement of PKC in the 
inhibition of the heteromeric Kir4.1-Kir5.1 channel by SP, DOI and TRH. Our results 
suggest that PKC activation also underscores the inhibition of the Kir4.1-Kir5.1 channel 
by these neurotransmitters. In cultured brainstem neurons, inhibition of PKC led to a 
dramatic attenuation of the augmentation of the firing frequency in neurons by SP and 
DOI, suggesting that PKC activation also underscores the SP and DOI dependent 
increase in the firing rate of the cultured brainstem neurons. 
The modulation of the Kir4.1-Kir5.1 channel by SP, 5-HT, and TRH does not 
compromise the channel sensitivity to pH, as we have shown that the application of both 
modulators combined had a greater inhibitory effect on the channel than either modulator 
alone. This is important physiologically as we know that during central CO2 
chemoreception, there is an amplification of the CO2 signal. 
The neural modulation described in the present study seems to enable the Kir4.1-
Kir5.1 channel to function as a distinct member in the Kir channel family. It is known 
that GIRK channels play a role in neurotransmission (Jan & Jan, 1997; Luscher et al., 
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1997; Yamada et al., 1998). A common characteristic of these channels is that their 
activity is controlled by neurotransmitters and hormones. Clearly such a property is 
shared by the Kir4.1-Kir5.1 channel, as shown in our current studies.  
The neural modulation shown in the present study does not occur in the 
homomeric Kir4.1 channel and relies on the Kir5.1 that is known to form heteromeric 
channels only with Kir4x (Casamassima et al., 2003; Konstas et al., 2003; Pessia et al., 
2001; Tanemoto et al., 2000). Thus, the expression of the Kir4.1 in cells allows two 
functional properties that both can control membrane potential and cellular excitability 
with one of them regulated by extracellular messengers. All of these functional properties 
therefore allow diverse cellular responses that appear to fit well to the diverse cellular 
functions in the brainstem and other systems.  
Previous studies have demonstrated the presence of CO2 chemosensitivity in both 
pre- and postsynaptic neurons (Kawai et al 1996; Kawai et al., 2006; Richerson 1995; 
Stunden et al 2001; Takakura 2006), which we inferred may allow an amplification of 
PCO2 signals detected by each cell. Consistent with this scenario, our results indicate that 
CO2 chemosensitivity is significantly reduced when 5-HT2A, NK1 or non-NMDA 
receptors are blocked, all of which are receptors for neurotransmitters that play an 
important role in the modulation of central respiratory activity and CO2 chemosensitivity 
(Feldman et al, 2003; Richerson 2004; Guyenet 2005). Blockade of the P2x receptor, 
however, did not produce evident attenuation of the CO2 chemosensitivity, consistent 
with two recent studies showing lack of effect on the CO2 chemosensitivity by P2x 
receptor blockade (Lorier et al., 2004; Mulkey et al. 2006). 
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IId. SUMMARY AND CONCLUSION 
 
The heteromeric Kir4.1-Kir5.1 channel is a candidate sensing molecule for CO2 
central chemoreception. Since CO2 central chemoreception is subject to neural 
modulations, we performed studies to test the hypothesis that the Kir4.1-Kir5.1 channel is 
modulated by the neurotransmitters critical for respiratory control, including serotonin (5-
HT), substance-P (SP), and thyrotropin releasing hormone (TRH). The heteromeric 
Kir4.1-Kir5.1 channel was strongly inhibited by SP, TRH, and 5-HT when expressed in 
Xenopus oocytes, whereas these neurotransmitters had no effect on the homomeric Kir4.1 
channel. Such an inhibition was dose-dependent and relied on specific Gαq-protein-
coupled receptors and protein kinase C (PKC). No direct interaction of the channel with 
G-proteins was found. Channel sensitivity to CO2/pH was not compromised with the 
inhibition by these neurotransmitters, as the channel remained to be inhibited by acidic 
pH following an exposure to the neurotransmitters. The firing rate of CO2-sensitive 
brainstem neurons cultured in microelectrode arrays was augmented by SP or a 5-HT2A 
receptor agonist, which was blocked by PKC inhibitors suggesting that PKC underscores 
the inhibitory effect of SP and 5-HT in cultured brainstem neurons as well. Immunostaining 
showed that both Kir4.1 and Kir5.1 proteins were co-localized in the cultured brainstem 
neurons. These results therefore indicate that the heteromeric Kir4.1-Kir5.1 channel is 
modulated by the neurotransmitters critical for respiratory control, suggesting a novel 
neuromodulatory mechanism for the chemosensitivity of brainstem neurons to elevated 
PCO2 and acidic pH. The CO2 chemosensitivity was reduced but not eliminated by blockade 
of presynaptic input from serotonin, substance P or glutamate neurons, indicating that both 
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pre- and postsynaptic neurons contribute to the CO2 chemosensitivity. This strongly 
suggests that the high sensitivity may be achieved by cellular mechanisms via synaptic 
amplification in cultured brainstem neurons. 
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IIIa. INTRODUCTION 
  
It is known that the central CO2 chemoreception and K+ transport in renal 
epithelium are regulated by neurotransmitters, hormones and pharmacological agents 
through specific intracellular signaling systems (Feldman et al., 2003; Germann & 
Stanfield, 2005; Richerson, 2004). Therefore, it is possible that the heteromeric Kir4.1-
Kir5.1 channel is regulated by certain second messenger systems. Such a modulation may 
enable cells expressing the Kir4.1-Kir5.1 channel to respond to PCO2 and pH changes 
according to systemic needs. One common intracellular signaling system activated by 
neurotransmitter and hormone is mediated by protein kinase C (PKC). Indeed, a number 
of consensus sequences of potential PKC phosphorylation sites exist in the Kir4.1 and 
Kir5.1 subunits. Supporting the idea of PKC phosphorylation are also previous reports 
indicating that other Kir channels such as Kir3.1-Kir3.4, Kir2.2, Kir2.3, and Kir6.2 are 
modulated by PKC with several phosphorylation sites identified in these channel proteins 
(Fakler et al., 1994; Henry et al., 1996; Light et al., 2000; Lin et al., 2000; Mao et al., 
2004; Stevens et al., 1999; Vorobiov et al., 1998; Zhang et al., 2004; Zhu et al., 1999; 
Zitron et al., 2004). Therefore, we performed experiments to test the possibility that PKC 
regulates the Kir4.1-Kir5.1 channel. Our results showed that the Kir4.1-Kir5.1 channel 
was strongly inhibited by the activation of PKC.  
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IIIb. RESULTS 
 
IIIb-1. Inhibition of the Heteromeric Kir4.1-Kir5.1 Channel by PMA  
 
In two-electrode voltage clamp, inward rectifying K+ currents were recorded from 
Xenopus oocytes 2-3 days post injection of the Kir4.1-Kir5.1 cDNA using a bath solution 
containing 90 mM K+. Typical Kir4.1-Kir5.1 currents were revealed: small outward 
currents and large inward currents with slow activation at highly negative membrane 
potentials (Fig. 1A). Following stabilization of the baseline currents, PMA, a specific and 
potent PKC activator, was added to the bath solution. The PMA exposure resulted in a 
strong inhibition of the Kir4.1-Kir5.1 currents. Higher concentrations of PMA resulted in 
a more rapid inhibition of the Kir4.1-Kir5.1 currents (Fig. 2E).  This inhibition was dose-
dependent (Fig. 3A, B): Evident channel inhibition was seen with PMA concentrations as 
low as 5 nM; maximum effect occurred with 1 µM PMA at which the Kir4.1-Kir5.1 
currents were inhibited by 93.3±1.4% (n=4); and 15 nM PMA inhibited the Kir4.1-Kir5.1 
currents by 41.4±2.2% (n=13). In comparison, the homomeric Kir4.1 channel showed no 
response to 15 nM PMA (Fig. 1B), and was slightly inhibited (8.4±8.6%, n=5) by 100 
nM PMA.  Numerous attempts were made to express the homomeric Kir5.1 channel.  
Unfortunately, we were unable to detect inward rectifying K+ currents that were sensitive 
to micromolar concentrations of barium in Xenopus oocytes and HEK293 cells.  
Therefore, we were unable to determine the effect of PMA on the Kir5.1 channel.   
The voltage dependence was analyzed using the current-voltage (I-V) plot. The 
currents recorded at -160 mV were normalized to the same level for both baseline and 
PMA treatment. When plotted in the I-V curve, the curve of the PMA treatment 
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overlapped that obtained from the baseline suggesting that the inhibition of the Kir4.1-
Kir5.1 currents by PMA is voltage independent (Fig. 1C). The same analysis on the 
Kir4.1 showed an identical effect (Fig. 1D).  
 When the time course of the Kir4.1-Kir5.1 channel inhibition by 15 nM PMA was 
plotted, the inhibition started 2 min after exposure to PMA and reached the maximum in 
~30 min (Fig. 1E). Thus, all PMA experiments were done with a PMA exposure of 20-40 
min. 
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Fig III-1. The Kir4.1-Kir5.1 channel but not homomeric Kir4.1 is sensitive to PMA. A. Using 
TEVC whole-cell Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days post-injection of 
the Kir4.1-Kir5.1 dimer cDNA. With 90 mM K+ in the extracellular solution inward rectifying 
currents were recorded at baseline. Membrane potential (Vm) was held at 0 mV. A series of 
command pulse potentials from –160 mV to 140 mV with a 20-mV increment was applied to the 
cell. Note that in highly negative membrane potentials, there was slow activation of the currents. 
Exposure to 15 nM PMA (a specific and potent PKC activator) inhibited the Kir4.1-Kir5.1 
currents by 40%. B. The same experiment was carried out with the homomeric Kir4.1. Exposure 
to 15 nM PMA failed to inhibit this channel. C, D. When baseline and peak PMA affected 
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currents were scaled to the same magnitude at -160 mV, the I/V relationship of the currents 
recorded under these two conditions were superimposed, suggesting that the effects were voltage-
independent. E. The time profile showed that the Kir4.1-Kir5.1 current amplitude decreased 
rapidly when PMA was present in the bath solution, and reached maximum inhibition in ~35 min. 
The Kir4.1 currents remained constant for 30 minutes during exposure to PMA. 
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Fig III-2. A. Inhibtion of Kir4.1-Kir5.1 by PMA and not 4α-PDD.  Using TEVC whole-cell 
Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days post-injection of the Kir4.1-Kir5.1 
dimer cDNA. With 90 mM K+ in the extracellular solution inward rectifying currents were 
recorded at baseline. Membrane potential (Vm) was held at 0 mV. A series of command pulse 
potentials from –160 mV to 140 mV with a 20-mV increment was applied to the cell. Exposure to 
100 nM PMA strongly inhibited the Kir4.1-Kir5.1 currents. B. The same experiment was carried 
out using the 4α-PDD (an inactive analogue of PMA) instead of PMA. Exposure to 20 nM 4α-
PDD failed to inhibit the Kir4.1-Kir5.1 channel. C, D. Shows the I-V curve relationships for the 
experiments carried out in A and B. E. The time profile shows that the Kir4.1-Kir5.1 current 
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amplitude decreased rapidly when PMA was present in the bath solution at a high concentration 
(100 nM), and reached maximum inhibition in ~25 min.  
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Fig III-3. Concentration-dependent response of  PMA. A. The effect of PMA on the Kir4.1-
Kir5.1 channel was clearly concentration-dependent. The Kir4.1-Kir5.1 channel was inhibited by 
very low concentrations of PMA. Exposure to 5 nM PMA suppressed Kir4.1-Kir5.1 channels by 
16.9±3.8% (n=5). 1 µM PMA maximally inhibited the Kir4.1-Kir5.1 currents by 93.3±1.4% 
(n=4). n≥4 for each concentration tested. B. The concentration-dependent response fits a sigmoid 
curve. This curve was used to more accurately obtain the IC50 concentration which was 15 nM 
PMA.  
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IIIb-2. Involvement of PKC 
  
To demonstrate that PKC activation underscores the PMA inhibition of Kir4.1-
Kir5.1, we took advantage of several other specific kinase activators and inhibitors. 
Exposure of the oocytes to phorbol ester (OAG), another PKC activator, resulted in a 
similar inhibition as PMA (Fig 4A, F). Thymeleatoxin (100 nM), that selectively 
activates the conventional PKC isoforms (α, β, & γ), brought about an inhibition of the 
Kir4.1-Kir5.1 channel (47.8±2.5%, n=5) to the same degree as PMA (P>0.05), 
suggesting that at least one of the conventional PKC isoforms is involved (Fig. 4B, F). In 
contrast, the homomeric Kir4.1 was not inhibited by OAG and thymeleatoxin, consistent 
with the results from PMA (Fig. 4D-F). An inactive analogue of PMA (4α-PDD, 15 and 
20 nM) failed to inhibit the Kir4.1-Kir5.1 channel (Fig. 4F; Fig. 2B, D, E). 
The cAMP dependent protein kinase A (PKA) has been shown to modulate Kir 
channels (Light et al., 2000; Lin et al., 2000; Wischmeyer & Karschin, 1996; Zitron et al., 
2004). We therefore used forskolin that activates the enzyme adenylyl cyclase leading to 
increases in the cAMP concentration and activation of PKA. With 100 µM forskolin, 
oocytes expressing the Kir4.1-Kir5.1 channel showed a modest inhibition of the Kir4.1-
Kir5.1 currents (10.2±3.3%, n=8; Fig. 4F), suggesting that the PMA-induced channel 
inhibition is not a result of PKA activation.  
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Fig III-4. PKC activation inhibits the Kir4.1-Kir5.1channel. A. Currents were recorded from an 
oocyte in the same condition as in Figure 1A. These currents were strongly inhibited (46.3%) by 
exposure to 50 µM OAG (another potent activator of PKC). B. Exposure of an oocyte expressing 
the Kir4.1-Kir5.1 channel to 100 nM thymeleatoxin (activator of the conventional PKC isoforms 
α, β, γ) resulted in a similar inhibition (48.9%). C. Currents were recorded from an oocyte in the 
same condition as in 3B. Prior to application of 100 nM thymeleatoxin the cell was pre-incubated 
with 100 µM Genistein (a potent and general tyrosine kinase inhibitor) for 1 hour. Blocking 
activation of tyrosine kinases failed to reduce the inhibition by thymeleatoxin. D, E. The same 
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experiments in 3A and 3B were carried out on oocytes expressing the homomeric Kir4.1 channel. 
This channel was barely inhibited by 50 µM OAG and 100 nM thymeleatoxin 8.9%, 6.8%, 
respectively. F. The effect of PMA appears to be via activation of PKC as Forskolin (a PKA 
activator) shows very little inhibition. Also, neither DMSO alone nor 4α-PDD (an inactive analog 
of PMA) had a significant effect. n≥4 for each experiment. 
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Specific PKC inhibitors were studied, in which oocytes were pre-incubated in 
chelerythrine or calphostin-C prior to PMA application to the recording solution. The 
pre-incubation of cells with 3 μM calphostin-C for 2 hours resulted in a complete 
elimination of the PMA-induced inhibition (Fig. 5A, B). A similar effect was seen with 
chelerythrine (50 µM for 1 hour), though to a lesser degree (Fig. 5B). Pre-incubation with 
genistein, a potent inhibitor of tyrosine kinases did not block the PMA effect (Fig. 4C, F). 
These results strongly suggest that the PMA inhibition of the Kir4.1-Kir5.1 channel is 
mediated by PKC, but neither by PKA nor by tyrosine kinase activation.  
 
 
121 
 
 
 
 
 
 
 
 
 
 
Fig III-5. PKC is necessary for inhibition of Kir4.1-Kir5.1 by PMA. A. Using TEVC whole-cell 
Kir4.1-Kir5.1 currents were recorded from an oocyte 3 days post-injection of the Kir4.1-Kir5.1 
dimer cDNA. With 90 mM K+ in the extracellular solution inward rectifying currents were 
recorded at baseline. Membrane potential (Vm) was held at 0 mV. A series of command pulse 
potentials from –160 mV to 140 mV with a 20-mV increment was applied to the cell.  Before 
exposure to 15 nM PMA the oocyte was pre-incubated with 3 µM Calphostin-C (a potent and 
specific inhibitor of PKC) for 2 hours. Inhibition of PKC drastically attenuated the effect of 
PMA. PMA exposure after incubation with calphostin-C slightly activated the Kir4.1-Kir5.1 
currents by 9.8%. B. Pre-incubation of oocytes with specific PKC inhibitors (50 μM chelerythrine 
or 3 μM calphostin-C) strongly attenuated the effect of 15 nM PMA (n≥4). C. Whole-cell currents 
were recorded from an oocyte 3 days post injection of the Kir4.1-Kir5.1V211L mutant channel 
recorded under the same condition as in A. This mutant is suggested to have increased PIP2 
affinity. Exposure of the oocytes to 15 nM PMA inhibited the Kir4.1-Kir5.1V211L currents by 
57.6%. D. The converse mutant was created on the Kir4.1 channel (Kir4.1L208V) and tested in 
an oocyte under the same experimental conditions as for Figure 4C. Similarly as for the wild-type 
channel this mutant failed to be inhibited by 15 nM PMA. 
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IIIb-3. Inhibition of the Kir4.1-Kir5.1 Channel by PKC activation in HEK293 cells 
 
 The Kir4.1-Kir5.1 channel was transiently expressed in HEK293 cells. Whole-cell 
voltage clamp was performed on GFP-positive cells. Both the bath and pipette solutions 
contained 145 mM K+. The Kir4.1-Kir5.1 positive transfected cells showed typical 
Kir4.1-Kir5.1 currents that were relatively big at the basal level upon the formation of the 
whole-cell configuration. Without any treatment the currents remained at this level for 
more than 5 min. The cells were held at a membrane potential of 0 mV.  Command 
pulses of -80 mV were applied to the cell every 3 seconds and the Kir4.1-Kir5.1 currents 
were recorded.  Application of 15 nM PMA strongly inhibited the Kir4.1-Kir5.1 channel 
by 39.3±2.1% (n=10) (Fig. 6A, D).  The inhibition by 15 nM PMA was greatly 
diminished [1.40±2.6% (n=6)] in the presence of the PKC inhibitor peptide (10 µM 
PKCi) that was added to the pipette solution (Fig. 6B, D).  100 nM thymeleatoxin similar 
to 15 nM PMA also inhibited the Kir4.1-Kir5.1 channel [44.7±2.6% (n=10)] expressed in 
HEK293 cells.  However, an inactive analogue of PMA (4α-PDD) only inhibited the 
Kir4.1-Kir5.1 currents in HEK293 cell by 10.7±2.7% (n=9) (Fig. 6D).  Taken together, 
these results suggest that the Kir4.1-Kir5.1 channel is inhibited by PKC activation in 
HEK293 cells in a similar manner as in Xenopus oocytes. 
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Fig III-6. PKC activation inhibits the Kir4.1-Kir5.1channel in HEK293 cells.  A. Whole-cell 
currents were recorded from an HEK293 cell transfected with the Kir4.1-Kir5.1 dimer cDNA 
with a holding potential at 0mV and command pulses of –80mV in every 3 seconds. After the 
whole-cell configuration was formed, the cell was perfused with the extracellular solution for a 2-
5 min period of baseline recording. The currents were inhibited by exposure to 15nM PMA. The 
arrow represents the magnification of the current at the time point and shown on the right.  B. In 
the presence of the PKC inhibitory peptide (10µM PKCi), 15nM PMA failed to inhibit the 
Kir4.1-Kir5.1 channel. C. Inhibition of the Kir4.1-Kir5.1 channel was also seen with exposure to 
100nM thymeleatoxin.  D. Bargraph showing that PKC activation results in inhibition of the 
Kir4.1-Kir5.1 channel. In each experiment n≥6.  
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IIIb-4. Single-channel Properties Affected 
 
The effect of PMA on the single-channel biophysical properties was studied in 
Xenopus oocytes using cell-attached patches with 145 mM K+ applied to the extracellular 
solution at a membrane potential of -80 mV. Only patches containing ≤4 active channels 
were considered in the experiment. Inward rectifying currents with single-channel 
conductance of ~40 pS were recorded from oocytes that were injected with the Kir4.1-
Kir5.1 cDNA 2-3 days prior to recordings. These currents were inhibited with an 
exposure of the cells to 15 nM PMA (Fig. 7A). The current inhibition was mainly 
produced by a suppression of the channel open-state probability (Popen), while the single-
channel conductance was barely effected (Fig. 7).  
IIIb-5. Independence of PIP2 
 
A number of Kir channels are regulated by membrane lipids including 
phosphatidylinositol bisphosphate (PIP2). The presence of this phospholipid has been 
shown to increase Kir channel activity, and consequently depletion of PIP2 leads to 
channel inhibition. To test the possibility that the PMA-induced Kir4.1-Kir5.1 channel 
inhibition is related to PIP2 depletion, we mutated the potential PIP2 binding sites in the 
channel to increase or decrease the channel affinity for the phospholipid based on a 
sequence alignment with other Kir channels (Du et al., 2004; Lopes et al., 2002; Mao et 
al., 2004). One mutant R178Q, that has previously been reported to increase PIP2 binding 
affinity (Yang et al., 2000), was created in the Kir5.1 and expressed with wild-type 
Kir4.1. This mutant channel showed a similar PMA sensitivity as the wild-type (Table 1). 
Another mutant Kir4.1-Kir5.1V211L, that has also been shown to increase the PIP2 
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sensitivity, did not affect the channel inhibition by 15 nM PMA (41.2±5.7%, n=10) (Fig. 
5C). A converse mutation, exchanging these residues at a different site on the Kir4.1 
(Kir4.1L208V) had no effect (Fig. 5D).  
 
 
126 
 
 
Fig III-7. Effects of PMA on the single channel properties of the Kir4.1-Kir5.1. A. Single Kir4.1-
Kir5.1 currents were recorded from an oocyte in a cell-attached patch configuration with 145 mM 
K+ in the patch pipette. At Vm of -80 mV, two active channels are seen at pH 7.4. Following 
stabilization, exposure to 15 nM PMA reduced the channel activity by a decrease in the NPo. 
Labels on the left: c, closure; 1, the first opening; 2, the second opening; etc. B, C. Bargraph 
showing that 15 nM PMA drastically reduced the Po, but did not affect the single-channel 
conductance (n≥6). 
 
 
 
127 
 
 To further assess the effect of PIP2 depletion in the channel inhibition, 
wortmannin that inhibits the phosphoinositide kinase-3 (PI3K) and thus the resynthesis of 
PIP2 from PIP3 was used to treat the oocytes prior to PMA exposure. Following 
incubation of oocytes with 10 µM wortmannin, PMA continued to inhibit the Kir4.1-
Kir5.1 channel by 41.4±8.8% (n=5) (Fig. 4F). Taken together these results suggest that 
PIP2 depletion does not seem to underlie the PMA-induced Kir4.1-Kir5.1 channel 
inhibition.  
IIIb-6. Lack of Evidence for Endocytosis 
 
 Several recent studies indicate that protein kinase activation can lead to 
endocytosis and thus the suppression of surface Kir channel activity (Lin et al., 2002; 
Sterling et al., 2002; Wang et al., 2002; Wang et al., 2006; Zeng et al., 2002). To evaluate 
the role of endocytosis in the inhibition of the Kir4.1-Kir5.1 channel by PKC activation, 
we carried out experiments with dynamin II and its dominant negative mutant where 
lysine at position 44 is mutated to alanine (K44A). We reasoned that co-expression of 
this dominant-negative dynamin II may abolish the effect of PKC if the Kir4.1-Kir5.1 
channel inhibition by PKC results in dynamin dependent endocytosis. The Kir4.1-Kir5.1 
channel was co-expressed with the wild-type dynamin II as well as the dynamin II K44A 
mutant. Exposure to 15 nM PMA led to inhibition of the currents by 53.2±4.4% (n=4) in 
the cells expressing the wild-type dynamin II (Fig. 8A, D) and by 49.5±6.8% (n=5) in 
cells expressing the dynamin II K44A mutant (Fig. 8B, D).  
Another mechanism of endocytosis involves clathrin-coated pits. Proteins that 
undergo clathrin-dependent endocytosis contain an internalization recognition motif in at 
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least one of the intracellular domains, usually in the C-terminal (Zeng et al., 2002). This 
motif [(Y/F)(D/E)NPXY] shares high homology in many proteins. A primary scan of the 
Kir4.1 amino acid sequence failed to show any similar recognition motif. However, a 
scan of the Kir5.1 led to the identification of such a motif. The second and third amino 
acids of the motif have been found to be critical for endocytosis of Kir1.1 (Zeng et al., 
2002). 
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Fig III-8. PKC activation inhibits Kir4.1-Kir5.1 currents independent of endocytosis. A. Whole-
cell currents were recorded from an oocyte 3 days following injection of the Kir4.1-Kir5.1 + 
dynamin II cDNAs (co-injection) under the same conditions as described for Figure 1A.  PMA 
exposure inhibited the Kir4.1-Kir5.1+ dynamin II currents by 53%. B. Whole-cell Kir4.1-Kir5.1 
currents were recorded from an oocyte 3 days following injection of the Kir4.1-Kir5.1 + dynamin 
II K44A mutant cDNAs (co-injection) using TEVC. Exposure to 15 nM PMA also inhibited the 
Kir4.1-Kir5.1+ dynamin II K44A (-49%). C. Whole-cell currents were recorded from an oocyte 3 
days following injection of the Kir4.1-Kir5.1E260A/S261A mutant channel. This mutant has lost 
the recognition site for CCV endocytosis. Exposure of the oocyte to 15 nM PMA inhibited the 
Kir4.1-Kir5.1E260A/S261A currents by 42%. D. Bargraph summarizing panels A, B, and C. 
Note that the Dynamin K44A mutant and the Kir4.1-Kir5.1E260A/S261A mutant showed no 
significant difference to the Kir4.1-Kir5.1 in respect to inhibition by PMA. n≥4 for each 
experiment. 
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 Therefore, we mutated these residues in Kir5.1. Consistent with the dynamin experiment 
we found that the Kir4.1-Kir5.1E260A/S261A mutant remained highly sensitive to PMA 
(Fig. 8C, D).  
 To further assess the possibility of channel endocytosis, whole cell currents were 
recorded from HEK293 cells before and during a treatment with thymeleatoxin. The 
whole cell capacitance (CAP) and series resistance (SR) were measured. If the Kir4.1-
Kir5.1 channel inhibition by PKC activation was a result of endocytosis, the whole cell 
capacitance would decrease following application of thymeleatoxin to the bath solution. 
The percent change in the whole cell capacitance of HEK293 cells expressing the Kir4.1-
Kir5.1 channel exposed to 100 nM thymeleatoxin for 15 min was 5.9±8.2% (n=4). This 
change in capacitance did not significantly differ from that of cells exposed to DMSO 
only (3.1±9.9%, n=4) (Fig. 9). The series resistance did not show a significant difference 
between cells exposed to DMSO versus cells exposed to 100 nM thymeleatoxin (Fig. 9).  
 We also performed immunocytochemistry to demonstrate membrane expression 
of the Kir4.1-Kir5.1 channel. Both the Kir4.1 and Kir5.1 antibodies are commercially 
available. By taking advantage of these antibodies and using immunocytochemistry we 
decided to look at membrane expression of the Kir4.1-Kir5.1 channel before and after 
exposure to PMA. HEK293 cells were transfected with the Kir4.1-Kir5.1 dimer. 
Immunocytochemistry was performed as described in the methods section. Prior to PMA 
exposure the channel showed membrane surface expression (Fig. 10A1-A3). After 
exposure to 15 nM PMA for 25 min the membrane expression was retained (Fig. 10B1-
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B3). Taken together these results suggest that the Kir4.1-Kir5.1 channel inhibition does 
not seem to be a result of endocytosis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig III-9. Endocytosis independent inhibition of Kir4.1-Kir5.1 in HEK293 cells.  Whole-cell 
currents were recorded from HEK293 cells 3 days post-transfection of the Kir4.1-Kir5.1 cDNA. 
Membrane potential (Vm) was held at 0 mV. A series of command pulse potentials from –120 mV 
to 80 mV was applied to the cell and the corresponding currents were recorded. Following 
stabilization 100 nM thymeleatoxin was applied to the bath solution and inhibited the Kir4.1-
Kir5.1 currents by 51.4±2.6% (n=4). Application of DMSO alone barely inhibited the Kir4.1-
Kir5.1 currents. During the experiments with thymeleatoxin and DMSO, the whole cell 
capacitance and series resistance were monitored. Neither capacitance nor series resistance 
changed significantly upon application of 100 nM thymeleatoxin or DMSO to the bath solution.  
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Fig III-10. Surfacce expression of the Kir4.1-Kir5.1.  Immunocytochemistry was performed on 
HEK293 cells 48 hours post-transfection of the Kir4.1-Kir5.1dimer cDNA together with the GFP 
cDNA. A. Prior to PMA exposure the channel was mainly expressed on the surface of the 
HEK293 cells, suggesting membrane expression. B. Following application of 15 nM PMA for 25 
minutes the channel maintained expression on the cell surface. ^ Denotes GFP fluorescence 
imaging. * Denotes Kir5.1 antibody was used as the primary antibody. GFP was used as an 
indicator of transfection efficiency.  Note that all HEK293 cells expressing GFP also expressed 
the Kir4.1-Kir5.1 channel although the GFP intensity was compromised by the fixation process. 
Bar=10 µm. 
A1 HEK-Kir4.1-Kir5.1+^GFP A2 HEK-Kir4.1-*Kir5.1 A3 Overlay
B1 HEK-Kir4.1-Kir5.1+^GFP B2 HEK-Kir4.1-*Kir5.1+PMA B3 Overlay
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IIIb-7. Phosphorylation Sites 
 
To identify the PKC phosphorylation site, a sequence scan of amino acids was 
made for both the Kir4.1 and Kir5.1 channels. Numerous putative PKC phosphorylation 
sites were found in Kir4.1 and Kir5.1, according to the consensus sequence, i.e., R(K)-X0-
2-T/S-X0-2-R(K). Four different phosphorylation prediction programs were also used to 
predict potential PKC phosphorylation sites (NetPhos, Scansite, ScanProsite, 
Phosphobase). We performed systematic screening of these predicted sites according to 
the prediction programs in both Kir4.1 and Kir5.1 by single mutation of the serines or 
threonines to an alanine residue. The effect of PMA on these mutants was tested 
subsequently in Xenopus oocytes. The mutant channels were grouped: the first group of 
mutants consisted of the potential phosphorylation sites that were predicted using all 
prediction programs and had the highest score for potential phosphorylation by PKC; the 
second group consisted of those residues that had a lower phosphorylation prediction 
score; and the third group was residues not predicted by the phosphorylation prediction 
programs, but was found in a sequence similar to the consensus sequence for PKC. We 
tested 30 mutant channels with a single mutation representing each group and 9 channels 
with double mutations. All single mutants tested except for Kir4.1-Kir5.1T174D 
remained highly sensitive to PMA (Fig. 11A, B, Table 1).   Further analysis of the 
Kir4.1-Kir5.1T174 position suggests that it is involved in another channel function as 
mutants carrying an alanine or lysine at this position remained sensitive to PMA (Fig. 
11G, Table 1).  Also the Kir4.1-Kir5.1T174D mutant also failed to respond to 15% CO2.  
Single channel analysis showed that the T174D mutant has an increased Popen (Fig. 11D).  
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Taken together we concluded that the T174 position is not a PKC phosphorylation site. 
The double mutants were created by comparing the PMA effect of the single mutants and 
selecting those that had a slightly lower PMA sensitivity. When tested, the double 
mutants also showed a PMA sensitivity similar to the wild-type. Therefore, the PKC 
phosphorylation sites remain to be demonstrated.  
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Fig III-11. A. T174 as a potential phosphorylation site.  Using TEVC whole-cell currents were 
recorded from an oocyte 3 days post-injection of the Kir4.1-Kir5.1T174D mutant. With 90 mM 
K+ in the extracellular solution inward rectifying currents were recorded at baseline. Membrane 
potential (Vm) was held at 0 mV. A series of command pulse potentials from –160 mV to 140 mV 
with a 20-mV increment was applied to the cell. Exposure to 15 nM PMA failed to inhibit the 
T174D currents. B. The same experiment was carried out using 1µM PMA.  Exposure to 1µM 
PMA also failed to inhibit the Kir4.1-Kir5.1T174D channel. C.  Unlike the wild-type Kir4.1-
Kir5.1 channel that is strongly inhibited by 15% CO2, the T174D currents were unaffected by 
such an exposure. D, E. Single channel recordings and analyses shows that the T174D mutant has 
a higher basal Popen than the wild-type Kir4.1-Kir5.1 although the conductances are the very 
similar (n≥5).  F. Shows the I-V curve relationships for the experiments carried out in A, B and 
C. G. Bargraph showing the effects of 15nM PMA on the T174 mutants.  Note that the T174D 
mutant had a much larger basal current and failed to be inhibited by PMA in comparison to the 
wild-type and the other T174 mutants (n≥5).  
 
 
137 
 
IIIb-8. Direct Phosphorylation of Kir4.1 and Kir5.1 
 
 The failure to demonstrate PKC phosphorylation sites raises a question as the 
whether the channel proteins are indeed phosphorylated by PKC. Thus, we performed in-
vitro phosphorylation experiments. Since most of the predicted PKC sites are located in 
the C-terminus of Kir4.1 and Kir5.1, MBP fusion peptides with the Kir4.1-C-terminus 
and Kir5.1C-terminus were produced as described in the Materials and Methods.  After 
extraction and purification, the fusion peptides were incubated with 32P-γ-ATP in the 
presence of the catalytically active subunit of PKC (20 ng). Such a treatment led to 
positive phosphorylation of these peptides suggesting that both Kir4.1 and Kir5.1 are 
directly phosphorylated by PKC (Fig. 12; Fig. 13).  
 
 
 
 
 
 
Fig III-12. Phosphorylation of MBP fusion proteins. A. 10% SDS-PAGE gel showing the 
presence of the Kir4.1-C-terminus-MBP (~65 kDa) (lane 2), Kir5.1-C-terminus-MBP (~70 kDa) 
(Lane 3), MBP alone (~42 kDa) (Lane 4) and Histone III-S (Lane 5).  The size is indicated by the 
ladder (Lane 1) (precision plus protein standards) (Biorad).  B. Autoradiograph after 12 hours 
showing phosphorylation of Kir4.1-C-terminus-MBP, Kir5.1-C-terminus-MBP, MBP, and 
Histone III-S.  The proteins were incubated in the presence of 32P-γ-ATP and the catalytically 
active PKC subunit.   
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Fig III-13. Schematic for the inhibition of Kir4.1-Kir5.1 channels by PKC. The inhibition of the 
Kir4.1-Kir5.1 channel is through the activation of PKC by way of DAG activation. The channel 
appears to be inhibited by PKC directly (phosphorylation) and not by a reduction of PIP2.  
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IIIc. DISCUSSION 
 
Protein phosphorylation is an important process in regulating cellular functions. 
Several inward rectifying K+ channels have been shown to be regulated by protein kinase 
phosphorylation (Beguin et al., 1999; Fakler et al., 1994; Henry et al., 1996; Light et al., 
2000; Lin et al., 2000; Mao et al., 2004; Stevens et al., 1999; Vorobiov et al., 1998; 
Wischmeyer et al., 1996; Zhang et al., 2004; Zhu et al., 1999; Zitron et al., 2004). For 
example, the heteromeric GIRK1/GIRK4 channel has previously been shown to be 
phosphorylated by protein kinase C at specific serine residues in the channel protein 
affecting channel gating (Mao et al., 2004). This phosphorylation underscored the effect 
of substance-P on this channel allowing the channel to partake in the cellular response to 
this neurotransmitter. 
In the present study we have presented evidence for the inhibition of the 
heteromeric Kir4.1-Kir5.1 channel by PKC. The Kir4.1-Kir5.1 channel is inhibited by 
nanomolar concentrations of PMA in a dose-dependent manner. Several experiments 
show that the effect of PMA is specific. Pre-incubation of the oocytes with specific PKC 
blockers (chelerythrine and calphostin-C) abolishes the PMA effect. Exposure of oocytes 
to 4α-PDD (an analogue of PMA incapable of activating PKC) fails to inhibit the Kir4.1-
Kir5.1 channel. On the other hand, two other PKC activators (OAG & thymeleatoxin) 
strongly inhibit the channel. The biophysical mechanism for the inhibition of the Kir4.1-
Kir5.1 channel by PKC appears to be mediated by reducing the channel open state 
probability without affecting the single channel conductance. The Kir4.1-Kir5.1 channel 
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inhibition does not seem to be produced by PKA and tyrosine kinase as forskolin and 
genistein have rather small effects. 
The PKC induced inhibition of the Kir4.1-Kir5.1 channel is independent of PIP2 
and does not seem to be mediated by endocytosis. Since PIP2 has been shown to regulate 
many Kir channels it is possible that the PKC induced inhibition of the Kir4.1-Kir5.1 was 
a result of PIP2 depletion. The above experiments show that PMA inhibits the Kir4.1-
Kir5.1 channel independent of PIP2 depletion. Similarly, mutant channels with increased 
PIP2 binding remains to be inhibited by PMA exposure to the same degree as the wild-
type. Also, pre-incubation of oocytes with worthmannin (a PI3K inhibitor that reduces 
PIP2) fails to abolish the PMA induced inhibition of the channel, suggesting that the 
channel inhibition is not a result of PIP2 depletion. Immunocytochemistry experiments 
demonstrating surface expression in addition to experiments using a defective dynamin II 
mutant show that the effect of PMA is not a result of endocytosis. Although there may be 
other mechanisms involved, these results suggest that activation of PKC inhibits the 
Kir4.1-Kir5.1 channel by changing the channel gating mechanism. 
Our biochemical experiments suggest a direct phosphorylation of the channel 
protein as both C-termini of Kir4.1 and Kir5.1 can be phosphorylated by PKC. To find 
the PKC phosphorylation sites, we screened more than 30 serine / threonine residues 
(some identified as phosphorylation sites by prediction software programs) by mutation 
to a non-phosphorylatable amino acid. None of the single mutations led to identification 
of the phosphorylation site, as all single mutants tested except for Kir5.1T174D remained 
highly sensitive to PMA. The Kir5.1T174 is not a PKC phosphorylation site either, as the 
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Kir5.1T174A and Kir5.1T174K mutants are strongly inhibited by PMA. The effect of the 
T174D mutation suggests that this residue or its surrounding area may play a role in the 
channel gating mechanism and/or regulation by other intracellular factors. This mutant 
channel lost the sensitivity to both CO2 and PKC. Since this area contains several charged 
residues it is possible that a change in electrostatic charge in this area by the T174D 
affects the process of channel gating. Several double mutations based on single sites 
shown by phosphorylation prediction programs were also tested. None of these double 
mutations affects the PMA sensitivity. Therefore, we believe that the heteromeric 
combination of the Kir4.1-Kir5.1 channel may introduce multiple phosphorylation sites 
whose phosphorylation collectively may result in a change in channel activity. Removal 
of one or two of the phosphorylation sites may not be adequate to abolish the channel 
inhibition by PKC. This is further supported by the in vitro phosphorylation experiments 
that shows both Kir4.1 and Kir5.1 C-termini are directly phosphorylated by PKC.  The 
Kir4.1 channel can express as a homomeric channel in several tissues (Ishii et al., 2003; 
Hibino et al., 1999; Hibino et al., 2004; Higashi et al., 2001; Ito et al., 1996; Kusaka et 
al., 1999). However, this channel has low pH sensitivity (Xu et al., 2000a; Xu et al., 
2000b; Xu et al., 2000c) and is insensitive to phosphorylation by PKC according to our 
current studies.  
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IIId. SUMMARY AND CONCLUSION 
 
 The Kir4.1-Kir5.1 channel expressed using a tandem dimer construct was 
inhibited by the PKC activator PMA in a dose-dependent manner. The channel inhibition 
was produced via reduction of the Popen. The effect of PMA was abolished by specific 
PKC inhibitors. In contrast, exposure of oocytes to forskolin (a PKA activator) had no 
significant effect on Kir4.1-Kir5.1 currents. The channel inhibition appeared to be 
independent of PIP2 depletion and PKC-dependent internalization. Several consensus 
sequences of potential PKC phosphorylation sites were identified in the Kir4.1 and Kir5.1 
subunits by sequence scan. Although the C terminal peptides of both Kir4.1 and Kir5.1 
were phosphorylated in vitro, site-directed mutagenesis of individual residues failed to 
reveal the PKC phosphorylation sites suggesting that the channel may have multiple 
phosphorylation sites. Taken together, these results suggest that the Kir4.1-Kir5.1 but not 
the homomeric Kir4.1 channel is strongly inhibited by PKC activation. 
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Table III-1. Effect of 15 nM PMA on wild-type Kir4.1, Kir4.1-Kir5.1 and mutant  
channels 
 
   Baseline (µA) PMA (µA) % effect  N 
Kir4.1-Kir5.1 (Dim) 6.5±0.6 3.8±0.43 -41.4±1.9 13 
Kir4.1+Kir5.1 (Co-inj) 8.9±2.1 5.2±1.2 -40.7±1.9 6 
Kir4.1(homomer) 15.3±2.3 15.23±2.2 -0.04±2.2 6 
Kir4.1K67M-Kir5.1 20.53±3.0 12.3±2 -41.35±3.23 6 
Kir4.1T178A-Kir5.1 3.4±0.7 2.22±0.43 -33.1±2.9 6 
Kir4.1S206A-Kir5.1 6.0±1.3 3.8±0.84 -36.7±3.7 13 
Kir4.1T214A-Kir5.1 3.3±0.2 2.1±0.2 -37.2±4.6 11 
Kir4.1T262A-Kir5.1 16.96±1.5 11.1±1.3 -34.9±3.5 5 
Kir4.1T262S-Kir5.1 14.1±0.7 9.7±0.6 -31.4±2.9 5 
Kir4.1S263A-Kir5.1 9.7±1.0 6.2±1.0 -36.2±3.9 4 
Kir4.1S299A-Kir5.1 8.8±1.6 5.4±1.0 -38.6±2.9 7 
Kir4.1S320A-Kir5.1 4.7±0.6 3.0±0.6 -39.0±5.0 7 
Kir4.1T346A-Kir5.1 4.8±0.4 2.75±0.48 -44.1±7.1 6 
Kir4.1S360A-Kir5.1 4.0±0.4 2.3±0.23 -40.3±5.8 4 
Kir4.1S373A-Kir5.1 4.1±0.4 2.46±0.23 -38.1±7.3 7 
Kir4.1-Kir5.1T68A 11.9±0.8 8.2±0.5 -30.5±1.5 7 
Kir4.1-Kir5.1T174A 3.1±0.3 1.9±0.27 -38.1±4.1 5 
Kir4.1-Kir5.1T174D 16.5±3.9 15.38±3.3 -0.9±7.2 8 
Kir4.1-Kir5.1T174K 5.1±1.1 2.94±0.61 -40.1±9.6 7 
Kir4.1-Kir5.1R178Q 6.2±0.5 3.88±0.54 -37.8±4.0 7 
Kir4.1-Kir5.1T181A 3.8±0.3 2.08±0.31 -45.8±4.7 5 
Kir4.1-Kir5.1S185A 10.1±0.6 6.28±0.64 -37.8±5.1 4 
Kir4.1-Kir5.1T215A 3.6±0.2 2.08±0.17 -40.8±7.2 5 
Kir4.1-Kir5.1T232A 4.0±0.5 2.3±0.27 -41.4±5.6 4 
Kir4.1-Kir5.1S298A 10.2±0.4 6.12±0.82 -39.4±8.5 4 
Kir4.1-Kir5.1T370A 3.6±0.4 2.26±0.25 -36.6±5.2 7 
Kir4.1T32A-S299A-Kir5.1 22.5±3.3 14.8±3.17 -36.4±5.8 6 
Kir4.1K67M-Kir5.1T68A 8.5±3.3 5.95±2.6 -35.8±5.2 4 
Kir4.1T262A-Kir5.1T68A 11.04±0.6 7.1±0.27 -35.3±3.4 5 
Kir4.1-Kir5.1V211L 4.5±0.6 2.6±0.4 -41.2±5.7 10 
Kir4.1L208V 10.4±2.0 9.45±1.9 -10.1±4.7 7 
Kir4.1L208I n.f. n.f.   
Kir4.1L208V-Kir5.1 7.8±1.46 4.77±0.8 -37.8±2.9 6 
Kir4.1L208I-Kir5.1 n.f. n.f.   
Abbreviations: n, number of observation; n.f., nonfunctional 
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IV. GATING OF THE ATP-SENSITIVE K+ CHANNEL BY A PORE-LINING 
  
PHENYLALANINE RESIDUE*  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These results have been published: 
 
Asheebo Rojas, Jianping Wu, Runping Wang, and Chun Jiang.  Gating of the ATP-
sensitive K+ Channel by a Pore-lining Phenylalanine Residue.  BBA-Biomembranes. 
(2007) 1768 (1):39-51.  
 
*In this part, Dr. Jianping Wu did 80 % of the single channel patch clamp recordings for 
me.   Ms. Runping Wang created 20 % of the mutations on the Kir6.2.  Their help is 
greatly appreciated.   
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IVa. INTRODUCTION 
The KATP channels are heteromeric consisting of four subunits of Kir6 and four 
subunits of sulphonylurea receptor (SUR). The Kir6, that forms the ion-conduction 
pathway with two transmembrane domains, possesses the essential machineries for 
channel opening and closure controls (Tucker et al., 1997).  A central question in 
understanding the KATP channel function is how the channel opening and closure is 
produced following ligand binding, a process that is known as channel gating. 
Experimental evidence suggests that transmembrane domains, especially the pore-lining 
membrane helices, play an important role in the channel gating (Bichet, et al., 2003; 
Doyle, 2004; Yellen, 2002). The Ca++-dependent gating of the bacterial MthK channel 
occurs through lateral movements of the inner transmembrane helices (TM2) while the 
outer transmembrane domain (TM1) remains relatively rigid and stable (Jiang et al., 
2002). Such TM2 helical movements during channel gating have also been implied in the 
KirBac1.1 and mammalian GIRK channels based on crystal structures (Jin et al., 2002; 
Kuo et al., 2003). In the latter two Kir channels, a phenylalanine located at the narrowest 
region of the inner vestibule appears to play a critical role in the channel gating (Jin et al., 
2002; Kuo et al., 2003). In Kir1.1 a leucine homologous to this phenylalanine was found 
to be essential for pH gating (Sackin et al., 2005). Such a phenylalanine residue (Phe168) 
is also found at the cytosolic end of the TM2 of the Kir6.2 subunit, which faces the ion-
conduction pathway when its amino acid (AA) sequence is aligned with the KirBac1.1. 
Phenylalanine is hydrophobic with an aromatic side group. Recent studies on crystal 
structures of the bacterial mechanosensitive MscL channel, nicotinic acetylcholine 
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receptor and the KirBac1.1 channel have indicated that nonpolar residues may form a 
gate through their hydrophobic interaction (Kuo et al., 2003; Sukharev et al., 2001; 
Unwin, 1995; Unwin, 2003). It is necessary to demonstrate that such a gate is not only a 
structural existence but also a functional entity. The functional role of Phe168 in Kir6.2 
gating was investigated by replacing this residue with amino acids having side chains of 
different size and hydrophobicity. Our results suggest that the aromatic group of 
phenylalanine may occlude the ion conduction pathway in the closed state (Jin et al., 
2002; Kuo et al., 2003). However, other residues with bulky or hydrophobic side chains 
at this location can also gate Kir6.2 in a similar manner. In addition to blockade of the ion 
pathway during the closed state, the Phe168 appears to lower the energy barrier necessary 
for the gating transition. Thus this phenylalanine may act as a hinderer and a facilitator in 
the Kir6.2 channel gating.  
IVb. RESULTS  
IVb-1. Phenylalanine 168 at the narrowest region of the ion conduction pathway 
AA sequence of several mammalian Kir channels were aligned with sequences of 
the bacterial KirBac1.1 and KcsA channels in a region from the selectivity filter to the 
proximal C-terminus. Based on the crystallographic structures of KcsA and KirBac1.1, a 
phenylalanine is found at the narrowest region of the inner vestibule of the ion-
conduction pathway in the Kir6 and Kir3 subfamilies (Fig. 1A, also see Sackin et al., 
2005). These Kir channels have rather low basal channel activity. A hydrophobic residue 
with an intermediate size side group (Leucine, methionine) is also seen in other Kir 
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channels, most of which show high baseline Po. Based on the crystal structure of the 
KirBac1.1 and KcsA channels (Doyle et al., 1998; Kuo et al., 2003), the phenylalanine 
residue faces the pore with its side chain projecting into the ion pathway (Fig. 1B). 
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Fig. IV-1. A. Phe168 is located in the narrowest sector of the ion conductive pore.  Alignment of 
the Kir6.2 with other K+ channels in a region from the selectivity filter to the proximal C-
terminus. B. Phe168 is located in the narrowest sector of the inner pore when aligned with the 
KcsA sequence and viewed using RasMol modeling (Capener et al., 2000). 
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Kir6.2 Human   GFGGRMVTEECPLAILILIVQNIVGLMINAIMLGCIFMKTA-QAHRRAETL  
Kir6.2 Mouse   GFGGRMVTEECPLAILILIVQNIVGLMINAIMLGCIFMKTA-QAHRRAETL  
Kir6.1 Mouse   GFGGRMMTEECPLAITVLILQNIVGLIINAVMLGCIFMKTA-QAHRRAETL  
Kir3.4 Mouse   GYGFRVITEKCPEGIILLLVQAILGSIVNAFMVGCMFIKIS-QPKKRAETL  
Kir3.1 Mouse   GYGYR-YSDKCPEGIILFLFQSILGSIVDAFLIGCMFIKMS-QPKKRAESL  
Kir2.3 Human   GYGFRCVTEECPLAVIAVVVQSIVGCVIDSFMIGTIMAKMA-RPKKRAQTL  
Kir2.1 Rat     GYGFRCVTDECPIAVFMVVFQSIVGCIIDAFIIGAVMAKMA-KPKKRNETL  
Kir5.1 Rat     GYGYRCVTEECSVAVLTVILQSILSCIINTFIIGAALAKMA-TARKRAQTI  
Kir4.2 Mouse   GYGVRSITEECPHAIFLLVAQLVITTLIEIFITGTFLAKIA-RPKKRAETI  
Kir4.1 Mouse   GYGFRYISEECPLAIVLLIAQLVLTTILEIFITGTFLAKIA-RPKKRAETI  
Kir1.1 Mouse   GYGFRFVTEQCATAIFLLIFQSILGVIINSFMCGAILAKIS-RPKKRAKTI  
Kirbac1.1      GYGD--MHPQTVYAHAIATLEIFVGMSGIALSTGLVFARFA-RPRAK---I  
KcsA           GYGD--LYPVTLWGRLVAVVVMVAGITSFGLVTAALATWFVGREQERRGHF  
A Filter M2 Phe168 C-Terminus
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IVb-2.  ATP- and H+-dependent channel gating with different residue mass and  
 
hydrophobicity at position 168  
 
Site-specific mutations of the Phe168 to small amino acids (alanine, glycine or 
serine) allowed expression of functional inward rectifying currents. However, these 
mutations severely disrupted the channel gating by intracellular ATP. The mutant 
channels barely responded to 3mM ATP, whereas the wild-type Kir6.2∆C36 channel was 
strongly inhibited by micromolar concentrations of ATP (Figs. 2C-E, F). In contrast to 
these mutations, the ATP-dependent channel gating was well maintained when the 
Phe168 was mutated to a bulky tryptophan (Fig. 2A). The F168W mutant showed a 
similar ATP sensitivity as the wild-type channel (Figs. 2F, 3F), suggesting that a bulky 
amino acid is necessary for the ATP-dependent channel gating. Slightly smaller than 
phenylalanine, histidine is a hydrophilic amino acid with a bulky side chain. The F168H 
mutation produced a channel that was poorly gated by intracellular ATP (Fig. 2F), 
suggesting that the residue mass is not the only player in the Kir6.2 channel gating, and 
hydrophobicity is also important. Further supporting this idea was that mutant channels 
carrying a hydrophilic amino acid (i.e., glutamine, asparagine, glutamate) at residue 168 
were also poorly gated by ATP (Fig. 2F, Table 1). Mutations to other massive and 
hydrophilic residues (tyrosine, arginine) did not yield functional channels. A similar 
phenomenon was observed in the presence of the sulphonylurea receptor 1 subunit 
(SUR1). In the presence of SUR1 the 168 position showed a size dependent effect similar 
to the Kir6.2∆C36. The presence of the SUR1 increased the channel sensitivity to ATP 
without affecting the gating mechanism (Fig. 3, Table 1). 
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Fig. IV-2. ATP sensitivity of the Kir6.2 channel and its mutants. A. Currents were recorded from 
an inside-out patch obtained from a cell expressing the Kir6.2∆C36 F168W. With ramp potentials 
from –150 to 150mV applied to the patch membrane inward rectifying currents were recorded. 
Exposures to ATP produced a dose-dependent inhibition of these currents with the ATP 
concentration for 50% current inhibition (IC50) ~300µM. B. The Kir6.2∆C36 F168Q mutant was 
only modestly inhibited by 1mM ATP. Note that eight superimposed traces are shown in each 
panel. C-E. The F168S, F168A, and F168G mutants of Kir6.2∆C36 barely responded to 3mM 
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ATP. F. The dose-response curves were produced using the Hill equation (see Methods). All 
mutants were obtained from Kir6.2∆C36. Data are presented as means ± s.e with IC50 shown in 
Table 1.  
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Fig. IV-3. ATP sensitivity of Kir6.2 channel and its mutants expressed with SUR1. Currents were 
recorded from an inside-out patch obtained from a cell expressing the Kir6.2-F168W+SUR1. 
With ramp potentials from –150 to 150mV applied to the patch membrane inward rectifying 
currents were recorded. Exposures to ATP produced a dose-dependent inhibition of the currents 
with the ATP concentration for 50% current inhibition (IC50) ~10µM. The Kir6.2-F168G+SUR1 
mutant barely responded to 3mM ATP. The dose-response curves were produced using the Hill 
equation (see methods).  
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The same gating pattern was observed for the proton-dependent gating of the Kir6.2. The 
F168A and F168G mutations greatly diminished or completely eliminated the channel 
gating by pH (Fig. 4D-F). The pH sensitivity was well maintained when the Phe168 was 
mutated to a bulky tryptophan (Fig. 4B). Mutation to an AA with a medium side-chain 
(glutamine, asparagine) had an intermediate effect (Figs. 4C, F), while mutation to 
glutamate or histidine reversed the pH response (Table 1).  
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When the ATP and pH sensitivities were plotted against the residue mass, we 
found that the effect of ATP and pH on channel activity was a function of the residue 
mass (Fig. 4F). With a residue of 165 Daltons or larger, the channels were fully 
functional. They were strongly activated by protons and inhibited by ATP, whereas 
mutations to a residue smaller than glutamine (146 Daltons) disrupted the channel gating 
by both ATP and pH. The transition occurs between 146 and 165 Daltons (Fig. 4F), 
suggesting that residue mass at this location is critical for the Kir6.2 channel gating. 
To understand whether the hydrophobic nature of phenylalanine is adequate for 
the channel gating, we also studied mutant channels with several other nonpolar amino 
acids such as valine, leucine, isoleucine and methionine at residue 168. None of these 
mutants produced detectable K+ currents (Table 1).  
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Fig. IV-4. A. Activation of Kir6.2∆C36 by hypercapnic acidosis. Whole-cell currents were 
studied in an oocyte injected with the Kir6.2∆C36 3 days earlier. With 90mM K+ in the 
extracellular solution inward rectifying currents were recorded at baseline. The currents were 
reversibly activated with a 5min exposure to 15% CO2 that acidifies the cytosol to pH 6.6. B. 
Mutation of Phe168 to tryptophan resulted in current activation similar to the Kir6.2∆C36. C. The 
channel was moderately activated when the Phe168 was mutated to glutamine. D,E. Mutation to 
alanine or glycine yielded channels that were insensitivity to CO2. F. The effects of ATP and CO2 
on single-channel and whole-cell currents were plotted against the residue mass (Kyte and 
Doolittle, 1982) at the Phe168 location. A marked reduction in the pH and ATP sensitivities 
occurred with residues smaller than glutamine (146 Daltons). In contrast, the channels showed 
fair ATP and pH sensitivities with residue mass greater than 165 Daltons. When both plots 
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combined, the critical mass of this residue is shown to be >155 Daltons for the full ATP and pH 
sensitivities. Note that the channel response to acidic pH is inversely plotted.  IC50= 
concentration for 50% inhibition.  I= current.  The open triangle represents the IC50 and the 
closed circles represent the % current change with CO2. G. The relationship of baseline Po 
with residue mass. The Po remained low no matter what AA the Phe168 was substituted with 
(open triangle). In higher magnification (solid triangle), the baseline Po was significantly higher 
with small residues than with large ones with the transition between 145-165 Daltons. H. The 
open-time constant (τo) and the long period of closed-time constant (τc3) obtained by fitting the 
dwell-time histogram as illustrated in Fig. 4 show a clear residue-mass dependence. Note that for 
comparison purpose, the open time was fitted with a single exponential for all channels. I. Similar 
mass-dependence was observed with the mean open time (MTo) and mean closed time (MTc). 
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IVb-3. Effects of residue mass and hydrophobicity on the single channel properties 
Consistent with previous reports (Tucker et al., 1997; Wu et al., 2002), single-
channel Kir6.2∆C36 currents showed short periods of openings with low baseline Po (Fig. 
5, Table 2). The F168W-mutant channel showed similar single-channel activity with 
moderate bursting activity (Fig. 7). It is worth noting that the F168W channel did not 
show rapid rundown. With a small residue at this position, the F168G channel had much 
longer openings and closures than the Kir6.2∆C36 (Figs. 5, 8), leading to a marked 
decrease in the closure-opening frequency. These mutant channels ran down rather fast in 
contrast to the F168W, especially when the patches were exposed to acidic pH that 
causes rundown in wild-type Kir6.2 as well, though to a lesser degree (Xu et al., 2001; 
Wu et al., 2002).  
 Although the baseline Po of all mutant channels remained low (Table 1), 
significant differences in the baseline Po was observed between large and small residues. 
The baseline Po of the F168G was almost twice as high as the Kir6.2∆C36 (P<0.01), 
despite the fact that its rapid rundown may have led to an under-estimation of the Po 
value. When the residue mass was plotted against Po, a clear transition of Po levels was 
also seen at the residue mass of 146-165 Daltons (Fig. 4G). We also examined the 
channel open- and closed-time properties and when plotted, the residue-mass dependence 
was observed in these open and closed time properties with a transition at 146-165 
Daltons (Fig. 4H, I).  
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Fig. IV-5. Single-channel analysis of the open and closed times of the Kir6.2∆C36 and its 
representative mutants. A-D. The Kir6.2∆C36 and F168W show brief openings and closures, 
while the openings and closures are much longer in F168G and F168Q. Labels on the right 
indicate the opening (o) and closure levels (c). 
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IVb-4. Mutations at position 168 in Kir6.2 also affect single-channel kinetics  
Channel open-time and closed-time properties were studied on the F168W, 
F168Q and F168G mutants that represent residues of different size and hydrophobicity 
(Figs. 7, 8, 9). The open time constant (τo) and the mean open time (MTo) of the F168W 
were comparable to those of Kir6.2∆C36 (Table 2, Table 4), although its bursting activity 
caused a reduction in long periods of closures leading to a modest decrease in the closed-
time constants (τc) and the mean closed time (TMc) (Table 2). The F168G and F168Q 
channels all showed much longer openings and closures (Table 2). They also had longer 
τo and τc as well as longer MTo and MTc (Table 2, Table 4). Thus the mutant channels 
without a bulky and hydrophobic residue at the 168 position tend to stay in long periods 
of openings and closures (Fig. 5C, D), strongly suggesting that the Phe168 is not only 
involved in blocking the ion pathway by its bulky side-group, but also facilitates the 
transition between channel openings and closures.  
Like Kir6.2∆C36 (Fig. 6), the F168W channel was fairly sensitive to ATP. The 
inhibition by ATP was produced by selective augmentation of the long closures with little 
or no effect on the openings (Fig. 7D, E). This led to an increase in the MTc with little 
effect on the MTo (Table 2). The F168G mutant was unaffected by ATP up to 3mM ATP. 
As a result, there were no evident changes in its single-channel kinetics with 1mM ATP 
(Fig. 8, Table 4). The F168Q was modestly inhibited by ATP. Such a small effect was 
also mediated by changes in the closed time constants (Fig. 9). Taken together, these 
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results suggest that the mechanism for ATP inhibition remains similar in the F168W and 
F168Q mutants although the magnitude of the inhibition is different.  
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Fig. IV-6. Single-channel kinetics analysis of Kir6.2ΔC36 channel. Data were obtained from an 
inside-out patch with each histogram constructed using >1min recording. A. Single-channel 
current recorded from the patch was studied with different levels of ATP. Channel activity (Po, 
shown on the right) decreased in the presence of 100μM ATP (lower trace). Labels on the left 
indicate the opening (o) and closure levels (c). The total number of events (TE) used to compute 
the histogram is also in the caption. B,C. Baseline open-time and closed-time histograms at pH 
7.4 in the absence of ATP. B. The open-time histogram was fitted with one exponential with τo = 
0.7 ms. C. The closed time was fitted with two exponentials with τc1 = 0.3 ms and τc2 = 28.8 ms. 
D, E. In the presence of 100μM ATP (pH 7.4), a third closure event appeared and was very long. 
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The time constant for the second closure was slightly changed, but the third closure was 
prolonged (τc2 = 33.7 ms, τc3 = 110.9 ms), while the other time constants were barely affected.  
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Fig. IV-7. Single-channel kinetics analysis of F168W. Data were obtained from an inside-out 
patch with each histogram constructed using two stretches of 20 s recording in B, C, F and G and 
one stretch in D and E. A. Single-channel current recorded from the patch was studied with 
different levels of ATP. Channel activity (Po, shown on the right) decreased in the presence of 
100μM ATP (lower trace). Labels on the left indicate the opening (o) and closure levels (c). The 
total number of events (TE) used to compute the histogram is also in the caption. B, C. Baseline 
open and closed time histograms at pH 7.4 in the absence of ATP. B. The open time histogram 
was fitted with one exponential with τo = 1.0 ms. C. The closed time was fitted with two 
exponentials with  τc1 = 0.8 ms and τc2 = 13.1 ms. D, E. In the presence of 100μM ATP (pH 
7.4), time constants for the second closure changed a little and a third closures became apparent 
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and was prolonged (τc2 = 15.4 ms, τc3 = 60.3 ms), while the other time constants were barely 
affected.  
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Fig. IV-8. Single-channel kinetics analysis of F168G. Data were obtained from an inside-out 
patch with each histogram constructed using ≥1min recordings. A. Single-channel current 
recorded from the patch was studied with different levels of ATP. Channel activity (Po, shown on 
the right) decreased in the presence of 1mM ATP (lower trace). Labels on the left indicate the 
opening (o) and closure levels (c). The total number of events (TE) used to compute the 
histogram is also in the caption. B,C. Baseline open and closed time histograms at pH 7.4 in the 
absence of ATP. B. The open time histogram was fitted with one exponential with τo1 = 5.14 ms. 
C. The closed time was fitted with three exponentials with τc1 = 0.6 ms, τc2 = 9.6 ms, τc3 = 
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437.9 ms. D, E. ATP (1mM, pH 7.4) had no effect on the time constants (τc1 = 0.5 ms, τc2 = 7.9 
ms,  τc3 = 407.9 ms). 
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Fig. IV-9. Single-channel kinetics analysis of F168Q. Data were obtained from an inside-out 
patch with each histogram constructed using ≥1min recordings. A. Single-channel current 
recorded from the patch was studied with different levels of ATP. Channel activity (Po, shown on 
the right) decreased in the presence of 1mM ATP (lower trace). Labels on the left indicate the 
opening (o) and closure levels (c). The total number of events (TE) used to compute the 
histogram is also in the caption. B,C. Baseline open and closed time histograms at pH 7.4 in the 
absence of ATP. B. The open time histogram was fitted with one exponential with τo1 = 6.6 ms. 
C. The closed time was fitted with three exponentials with τc1 = 0.2 ms, τc2 = 3.0 ms, τc3 = 
563.6 ms. D, E. In the presence of 1mM ATP (pH 7.4), time constants for the second and third 
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closures were slightly prolonged (τc1 = 0.2 ms, τc2 = 5.0 ms, τc3 = 640.0 ms), while the other 
time constants were barely affected.  
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IVb-5. Kinetics modeling  
 The rate constant kinetics was determined for the Kir6.2∆C36 in the basal 
condition as well as in the presence of ATP (Colquhoun & Hawkes, 1995; Trapp et al., 
1998). We adopted a simple kinetic scheme used previously for the KATP channel (Trapp 
et al., 1998). In an ATP-free condition, the Kir6.2∆C36 channel has a single O with C1, 
and C2. The C1 is the short-lived closed state that can be seen in bursts of openings, and 
C2 is the long-lived closed state that determines the duration between bursts. During 
baseline levels the Kir6.2∆C36 channel exhibits bursting that is reflective in the rate time 
kinetics (Table 1). This channel tends to have alternating fast and slow kinetics between 
open and closed states. The scheme is supported by the rate constant kinetics calculated 
based on the equations described in the methods section. The kinetic model suggests that 
the Kir6.2∆C36 channel spends very little time in either the closed or open states. The 
transitions between the states are very rapid. During channel opening there is a fast 
transition to the short-lived closed state. In the absence of ATP the kinetics favor a very 
fast transition from the short-lived closure to the open state and also a very fast transition 
from the open state to the long-lived closed state. This explains why in the basal 
condition this channel exhibits bursting or flickering activity. When ATP is present, a 
second long-lived closed state (C3) appears in the Kir6.2∆C36 (Scheme 1). The kinetics 
favors a very fast transition towards C3 in the presence of ATP as indicated by the bold 
arrow. As a result the C2 is shortened by ATP. Therefore, ATP inhibits the channel by 
extending the long-lived closed state.  
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To determine whether the Phe168 is critical for this gating transition, we 
calculated the rate constant kinetics for the F168G mutant that causes severe disruption of 
channel gating, and compared them with the rate constant kinetics of the Kir6.2∆C36. 
The data for the F168G was fitted with the kinetic scheme 2. When the kinetics was 
entered into the scheme it supported the idea that the F168G mutation has an increased 
barrier of energy necessary for the gating transitions. The rate constant kinetics for this 
mutant favors the transition towards openings from both C1 and C2 allowing the channel 
to stay in the open state (Table 3). The transition from open to C1 is lessened as noted by 
the dashed arrow (Table 3). Furthermore, the kinetics also favors the transition from C2 
to C3 stabilizing at the long-lived close state (Table 3). Therefore, the F168G mutant 
unlike the Kir6.2∆C36 has long periods of closures followed by long periods of openings. 
This results in the slow transition between channel opening and closure, a completely 
opposite effect to the bursting activity seen in the Kir6.2∆C36.  
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IVc. DISCUSSION 
  
Our results have shown that a bulky and hydrophobic AA is required at residue 
168 for the Kir6.2 channel gating. With a small residue at this site, the mutant channels 
remain conducting inward rectifying K+ currents, but fail to be gated by ATP and 
protons. The requirement of a bulky residue on the ion-conduction pathway for channel 
gating therefore suggests a steric hindrance effect. In addition to the residue-mass 
dependence, hydrophobicity of residue 168 is important for the Kir6.2 channel gating. 
The size of the residue at position 168 cannot completely account for full channel gating. 
Various side chain characteristics may contribute to the gating properties. This is 
apparent in channels carrying charges at the 168 position such as F168E and F168H. 
These two channels show disrupted pH gating which may attribute to the charge carried 
by these amino acids. The Kir6.2 channel is well gated with a hydrophobic but not a 
hydrophilic residue. These results are consistent to what has been reported for the pH 
gating of Kir1.1 (Sackin et al., 2005). 
Based on crystal structures of the bacterial mechanosensitive MscL channel, 
nicotinic acetylcholine receptor and the KirBac1.1 channel, a hydrophobic residue is 
often found at the narrowest region of the ion-conduction pathways (Kuo et al., 2003; 
Sukharev et al., 2001; Unwin, 1995; Unwin, 2003), leading to the “hydrophobic gate” 
hypothesis: Gating of these channels involves movements of the pore-lining helices with 
the pore widened during channel opening, while constriction of these pore-lining helices 
during channel closure brings the nonpolar residues in each subunit of a multimeric 
channel in contact with each other, thereby sealing the ion-conduction pathway (Doyle, 
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2004). Our studies have evaluated this hypothesis by looking at functional consequences 
of different amino acid properties at residue 168. Our results have shown that a 
hydrophobic residue is necessary for the Kir6.2 channel gating. The channel gating is 
severely compromised when the Phe168 is mutated to a hydrophilic amino acid including 
histidine that has almost the same residue mass as phenylalanine. Thus, these results 
provide functional evidence supporting the hydrophobic gate hypothesis. 
 
Fig. IV-10. A. A structural representation of the residues in the lower TM2 domain. The Kir6.2 
was aligned with the KirBac1.1 and displayed based on the KirBac1.1 X-ray crystallographic 
structure [Kuo et al., 2003]. Shown are two of the channel subunits in a cis configuration. The 
Phe168 is labeled in black. Also labeled by color are other hydrophobic residues located in the 
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TM2 domain that may possibly interact with each other in the absence of the Phe168. B. When 
the Phe168 is aligned with the KscA model [Doyle et al., 1998], the Phe168 is located at the 
narrowest part of the ion-conduction pathway of the inner vestibule, and points its side chain 
toward the pore.  
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 Phenylalanine has an aromatic side group. According to the KirBac1.1 model 
(Kuo et al., 2003), the Phe168 faces the pore and may block the ion-conduction pathway 
by the bulky side group (Fig. 10). The involvement of such a phenylalanine residue in 
channel gating has been suggested in KirBac1.1 and GIRK channels. In the GIRK4 
channel, Phe187 is located at the narrowest part of the ion-conduction pathway. The 
channel gating requires flexibility of the TM2 helix above the Phe187, while introduction 
of flexibility at the helical turn below the Phe187 renders the TM2 helix unable to 
transduce the force exerted at its end by the channel-G-protein interaction and fails to 
produce functional channels (Jin et al., 2002). In the KirBac1.1 channel, a phenylalanine 
(Phe146) is identified at the corresponding site to the Phe187 in GIRK4 and Phe168 in 
Kir6.2. Side chains of the Phe146 have been shown to form structural obstacles in the 
ion-conduction pathway in the closed state (Kuo et al., 2003). Similarly, leucine residues 
at a homologous position on Kir1.1 occlude the permeation path of Kir1.1 in the closed 
state (Sackin et al., 2005).  According to the White-Wimley hydropathy scale (Wimley & 
White, 1996; White & Wimley, 1999), leucine is more hydrophobic than its counterpart 
isoleucine and valine, suggesting that this leucine residue in the Kir1.1 channel may act 
similarly as Phe168 in the Kir6.2 channel. 
 In Kir6.2, the baseline channel openings are maintained by the intrinsic 
conformation of the channel protein, phosphorylation and other KATP channel regulators 
such as phospholipids, ADP and protons (Baukrowitz et al., 1998; Light et al., 2000; Lin 
et al., 2000; Shyng & Nichols,1998; Wu et al., 2002; Xu et al., 2001). ATP binding to 
intracellular protein domains (Tanabe et al., 1999; Tsubo et al., 2004) may produce a 
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conformational change of the inner helices. When the phenylalanine from each subunit 
are close enough, they can interact with each other through hydrophobic forces and close 
the ion pathway (Fig. 10), as indicated in the KirBac1.1 crystallographic structure (Kuo et 
al., 2003). Substitution of this Phe168 residue with a smaller amino acid eliminates the 
gating ring, and disrupts the channel gating. The pore blockade may be removed during 
channel opening, as it is known that the inner helix bundle-crossing moves and the inner 
pore is widened with channel opening (Armstrong, 1966; Davies, 1990;  Flynn & 
Zagotta, 2001; Jiang et al., 2002; Johnson & Zagotta, 2001; Perozo et al., 1999; Phillips 
et al., 2003; Shin et al., 2001), suggesting that the Phe168 also acts on the channel gating 
by the steric hindrance effect.  
A kinetic model is helpful to understand how this phenylalanine can have this 
steric hindrance effect. We thus used the simplest kinetic scheme to explain our data for 
the Kir6.2∆C36 and the F168G mutant channels. In the basal condition, the Kir6.2∆C36 
channel contains two close states (C1, C2) and one open state (O). A third long-lived 
closed state appears when ATP is present in the solution. In contrast to the Kir6.2∆C36, 
the F168G mutant contains one open state and three closed states (C1, C2, C3) in the 
absence of ATP. The C1 and C2 are similar to those in the Kir6.2∆C36, while the C3 is a 
long-lived closed state independent of ATP. Kinetic analysis shows that the F168G 
mutant tends to be stabilized in the open and long-lived closed states. Under such a 
condition, higher free energy is needed to fulfill the gating transitions. This is consistent 
with the observation that this mutant channel is no longer sensitive to ATP concentrations 
that strongly inhibit the Kir6.2∆C36. The mere presence of a phenylalanine at position 
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168 in the Kir6.2∆C36 appears sufficient to lower the barrier of energy necessary for the 
gating transitions. In this respect, phenyalanine is likely to act as a facilitator of the 
channel gating. Thus, a bulky and hydrophobic residue like phenylalanine and tryptophan 
may block the ion-conduction pathway in the closed state and facilitate the closure-
opening transition in channel gating. Apparently this is a consequence of evolutionary 
optimization of protein function. This phenylalanine is not seen in several other Kir 
channels including Kir1.1, Kir2.1 and Kir4.1. Instead, a leucine or methionine is found in 
those channels. It is known that some of these hydrophobic residues with an intermediate 
side chain also serve as a gate as in the Kir1.1 channel (Sackin, 2005). Under such a 
condition, a reduced hydrophobicity of the pore-lining residues may be necessary for 
preventing pore collapse or channel rundown. 
IVd. SUMMARY AND CONCLUSION 
ATP-sensitive K+ (KATP) channels are gated by intracellular ATP, proton and 
phospholipids. The pore-forming Kir6.2 subunit has all essential machineries for channel 
gating by these ligands. It is known that channel gating involves the inner helix bundle of 
crossing in which a phenylalanine residue (Phe168) is found in the TM2 at the narrowest 
region of the ion-conduction pathway in the Kir6.2. Here we present evidence that 
Phe168-Kir6.2 functions as an ATP- and proton-activated gate via steric hindrance and 
hydrophobic interactions. Site-specific mutations of Phe168 to a small amino acid 
resulted in losses of the ATP- and proton-dependent gating, whereas the channel gating 
was well maintained after mutation to a bulky tryptophan, supporting the steric hindrance 
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effect. The steric hindrance effect, though necessary, was insufficient for the gating, as 
mutating Phe168 to a bulky hydrophilic residue severely compromised the channel 
gating. Single-channel kinetics of the F168W mutant resembled the wild-type channel. 
Small residues increased Popen, and displayed long-lasting closures and long-lasting 
openings. Kinetic modeling showed that these resulted from stabilization of the channel 
to open and long-lived closed states, suggesting that a bulky and hydrophobic residue 
may lower the energy barrier for the switch between channel openings and closures. 
Thus, it is likely that the Phe168 acts as not only a steric hindrance gate but also 
potentially a facilitator of gating transitions in the Kir6.2 channel. 
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Table IV-1. WT and mutant channels tested and their pH and ATP sensitivities 
 
  IC50 ATP % CO2 Effect Baseline Po MW Hydropathy1 Hydropathy2
F168G >9,000 (4) 4.5 ± 3.8 (8) 0.052 ± 0.004 (6) 75 −0.4 0.01 
F168A >9,000 (4) 6.7 ± 2.6 (9) 0.053 ± 0.004 (6) 89 1.8 0.17 
F168S 8,061 ± 1,254 (6) 11.9 ± 2.2 (7) 0.055 ± 0.003 (4) 105 −0.8 0.13 
F168V NF NF NF 117 4.2 0.07 
F168C NF NF NF 121 2.5 -0.24 
F168I NF NF NF 131 4.5 -0.31 
F168L NF NF NF 131 3.8 -0.56 
F168N 6,562 ± 797 (5) 15.8 ± 4.0 (5) 0.050 ± 0.005 (6) 132 -3.5 0.42 
F168Q 6,274 ± 656 (4) 23.1 ± 2.9 (10) 0.056 ± 0.006 (13) 146 −3.5 0.58 
F168K NF NF NF 146 −3.9 0.99 
F168E 5,989 ± 1,441 (6) −7.5 ± 4.6 (6) 0.036 ± 0.005 (4) 147 −3.5 2.02 
F168M NF NF NF 149 1.9 -0.23 
F168H 4,198 ± 375 (4) −24.6 ± 3.4 (6) 0.046 ± 0.005 (4) 155 −3.2 0.96 
Kir6.2ΔC36 109 ± 17 (14) 130.3 ± 12.2 (9) 0.029 ± 0.005 (7) 165 2.8 -1.13 
F168R NF  ± NF NF 174 −4.5 0.81 
F168Y NF NF NF 181 −1.3 -0.94 
F168W 195 ± 24 (6) 150 ± 16.6 (10) 0.039 ± 0.003 (13) 204 -0.9 -1.85 
*Kir6.2F168G >9,000 (6)  0.070 ± 0.004 (5)    
*Kir6.2+Sur1 7 ± 0.6 (11)  0.169 ± 0.014 (4)    
*Kir6.2F168W 13 ± 2.6 (5)  0.243 ± 0.016 (11)    
The ATP sensitivity was studied in excised patches and is expressed by fitting the data 
using the Hill equation. Hill coefficients are 1.0−1.2 (not shown). All mutants were created on 
Kir6.2ΔC36. Abbreviations: MW, molecular weight; NF, nonfunctional. Data are presented as 
means ± s.e with n (in the parentheses) = number of patches. Hydropathy was used to indicate 
whole-residue hydrophobicity according to the interface scale (Kyte & Doolittle, 1982; Wimley 
& White, 1996; White & Wimley, 1999). Hydropathy1 refers to the Kyte-Doolittle hydropathy 
scale and hydropathy2 refers to the White-Wimley scale. Asterisk indicates the channel expressed 
with SUR1. 
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Table IV-2. Single channel data of wild-type and representative mutant channels 
 
 F168G F168Q Kir6.2ΔC36 F168 F168W 
pH7.4, no ATP     
Po 0.049 ± 0.003 (17) 0.056 ± 0.007 (14) 0.029 ± 0.004 (7) 0.039 ± 0.004 (9) 
MTo 2.1 ± 0.1 ms (11) 2.3 ± 0.5 ms (14) 0.7 ± 0.1 ms (6) 0.6 ± 0.1 ms (9) 
MTc 48.4 ± 7.0 ms (11) 36.4 ± 3.6 ms (14) 18.1 ± 2.6 ms (6) 15.3 ± 1.3 ms (9) 
pH7.4, 100μM ATP     
Po − − 0.008 ± 0.002 (4) 0.021 ± 0.002 (4) 
MTo − − 0.8 ± 0.0 ms (4) 0.6 ± 0.0 ms (4) 
MTc − − 67.1 ± 4.3 ms (4) 22.4 ± 2.7 ms (5) 
pH7.4, 1mM ATP     
Po 0.047 ± 0.008 (7) 0.040 ± 0.007 (6) − − 
MTo 2.6 ± 0.3 ms (7) 2.7 ± 0.5 ms (6) − − 
MTc 60.2 ± 7.6 ms (7) 64.0 ± 7.5 ms (6) − − 
The open-state probability (Po), mean open time (MTo), and mean closed time (MTc) were studied 
in patches with a single active channel. Excised inside-out patches were exposed to 100μM ATP 
or 1mM ATP as dependent upon the IC50 of the mutant and compared to controls with no ATP. 
All mutants were based on the Kir6.2∆C36. Data are presented as means ± s.e. with n shown in 
parentheses and represents the number of patches. 
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Table IV-3. Rate constants used for kinetic modeling 
 
  Kir6.2ΔC36 Kir6.2ΔC36-F168G 
τo1 0.6 4.2
τc1 0.2 0.3
τc2 38.0 2.5
τc3 − 255.6
τc2' 27.4 −
τc3' 197.3 −
  
k1 720.2 162.1
k-1 4,545.4 4,000.0
k2 1,065.5 76.0
k-2 26.3 257.5
k3 − 138.5
k-3 − 3.9
k'3 102,230.0 −
k'-3 5.1 −
The average rate constants were calculated at -80mV. The τc2', τc3', k’3 and k’-3 were obtained in 
the presence of 100μM ATP.  
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Table IV-4. Open and closed time constants for wild-type and mutant channels 
 
 Kir6.2ΔC36 
Kir6.2ΔC36-
F168W 
Kir6.2ΔC36-
F168Q 
Kir6.2ΔC36-
F168G 
     
τo1 0.56±0.04 (5) 0.5±0.06 (5) 3.5±1.0 (5) 4.2±0.55 (4) 
τc1 0.22±0.02 (5) 0.3±0.0 (5) 0.3±0.1 (5) 0.3±0.03 (4) 
τc2 38.02±11.18 (5) 17.86±2.72 (5) 10±2.4 (5) 2.5±0.74 (4) 
τc3 - - 162.2±74.2 (5) 255.55±79.65 (4) 
     
     
∗τo1 0.68±0.066 (5) 0.95±0.1 (4) 4.0±0.7 (5) 4.2±0.6 (4) 
∗τc1 0.3±0.05 (5) 0.65±0.06 (4) 0.4±0.0 (5) 0.3±0 (4) 
∗τc2 27.38±12.83 (5) 14.13±2.76 (4) 13.8±2.1 (5) 2.9±0.8 (4) 
∗τc3 197.26±84.55 (5) 94.53±25.16 (4) 240.5±64.4 (5) 254.9±78.7 (4) 
The open time constant (τo1) and the closed time constants (τc1, τc2, τc3) were studied in 
patches with a single active channel. Excised inside-out patches were exposed to 100μM ATP or 
1mM ATP as dependent upon the IC50 of the mutant and compared to controls with no ATP. All 
mutants were based on the Kir6.2∆C36. Data are presented as means ± s.e. with n shown in 
parentheses and represents the number of patches. Asterisk represent data obtained in the 
presence of ATP. 
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K. GENERAL DISCUSSION 
 
K-1. Central CO2 chemoreception 
 
The process by which the body senses CO2 is finely tuned, covering a wide range 
of CO2 changes.  The basal level of CO2 in the body is ~5% CO2.  This is a partial 
pressure of CO2 (pCO2) ~ 38 mmHg.  In humans the range of pCO2 detected is from 38 
mmHg to ~80 mmHg.  pCO2 levels above 80 mmHg is considered a patho-physiological 
condition that rapidly results in the stoppage of breathing.  Even with such a broad range 
of pCO2 levels being detected the central CO2 chemoreception system remains highly 
sensitive to changes in CO2.  A change in pCO2 as low as 1 mmHg results in a significant 
change in ventilation (Nattie, 1999; Putnam et al., 2004).  This minute change in the 
partial pressure of CO2 results in only a minuscule change in blood pH (~0.001%).  This 
creates a paradox that is:  how can the CO2 sensing mechanism in the brainstem maintain 
such a high sensitivity to CO2 and at the same time cover a wide range of changes in the 
pCO2?  Researchers have been trying to address this question for many years.    
K-2. Neuromodulation and central chemoreception 
 
 In some cases instead of changing the frequency of action potentials, 
neurotransmitters may change the pattern of the firing.  For example, neurons that are 
normally tonic bursters may become phasic burster following the neurotransmitter 
binding and vice versa.  The response of the neuron to these neurotransmitters depends 
on several factors such as the receptor subtype, the intracellular cascades activated, 
receptor number, target molecule number and distribution, as well as the amount of 
neurotransmitter released.  Some neurotransmitters such as serotonin have many receptor 
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subtypes.  These different receptors although share a commonality in binding serotonin 
may all lead to the activation of different intracellular cascades and molecules leading to 
different neuromodulations.  In this way it becomes extremely important in identifying 
which receptor subtype is present in these chemosensitive neurons and what intracellular 
cascades are activated following ligand binding.  With such specificity the 
neuromodulation may be confined to a specific cell type.  In this way neuromodulation 
may affect the cellular response to CO2 that may also explain how the CO2 signal may be 
amplified leading to a highly sensitive detection system.  In this thesis I have performed 
experiments to test the hypothesis that blockade of synaptic transmission results in a 
lower sensitivity to CO2 in cultured brainstem neurons.  Brainstem neurons were 
dissociated and cultured on MEA dishes.  The response to CO2 was determined for 
individual units.  Following the blockade of synaptic transmission by the application of 
specific neurotransmitter blockers to the bath solution the CO2 sensitivity of identified 
units were determined to be lower than that prior to the application of the 
neurotransmitter blocker.  I was able to demonstrate that blockade of synaptic 
transmission involving substance P, serotonin, and glutamate resulted in a lower response 
to acidification, suggesting that cultured brainstem neurons have adopted synaptic 
transmission as a means of amplifying the response to changes in CO2. 
The high pH sensitivity of the Kir4.1-Kir5.1 channel in the physiological range 
suggests that this channel may be a good candidate CO2 chemoreceptor molecule.  To 
strengthen the candidacy of this channel as a chemoreceptor molecule we found it 
necessary to demonstrate how the neurotransmitters and CO2 affect the channel activity.  
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We hypothesized that the neurotransmitters and CO2 inhibits the channel activity via 
different mechanisms.  Therefore, we performed experiments to test this hypothesis.  We 
found that although both CO2 and the neurotransmitters (SP, 5-HT, and TRH) can inhibit 
the channel, the inhibition appeared to be though different and independent mechanisms.  
This is an important finding as this suggests that both modulators combined may have a 
greater effect on the channel than either modulator alone.  This potentially implies that 
the presence of the neurotransmitters may increase the channel’s sensitivity to CO2.  This 
is significant as we know that the have to be amplification of the signal during central 
CO2 chemoreception (discussed earlier).  This potentially may be one mechanism for 
amplifying the signal the signal in central CO2 chemoreception. 
K-3. Inward rectifier potassium channels as chemoreceptor molecules 
 
A previous study performed by Wu et al., in 2004 demonstrated the presence of 
mRNA for both Kir4.1 and Kir5.1 in the same brainstem chemosensitive neurons.  This 
study used in situ hybridization to identify mRNA of Kir4.1 and Kir5.1 in CO2 
chemosensitive sites.  Although mRNA for the Kir4.1 and Kir5.1 positively identified in 
the same chemosensitive brainstem neurons suggested that the heteromeric Kir4.1-Kir5.1 
is expressed, the weakness of this study is that mRNA is only suggestive.  The presence 
of mRNA is not indicative of the protein expression.  The presence of mRNA does not 
necessarily confer that the Kir4.1 and Kir5.1 proteins are present.  Therefore, in this 
dissertation I wanted to solidify the expression of the heteromeric Kir4.1-Kir.1 channel in 
chemosensitive brainstem neurons.  It was very imperative that we demonstrate 
expression of the Kir4.1 and Kir5.1 proteins in neurons as both Kir4.1 and Kir5.1 
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subunits are suggested to express only in glial cells where they function in potassium 
recycling.  Although we agree that the Kir4.1 and Kir5.1 subunits are expressed in glial 
cells we also believe that they are expressed in neurons as well where they may form the 
heteromeric Kir4.1-Kir5.1 channel that would have a different function than potassium 
recycling.  Using DAB immunocytochemistry and immunofluorescence I have presented 
evidence in this thesis for the expression of the Kir4.1-Kir5.1 channel in chemosensitive 
neurons.  This neuronal expression suggests that this channel may have a different 
function than potassium recycling in neurons compared to the homomeric counterparts 
expressed in glial cells.  In addition to demonstrating neuronal expression I also have 
demonstrated expression of the Kir4.1-Kir5.1 channel in chemosensitive neurons.  I 
showed that the channel is expressed in primary sensory neurons such as LC neurons as 
well as in chemosensitive motor neurons such as the hypoglossal motor neurons.  The 
demonstration of the presence of this Kir4.1-Kir5.1 channel in these chemosensitive 
brainstem nuclei strengthens the candidacy of this channel as a central CO2 
chemoreceptor molecule. 
In this thesis I have also demonstrated another important regulation of the Kir4.1-
Kir5.1 channel critical for central chemoreception that is the modulation by 
neurotransmitters critical for respiratory control.  Recall that one of the requirements of a 
central CO2 chemoreceptor molecule is that it should be subject to modulation by 
neurotransmitters critical for respiratory control.  The neurotransmitters 5-HT, SP, and 
TRH are all critical for respiratory control.  Therefore, I hypothesized that the Kir4.1-
Kir5.1 channel is regulated by these neurotransmitters as the immunocytochemistry 
 
 
186 
 
experiments show co-expression of the Kir4.1-Kir5.1 channel with the NK1R.  Xenopus 
laevis oocytes co-expressing the natural receptors for these neurotransmitters and the 
Kir4.1-Kir5.1 channel were exposed to the neurotransmitters.  Bath application of all 
three neurotransmitters inhibited Kir4.1-Kir5.1 currents and reduced the channel activity.  
The effects of the neurotransmitters were dose dependent and specific.  More 
importantly, the effects of the neurotransmitters required co-expression of the Kir5.1 as 
the homomeric Kir4.1 channel expressed with the neurotransmitters failed to be regulated 
by the neurotransmitters.  This important finding may prove to be a useful tool for future 
experiments with the heteromeric channel in vivo.  The activation of PKC has been 
demonstrated to underscore the inhibition of G-protein gated inward rectifier potassium 
channels (GIRK) by SP (Mao et al., 2004).  Therefore we wanted to know whether 
protein kinase C was involved in the inhibition of the Kir4.1-Kir5.1 by the 
neurotransmitters 5-HT, SP, and TRH.  Indeed, similar to GIRK channels we showed that 
PKC activation was involved in the inhibition of the channel by the neurotransmitters. 
Since the channel modulation by neurotransmitters depended upon protein kinase 
C activation, we hypothesized that the Kir4.1-Kir5.1 channel may be phosphorylated by 
PKC.  Indeed, several other Kir channels have been shown to be phosphorylated by PKC 
and PKC phosphorylation sites have been identified (Fakler et al., 1994; Henry et al., 
1996; Light et al., 2000; Lin et al., 2000; Mao et al., 2004; Stevens et al., 1999; Vorobiov 
et al., 1998; Zhang et al., 2004; Zhu et al., 1999; Zitron et al., 2004).  Both the Kir4.1 and 
Kir5.1 channels were screened to identify potential PKC phosphorylation sites.  Both 
subunits contained numerous putative PKC phosphorylation sites in the C-termini, 
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suggesting that PKC may phosphorylate the Kir4.1-Kir5.1 channel at residues in the C-
termini.  In this thesis I showed that Kir4.1-Kir5.1 is inhibited by PKC activation and that 
PKC could directly phosphorylate the C-termini of both Kir4.1 and Kir5.1.  
Unfortunately, I was unable to identify the PKC phosphorylation site(s) as I think that the 
channel contains multiple phosphorylation sites.  In this way, single mutation of potential 
phosphorylation sites may not lead to an identification of the phosphorylation site.  
Indeed, the biochemistry experiments demonstrated that both Kir4.1 and Kir5.1 C-termini 
can be directly phosphorylated by PKC which supports the idea that the heteromeric 
interaction introduces additional potential phosphorylation sites.  Although the Kir4.1 C-
terminus was shown to contain phosphorylation sites that could be phosphorylated 
directly by PKC the Kir4.1 channel expressed in xenopus oocytes failed to be regulated 
by PKC activation suggesting that the presence of Kir5.1 allows for the regulation by 
PKC.  This is another regulatory function displayed by the Kir4.1-Kir5.1 channel that is 
absent in the Kir4.1 homomeric channel.  This may be proven to be a useful tool for 
characterizing the heteromeric channel function in the future. 
K-4. Kir channel gating 
 
   Ligand modulated ion channels have four properties that are:  ion selectivity;  
ion permeation, ligand binding, and gating.  Of all these properties channel gating is the 
least understood.  Gating refers to the opening and closure of ion channels.  Ion channels 
can adopt at least two conformations; an open conformation and a closed conformation.  
This suggests that ion channels can switch between these two conformations at any 
giving time (gating).  In ligand modulated channels, ligand binding results in a change in 
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the channel gating mechanism. With the discovery that CO2 and the neurotransmitters 
affect the Kir4.1-Kir5.1 channel via different mechanisms, I then tried to identify the 
exact mechanism for the channel inhibition by these modulators.  I hypothesized that Kir 
channels have common gate that can be modulated by CO2.  Since the protonation site in 
the Kir4.1-Kir5.1 channel has not been clearly identified I decided to examine the gating 
mechanism by CO2 using the Kir6.2+SUR1 channel.  The Kir6.2+SUR1 channels have 
several advantages over the Kir4.1-Kir5.1 channel for studying gating.  The 
Kir6.2+SUR1 channel’s CO2 sensitivity have been well documented.  This channel in 
addition to being pH sensitive is also ATP sensitive.  And the channel has clearly 
demonstrated ligand binding sites as well as gating sites.   
 I noticed that in the Kir6.2+SUR1 there was only one bulky hydrophobic residue 
in the TMD2 domain (Phenylalanine 168).  Therefore, I hypothesized that the bulky 
hydrophobic phenylalanine 168 in the Kir6.2 was involved in channel gating by exposing 
its bulky side chain to block the channel pore.  I tested this hypothesis using site directed 
mutagenesis and found that Phe168 acts as a gate in the Kir6.2+SUR1 channel.  I found 
that Phe168 not only hinders ion flow, but also facilitates it.  How can one residue hinder 
and facilitate ion flow?  During basal conditions the bulky side chain of Phe168 clogs the 
channel pore and hinders the flow of ions though the ion conducting pathway.  Upon 
ligand binding the TMD2 undergoes elaborate conformational changes that results in the 
moving away of the bulky phenylalanine side chain from the pore.  I showed that when 
the 168 position is mutated to small amino acids the mutant channels tend to lose their 
sensitivity to ATP and pH.  Single channel analysis demonstrated that this is a result of 
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the channels staying in long periods of openings and closures with more closures than 
openings.  However, the presence of a bulky hydrophobic residue at the 168 position 
allows the channels to gate more readily.  I demonstrated that the presence of 
phenylalanine 168 lowers the energy barrier necessary for the transition from open to 
close; thus being a facilitator of channel gating.  I found that both ATP and proton 
binding regulated the channel gating at this position, suggesting that the gate is shared by 
multiple ligands.  This is the first demonstration of a functional gate in the Kir6.2+SUR1 
channel.    As mentioned before, all Kir channels have a bulky hydrophobic residue 
located around the narrowest region of the ion conductive pathway.  It now becomes 
necessary to demonstrate the importance of this gate during ligand modulation in other 
Kir channels.  For the Kir6.2+SUR1 and the Kir4.1-Kir5.1 channel, the demonstration of 
a functional pH modulation gate is critical for understand the role these channels may 
play in central CO2 chemoreception. 
 The Kir6.2+SUR1 channel is a strong chemoreceptor molecule.  We now know 
that this channel is expressed in brainstem inspiratory neurons, the channel is sensitive to 
pH within a physiological range, it can change the membrane excitability of neurons, and 
it is gated by protons.  The presence of the Kir6.2+SUR1 channel in inspiratory neurons 
suggests that the channel functions in these cells (Haller et al., 2001).  Since the 
Kir6.2+SUR1 channel is stimulated by intracellular acidification, then channel may be 
involved in the inhibition of these expiratory neurons during acidosis that is necessary.  
The activation of this potassium channel would lead to release of potassium to the 
extracellular space resulting in hyper polarization of these expiratory neurons.  This 
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hyper polarization would inhibit these neurons leading to a decrease in their firing 
frequency and thus a decrease in their information relay to the respiratory muscles.  This 
is important physiologically as we know that the brain contains inspiratory and expiratory 
neurons.  During inspiration the respiratory neurons are inhibited where as during 
expiration the inspiratory neurons are inhibited.  Therefore, during inspiration activation 
the Kir6.2+SUR1 channel is a mechanism that can potentially lead to the inhibition of 
expiratory neurons.  Recordings from brainstem expiratory neurons containing the 
Kir6.2+SUR1 channels demonstrating the importance of this channel in these neurons 
now becomes necessary for solidifying the role of this channel in central CO2 
chemoreception. 
 The Kir4.1-Kir5.1 is also a strong central CO2 chemoreceptor candidate molecule.  
We now know that this channel is expressed in the brainstem, it has high pH sensitivity 
within the physiological range, it can detect both alkaline and acidic pH levels, it can 
change the cellular excitability, it is subject to neuromodulation by neurotransmitters 
critical for respiratory control, it is gated by protons.  Similar to the Kir6.2+SUR1 the 
presence of the Kir4.1-Kir5.1 channel in chemosensitive brainstem neurons suggest that 
the channel may play an important role in these cells.  The Kir4.1-Kir5.1 channel unlike 
the Kir6.2+SUR1 is inhibited by intracellular acidosis.  The heteromeric Kir4.1-Kir5.1 
channel unlike the Kir6.2+SUR1 channel is inhibited by intracellular acidification.  As 
discussed earlier the inhibition appears to occur via protonation of lysine residues.  Since 
the Kir4.1-Kir5.1 channel is inhibited by intracellular acidosis its role in primary sensory 
chemosensitive neurons may be to augment the firing activity of these neurons.  The 
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inhibition of the Kir4.1-Kir5.1 channel by CO2 would result in the cease of flow of 
potassium out of the neurons resulting in the depolarization of the neurons.  
Depolarization would lead to an increase in the firing frequency of these brainstem 
neurons that would be relayed to the respiratory muscle leading to an increase in 
ventilation.  In addition to being inhibited by CO2 the Kir4.1-Kir5.1 channel may also be 
inhibited by neurotransmitters critical for respiratory control thereby increasing the CO2 
stimulus and the response during the relay to the respiratory muscles.  The demonstration 
of the modulation of the Kir4.1-Kir5.1 channel by neurotransmitters critical for 
respiratory control is important physiologically as this suggests that the channel may play 
in role in the control of respiration.  This also suggests that the Kir4.1-Kir5.1 channel has 
an additional function that the homomeric channels do not have. 
 The two channels studied and discussed in this dissertation are just two of the 
potential chemoreceptor candidates.  There are other candidates that were not studied as 
they are weak candidates failing to satisfy the requirements for a central CO2 
chemoreceptor molecule.  For many years researchers have searched for the central CO2 
chemoreceptor molecule.  What we are proposing in this dissertation is that there may be 
multiple CO2 chemoreceptor molecules.  This idea can explain how central CO2 
chemoreception can maintain a high sensitivity while spanning a broad range of changes 
in pCO2.  The potential CO2 receptor molecules may all be able to detect CO2/pH in 
different levels such that collectively they would allow for the detection of a broad range 
of changes in pCO2.  Indeed, this is what is found for temperature sensing in the body.  
Transient receptor potential channels are non selective cation channels.  This channel 
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super family contains many members that detect temperatures at different levels in such a 
way that together they span a broad range of temperatures from cold to hot.  We propose 
that CO2 sensing has adopted a similar mechanism for detecting such a broad range of 
pCO2.  In this way both the heteromeric Kir4.1-Kir5.1 and the Kir6.2+SUR1 proposed in 
the beginning of this dissertation may be central CO2 chemoreceptor molecules. 
 
 
193 
 
 
L. GENERAL CONCLUSION 
 
 The experiments performed in this dissertation using heterologous expression 
systems demonstrate the modulation of Kir channels.  The results shown here strengthen 
the candidacy of these channels as central CO2 chemoreceptors.   In addition to the 
findings of other researchers my studies demonstrate the ligand regulation of Kir 
channels.  I have presented additional evidence for the expression of the Kir4.1-Kir5.1 
channel in the brainstem, modulation of the channel by neurotransmitters critical for 
respiratory control and CO2, identification of the molecular mechanism underlying this 
modulation, as well as identifying a functional pH regulated gate in the Kir6.2+SUR1 
channel that appears to be shared by other Kir channels.  These properties are critical to 
the function of these channels as central CO2 chemoreceptor molecules that can couple 
CO2 sensing to cellular excitability and thus an appropriate response by the respiratory 
system.  Therefore, the information obtained and presented in this dissertation about the 
molecular mechanisms underlying the regulation of Kir channels by neurotransmitters 
and CO2 constitutes a significant step towards the understanding of the role that may be 
played by these channel as CO2 sensing molecules, and may have an impact on the 
understanding of respiratory control diseases and on the formation of therapeutic 
modalities by the manipulation of these channels. 
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